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ABSTRACT
vii
In the last few decades, much research has been undertaken to characterize the
antimicrobial and preservative qualities of many bacteriocins produced by lactic acid
bacteria (LAB). In addition to nisin and pediocin PA-1/AcH, which have gained wide
commercial use as natural food biopreservatives, many other bacteriocins offer
promising perspectives in terms of preservation and shelf-life extension of food
products. Chapter I reviews the studies detailing the characterization and bio-
preservative applications of five bacteriocins, namely lacticin 3147, enterocin AS-48,
lacticin 481, variacin, and sakacin P, which have proved to be very effective and
should find commercial application in food preservation in the near future.
A transcriptomic approach was used to gain insights into the global molecular
response of Lactococcus lactis IL1403 at the early stages of infection with the lytic
phage c2. The phage presence is sensed as a membrane stress in L. lactis IL1403,
which activated a targeted response probably orchestrated by membrane Phage Shock
Protein C-like homologues, the global regulator SpxB and the two-component system
CesSR. The bacterium upregulated genes (ddl and dltABCD) responsible for
incorporation of D-alanine esters into LTAs, an event associated with increased
resistance to phage attack in gram-positive bacteria. The expression of genes (yshC,
citE, citF) affecting both PMF components was also regulated, probably to restore the
physiological PMF that was disrupted following phage infection. While mobilizing
the response to the phage-mediated stress, the bacterium activated an energy-saving
programme by repressing growth-related functions and switching to anaerobic
fermentation, probably to sustain the PMF and the overall cell response to phage.
An intriguing abundance and diversity of plasmids was found in 17 natural
lactococcal isolates from raw milk cheeses, which prompted the sequencing of the 8-
plasmid complement of L. lactis subsp. cremoris DPC3758. The complete sequences
of pAF22 (22,388 bp), pAF14 (14,419 bp), pAF12 (12,067 bp), pAF07 (7,435 bp)
and pAF04 (3,801 bp) were obtained, whereas gene functions of technological
interest were mapped to pAF65 (65 kb) and pAF45 (45 kb) by PCR. These plasmids
encode many phenotypes with the potential to improve the technological properties of
dairy starters, including three anti-phage restriction/modification (R/M) systems,
immunity/resistance to nisin, lacticin 481, cadmium and copper, as well as six
conjugative/mobilization functions. By using cadmium selection and conjugative
matings, the R/M plasmids were sequentially stacked into a plasmid-free lactococcal
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host, thus generating a food-grade derivative with increased protection against 936-
and c2-type phages.
The four plasmid-complement of the raw milk cheese isolate L. lactis subsp.
lactis biovar. diacetylactis DPC3901 was sequenced and some genetic features
functionally analyzed. The complete sequences of pVF18 (18,977 bp), pVF21
(21,739 bp) and pVF22 (22,166 bp) were obtained whereas 49 of the predicted 50 kb
of pVF50 were assembled in three contigs. Each plasmid contains genes novel to
Lactococcus and typical of bacteria associated with plants, in addition to genes
associated with plant-derived lactococcal strains. Among the novel phenotypes are
activities of plant cell wall modification and a predicted high-affinity regulated
system for cobalt uptake, which is functional as demonstrated following plasmid
curing. Additional metal transporters could enhance host ability to uptake growth-
limiting amounts of biologically essential ions within the soil. In addition, vast and
high homology is shared with the plant-derived pGdh442, which includes phenotypes
so far exclusive to this plasmid in Lactococcus. This wealth of plasmid-encoded
plant-associated markers suggests a plant origin for L. lactis DPC3901 and provides
for the first time the genetic basis to support the concept of the plant-milk transition
for Lactococcus strains.
The impact of carrying the 60.2-kb plasmid pMRC01, encoding for an abortive
infection bacteriophage resistance system and production of the antimicrobial lacticin
3147, on the metabolism and performance of five lactococcal starters was
investigated by comparing growth, acidification and viability rates of parental and
transconjugant strains. The burden imposed by pMRC01 on host metabolism results
in lower specific growth rates and increased cell permeability and autolysis, as
revealed by flow cytometry following live/dead™ staining and measurement of
released levels of lactate dehydrogenase. The magnitude of these effects appears to be
strain dependent but not related to the production of lacticin 3147. Presence of
pMRC01 does not significantly affect the acidification capacity of the starters, which
implies that plasmid-improved derivatives of starter cultures can be efficiently used in
dairy industry. Also, strains prone to early lysis are often utilized as component of
dairy starters due to their ability to accelerate cheese ripening and flavour
development.
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Microarrays were used to analyze changes in pMRC01 gene expression at an early
(15 min) and late (30 min) stage of infection with the lytic phage c2 in order to detect
the putative activation of the abortive infection (Abi) system of pMRC01. Results
suggest that the functioning of the Abi system could be subjected to a complex
regulatory control by the bivalent Rgg-like ORF51 and CopG-like ORF58 proteins.
These regulators are likely to modulate the activity of the putative Abi effectors,
which might be the constitutive proteins ORF50 and ORF49 exhibiting topology and
functional similarities to the two-component Rex system that aborts phage λ lytic 
growth via membrane depolarization. Similarly to RexA, the membrane-anchored
ORF50 might use its protein kinase-like activity to cause a conformational change in
the putative channel protein RexB-like ORF49, thereby triggering channel opening
and consequent membrane depolarization. ORF58 and ORF51 might control,
individually or as a network, the activity of ORF50.
Chapter I
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1. ABSTRACT
In the last few decades, much research has been undertaken to characterize the
antimicrobial and preservative qualities of many bacteriocins produced by lactic acid
bacteria (LAB). To date, only nisin and pediocin PA-1/AcH have gained wide
commercial use as natural food biopreservatives. However, many other bacteriocins
also offer promising perspectives in terms of preservation and shelf-life extension of
food products. Some of them exhibit narrow-spectrum activity and therefore may be
used in applications requiring the selective inhibition of certain food pathogens (i.e.,
Listeria monocytogenes) without affecting the natural beneficial microflora. Others
with broad-spectrum activity potentially present wider uses. Additionally, when used
in combination with selected hurdles (physico-chemical treatments, antimicrobial
agents or peptides), these bacteriocins have proved a highly effective form of
preservation and should find commercial application as food preservatives in the near
future.
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2. INTRODUCTION
Many microrganisms, including lactic acid bacteria (LAB), produce the
ribosomally-synthesized peptides known as bacteriocins. These peptides are
considered to be natural preservatives and their potential application in the food
industry has attracted the interest of both researchers and consumers, in search of
foods which are minimally processed, naturally preserved and richer in organoleptic
and nutritional properties. Among LAB bacteriocins, only nisin and pediocin PA-
1/AcH are extensively used commercially and use of their powder preparations for
food preservation is now largely established. However, other bacteriocins have
recently emerged that also hold great potential for biopreservation and shelf-life
extension. Some of them exhibit narrow-spectrum activity and therefore may be used
in applications requiring the selective inhibition of certain food pathogens (i.e.,
Listeria monocytogenes) without affecting the natural beneficial microflora. Others
with broad-spectrum activity potentially present wider uses (Galvez et al., 2007,
Galvez et al., 2008, Ross et al., 1999, Ross et al., 2000). This chapter will review the
studies detailing the characterization and biopreservative applications of five of the
most promising bacteriocins: lacticin 3147, enterocin AS-48, lacticin 481, variacin,
and sakacin P.
3. The potential of lacticin 3147 for food biopreservation
3.1 History, isolation and generally recognized as safe (GRAS) status of the
producing strain
Lacticin 3147 is a plasmid-encoded bacteriocin produced by Lactococcus lactis
subsp. lactis DPC3147, a strain isolated from an Irish Kefir grain during a screening
of natural sources for food-grade producers of antimicrobial compounds (Rea and
Cogan, 1994). Other lacticin 3147 producers have been successively isolated such as
the strain L. lactis IFPL105 (Martinez-Cuesta et al., 2000). These, and other
lactococci, are considered GRAS organisms, since they have been isolated from
natural food sources, and, more importantly, because lactococci from dairy products
have a long history of safe use and consumption by humans (Casalta and Montel,
2008).
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3.2 Characterization, structure and genetics
Lacticin 3147 is a heat-stable proteinaceous compound produced during the
exponential phase of bacterial growth (Ryan et al., 1996). FPLC purification of the
bacteriocin from the supernatant of L. lactis DPC3147 showed that lacticin 3147 is
composed of two peptides (LtnA1 and LtnA2) whose synergistic activity is required
for full antimicrobial activity (McAuliffe et al., 1998). LtnA1 is a 30-amino acid
peptide with a mass of 3,306 Da, whereas LtnA2 is a 29-amino acid peptide with a
mass of 2,847 Da. They are encoded as precursor peptides of 59 (LtnA1) and 64
(LtnA2) amino-acids that are subsequently processed to form the biologically active
peptides. Maturation of LtnA1 and LtnA2 involves a series of complex post-
translational modifications, which includes serine to D-alanine conversion,
dehydration of serines and threonines, lanthionine bridge formation, and leader
peptide cleavage (Morgan et al., 2005, Ryan et al., 1999). Lacticin 3147 is therefore
classified as a member of Class I lantibiotics (“lanthionine-containing antibiotic”), a
unique group of small (< 5 kDa) bacteriocins containing the unusual thioether amino-
acids lanthionine (Lan) and -methyllanthionine (MeLan), which form characteristic
intramolecular rings, in addition to a number of dehydrated amino-acids (McAuliffe
et al., 2001b). Both lacticin 3147 peptides contain Lan residues (Ryan et al., 1999),
but a study of their three-dimensional structures by Nuclear Magnetic Resonance
(NMR) revealed that the Lan bridging pattern of LtnA1 closely resembles that of the
globular type-B lantibiotic mersacidin, whereas LtnA2 has a more elongated structure
similar to type-A lantibiotics (Figure 1a) (Martin et al., 2004). Both peptides also
contain D-alanine residues that derive from conversion of L-serine in a two-step
reaction having dehydroalanine (Dha) as intermediate (Ryan et al., 1999). It has been
demonstrated that this post-translational conversion is vital for optimal production
and activity of the lantibiotic lacticin 3147 (Cotter et al., 2005). LtnA1 was found to
exhibit independent inhibitory activity (MIC50 = 200 nM), which was greatly
enhanced by the presence of LtnA2, whereas LtnA2 on its own possessed no activity
(Morgan et al., 2005).
The genetic determinants for lacticin 3147 production and immunity are encoded
on a 60.2 kb conjugative plasmid, pMRC01, the sequence of which has been fully
determined (GenBank accession n. AE001272) (Dougherty et al., 1998). Biosynthesis
and immunity to lacticin 3147 is encoded by ten genes organized in two divergently
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transcribed operons, ltnRIFE and ltnA1A2M1TM2J (Figure 1b), stretching over 12.6 kb
(Dougherty et al., 1998, McAuliffe et al., 2000a). The larger operon, ltnA1A2M1TM2J,
is responsible for bacteriocin production, modification and export. The ltnA1 and
ltnA2 genes encode the precursors that will be processed to give rise to the mature
LtnA1 and LtnA2 peptides (Ryan et al., 1999). The products of ltnM1 and ltnM2 act
as modification enzymes by catalysing the dehydration and thioether-forming
reactions, which result in Lan bridge formation. Mutagenesis experiments, where the
genes were individually inactivated by frameshift mutations, demonstrated that both
modification enzymes are necessary for lacticin 3147 activity, with LtnM1 being
required to produce mature LtnA1, and LtnM2 required to produce mature LtnA2
(McAuliffe et al., 2000a). LtnT encodes a putative ABC-transporter implicated in the
secretion of lacticin 3147 (Dougherty et al., 1998); it also contains a proteolytic
domain which is probably involved in the cleavage of the leader peptides during
export (Ryan et al., 1999). Finally, ltnJ encodes a protein sharing significant
homology to zinc-containing alcohol dehydrogenases and shown to be responsible for
the conversion of Dha to D-alanine (Cotter et al., 2005).
Lacticin 3147 immunity is regulated by the second operon, ltnRIFE, divergently
located upstream of the biosynthesis operon. LtnE and ltnF encode proteins with
significant sequence homologies to multicomponent ABC transporters involved in
immunity to staphylococcal and lactococcal lantibiotics; this supported the initial idea
that they might play a similar role in lacticin 3147 too (Dougherty et al., 1998).
Surprisingly, deletion analysis excluded their involvement in bacteriocin immunity,
and indicated instead the product of ltnI as the sole protein responsible for conferring
the host with protection to lacticin 3147 (McAuliffe et al., 2000b). Finally, ltnR
encodes a 79-residue protein sharing homology with a number of transcriptional
repressors of the PBSX (Xre) family that are known to auto-regulate their own
production. Interesting observations were made on studying the regulation of lacticin
3147 biosynthesis and immunity. While the promoter controlling lacticin 3147
biosynthesis appears to be constitutive, a stem loop structure within the ltnM1 gene
acts as a rho-independent attenuator that controls the level of transcription of
downstream genes in order to maintain the correct stoichiometry between the
structural peptides and the biosynthetic machinery (McAuliffe et al., 2001a). The
authors also demonstrated that LtnR regulates producer immunity to lacticin 3147 by
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binding to a region that overlaps the promoter of the ltnRIFE operon and thus
repressing its own transcription and that of the downstream immunity genes, ltnIFE.
3.3 Spectrum of inhibition and mode of action
The inhibitory spectrum of lacticin 3147 was defined using a panel of 54
indicator strains chosen from a number of gram-positive and gram-negative genera.
On agar plate assays, a very broad spectrum of inhibition was observed, closely
resembling that of nisin. All gram-positive bacteria tested were inhibited, including
the pathogens Listeria, Clostridium, Staphylococcus and Streptococcus species.
Moreover, a number of gram-positive strains which exhibited reduced sensitivity to
lacticin 3147 in agar plate assays, such as methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant Enterococcus faecalis (VRE), penicillin-resistant
Pneumococcus (PRP), Propionibacterium acne and Streptococcus mutans, were
found to be efficiently killed in broth (Galvin et al., 1999). No activity was detected
against gram-negative bacteria (Ryan et al., 1996).
The mode of action of lacticin 3147 has been the subject of extensive studies
leading to the first detailed analysis of the synergistic activity of a two-peptide
bacteriocin at the molecular level (Martin et al., 2004, McAuliffe et al., 1998,
Morgan et al., 2005, Wiedemann et al., 2006). In a three-step model proposed by
Wiedemann et al. (2006) (Figure 1c), the membrane-bound cell wall precursor, lipid
II, is used as a docking molecule for the formation of defined and stable pores. LtnA1
first binds to lipid II and this binding induces a conformational change in LtnA1
which unveils a previously inaccessible binding site for LtnA2. Thus, the LtnA1:lipid
II complex is able to recruit LtnA2 . Interaction of LtnA2 with LtnA1:lipid II results
in a stable three-component complex with high-affinity for the membrane that allows
LtnA2 to insert deeper into the membrane assuming a trans-bi-layer conformation and
consequently forming a defined pore. According to these authors, the affinity of
LtnA1 for lipid II is low and strongly increases after addition of LtnA2. The
synergistic action of LtnA1 and LtnA2 is therefore essential for stabilizing the
interaction with the target membrane and to provide lacticin 3147 with dual mode of
action: pore formation and inhibition of cell wall biosynthesis by sequestration of the
precursor. By using planar bi-layer model membranes supplemented with lipid II, the
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same authors observed that lacticin 3147 was able to form defined pores of a diameter
of 0.6 nm. McAuliffe et al. (1998) found these small pores to be selective for
potassium ions and inorganic phosphate but not for larger compounds such as amino-
acids and ATP; the leakage of ions from sensitive cells is accompanied by a change in
electrical charge across the membrane that causes immediate and selective dissipation
of the membrane potential (ΔΨ). In a futile attempt to recover these ions by use of 
ATP-dependent uptake systems, the cells rapidly consume the available internal ATP
leading to the eventual collapse of the pH gradient (ΔpH) and, ultimately, to cell
death.
3.4 Applications
The ability of lacticin 3147 to inhibit a wide range of food pathogens prompted a
series of studies to evaluate its preservative potential in a variety of food systems,
either in the form of ex-situ produced bacteriocin or of in-situ production by
bacteriocinogenic strains. Preparation of a bioactive powdered ingredient containing
lacticin 3147 was optimised by growing L. lactis DPC3147 in 10% reconstituted
demineralized whey powder at a constant pH of 6.5 and spray-drying conditions that
maintained optimal bacteriocin activity (10,240 AU/ml). Initial results with this
powder were promising, as the lacticin 3147-enriched powder was able to reduce
numbers of L. monocytogenes ScottA and Staphylococcus aureus (Morgan et al.,
1999). This led to further investigations in more complex food systems. Addition of
10% lacticin 3147 powder to natural yogurt resulted in a 98% reduction of L.
monocytogenes Scott A (104 cfu/ml) within 5 min at 30°C, and no viable cells were
detected after 60 min. When the same challenging parameters were tested in cottage
cheese, viable cells of Listeria were reduced by 40% within 5 min and by 85% within
120 min at 30°C. Even greater efficacy was observed in powdered soup contaminated
with Bacillus cereus (105 cfu/ml); a 5% bacteriocin powder was sufficient to
completely eliminate the pathogen within 1 h, whereas a 1% preparation reduced the
bacilli population by 80% within 3 h (Morgan et al., 2001). In minced pork-meat,
addition of 1.5% powdered lacticin 3147 decreased the population of Listeria innocua
by 50% (Soriano et al., 2004). Moreover, the efficacy of lacticin 3147 powder can be
increased in combination with selected hurdles. A doubling in bacteriocin activity
was observed following treatment of lacticin 3147 preparations with high hydrostatic
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pressure (HHP) greater than 400 MPa. The combined use of lacticin 3147
concentrates (1-log reduction) and 250 MPa HHP (2.2-logs reduction) demonstrated
greater than an additive effect (6 logs reduction) against S. aureus ATCC6538 and L.
innocua DPC1770 in milk and whey (Morgan et al., 2000). Addition of organic acids
(sodium citrate or sodium lactate) also enhanced the activity of lacticin 3147 against
food-borne pathogens (Salmonella kentucky and Clostridium perfringens) and
spoilage bacteria in fresh pork sausage (Scannell et al., 2000b).
In-situ production by bacteriocinogenic strains represents another means of
exploiting the preservative qualities of bacteriocins via incorporation of bacteriocin-
producing cultures into foods. This approach harbours several advantages over the
addition of concentrated bacteriocin preparations as it lowers the cost of the
biopreservation process and, unlike bacteriocin concentrates which may be
considered as additives, no regulatory barrier exists since the bacteriocin is not added
to the food but produced during its manufacture (Galvez et al., 2007, Ross et al.,
1999). Lacticin 3147-producing cultures are very promising for such applications.
The presence of the lacticin 3147 genetic machinery on a conjugative plasmid
(pMRC01) has allowed the creation of a vast and heterogeneous array of commercial
starter cultures with improved technological features, namely bacteriocin production
and phage resistance, by using a food-grade approach. These specialised starters
retained acidification properties sufficient for use in Cheddar cheese manufacture, can
generate significant levels of bacteriocin throughout the cheese ripening process, and
have proved to be very effective in increasing the safety of fermented dairy foods
(Coakley et al., 1997, Ross et al., 1999, Ryan et al., 1996). As protective cultures on
the surface of mould-ripened (Ross et al., 2000) and smear-ripened cheeses
(O'Sullivan et al., 2006), lacticin 3147-producing cultures were capable of controlling
deliberately inoculated L. monocytogenes Scott A. In both cases, spraying the lacticin
3147 producer on the cheese surface resulted in a 1000-fold reduction of the initial
pathogen counts (104 cfu/ml). In cottage cheese produced with a lacticin 3147-
producing transconjugant (L. lactis DPC4275), a 3-log reduction in counts of L.
monocytogenes Scott A (104 cfu/g cheese) was observed after 5 days of storage at 4º
C (McAuliffe et al., 1999). In this case, the protective effect was most likely to be
associated with residual lacticin seeded into the cheese as the starter does not survive
the heating step in cottage cheese manufacture. L. lactis DPC4275 was also found to
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significantly reduce the levels of L. innocua and S. aureus in beaker sausage(Scannell
et al., 2001), in addition to performing satisfactorily as a single starter for
manufacture of salami (Coffey et al., 1998) and fermented sausage (Scannell et al.,
2001). In a further step to obtain more stable and long-term production of lacticin
3147 in such systems, L. lactis DPC3147 was efficiently immobilised on double-
layered calcium alginate beads. Results showed that bacteriocin production from the
immobilised cells remained constant for 180 h, compared to production by free cells
which had declined after 80 h (Scannell et al., 2000a). This technique may improve
the protective efficacy of lacticin 3147 on food surfaces as the immobilizing
substrates act as reservoirs in which bacteriocin molecules are protected from
inactivation by food components (Galvez et al., 2007).
It is interesting to note that lacticin 3147-producing starters have been also
shown to contribute to enhanced cheese quality and aroma while protecting its safety.
Cheddar cheese manufactured with L. lactis DPC4275 was shown to contain 100-fold
less adventitious nonstarter lactic acid bacteria than control cheese after 6 months of
ripening, while maintaining unaltered physicochemical and organoleptic qualities
(Fenelon et al., 1999, Ryan et al., 1996, Ryan et al., 2001). In addition, lacticin 3147-
producing starters were found to be more susceptible to permeabilization and
autolysis (Fallico et al., 2009) and this has been shown to be associated with
improved cheese flavour due to increased proteolysis and enhanced amino-acid
transamination and α-keto acids formation (Martinez-Cuesta et al., 2002, Martinez-
Cuesta et al., 1998, Martinez-Cuesta et al., 2006).
4. The potential of enterocin AS-48 for food biopreservation
4.1 History, isolation and GRAS status of the producing strain
Enterocin AS-48 (AS-48) is a plasmid-encoded bacteriocin whose activity was
first recognized in Enterococcus faecalis subsp. liquefaciens S-48, a strain isolated
during a screening for the production of bacteriocin-like substances by enterococci
(Galvez et al., 1986). A PCR-based study showed that the ability to produce peptides
identical or similar to AS-48 is very widespread among enterococci (Joosten et al.,
1997). Though some of these variants have been designated differently, e.g. AS-48RJ
(Abriouel et al., 2005), enterococcin EFS2 (Maisnier-Patin et al., 1996), enterocin 4
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(Joosten et al., 1996), and bacteriocin 21 (Tomita et al., 1997), they all share
significant homology, if not identity, with AS-48 at the genetic and/or structural level
(Maqueda et al., 1998). However, none of the producing strains concerned have been
accorded GRAS status, as enterococci are organisms considered at the crossroads of
food safety. They have been ascribed beneficial roles such as producing antilisterial
bacteriocins, contributing to ripening and flavour development in some artisanal
cheeses, and as probiotics to improve the microbial balance of the intestine and for
treating gastroenteritis in humans and animals. However, in contrast to this, there is
serious concern about the safety of enterococci as a result of their implication in
outbreaks of food-borne illness and their recognised role in bacteraemia, endocarditis,
and urinary tract infections (Franz et al., 1999).
4.2 Characterization, structure and genetics
AS-48 is a proteinaceous substance that is extremely thermo-stable (Cobos et al.,
2001, Cobos et al., 2002). It is active at temperatures of up to 80 ºC or below freezing
throughout pH values ranging from 3 to 8 (Maqueda et al., 2004). Optimal production
of AS-48 may be obtained by growing the producer strain at 37 ºC in a complex
medium broth supplemented with brain-heart infusion, glucose and magnesium
sulphate (Galvez et al., 1986). A simple two-step procedure, consisting of cation
exchange followed by reversed phase chromatography, guarantees a recovery of up to
9 mg of highly purified bacteriocin AS-48 directly from a pH-controlled 25-liter
culture broth (Abriouel et al., 2003, Galvez et al., 1989a). AS-48 is a 70-amino acid
peptide with a mass of 7,149.17 Da and represents the very first example of a cyclic
bacteriocin to be described in literature, with the cyclic structure originating from a
post-translational “tail-to-head” peptide bond formation (Samyn et al., 1994). AS-48
is a strongly basic peptide (pI close to 10.5) and lacks any cysteine or modified
residues, such as Lan or MeLan. AS-48 has been therefore included in the class IId of
thermostable non-lantibiotics circular bacteriocins (Nes et al., 2002). NMR
determination of the 3-D structure of AS-48 in aqueous solution showed a globular
arrangement of five -helices (1 to 5) enclosing a compact hydrophobic core
(Figure 2a). AS-48 may adopt two different dimeric forms in crystals. The molecules
in dimeric form I (DF-I) interact through the hydrophobic helices 1 and 2,
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suggesting a DF-I for the peptide when in solution. In contrast, dimeric form II (DF-
II) involves the interaction of the hydrophilic helices 4 and 5, with the
hydrophobic moiety buried within the membrane and the hydrophilic moiety exposed
to the solvent. AS-48 may adoptthe DF-II structure when inserts itself into the
membrane (Sanchez-Barrena et al., 2003).
The genetic determinants for AS-48 biosynthesis and immunity were first
detected on the 68-kb conjugative and pheromone-responsive plasmid pMB2 carried
by E. faecalis S-48 (Martinez-Bueno et al., 1990). The gene cluster of AS-48 extends
over 10.4 kb of sequence and is composed of ten genes, transcribed in the same
direction and organized in two operons, as-48ABCC1DD1 and as-48EFGH (Figure
2b). The bacteriocin structural gene, as-48A, encodes a precursor peptide of 105
amino-acids (Martinez-Bueno et al., 1994) whose 70 C-terminal residues coincide
with the mature AS-48 peptide (Samyn et al., 1994). The gene products of as-48B,
as-48C1 and as-48D are thought to form a putative multicomponent system able to
carry out the simultaneous maturation (involving removal of the leader peptide and
head-to-tail cyclization) and secretion of AS-48. As-48D1 encodes a small cationic
hydrophobic peptide and studies of functional analysis demonstrated that it confers
some degree of bacteriocin resistance to the producer (Martinez-Bueno et al., 1998).
However, appropriate levels of resistance against AS-48 are reached only when the
expression of the as-48D1 immunity gene is combined with that of the as-48EFGH
operon, which has been proposed to encode a multi-component ABC system: As-48G
would be the ATP-binding domain, As-48E and As48-H the trans-membrane
subunits, and As-48F an accessory proteins. This second transporter would be mainly
responsible for higher levels of producer self-protection against AS-48, whereas the
As-48D1 immunity protein would operate as a second resistance mechanism (Diaz et
al., 2003).
4.3 Spectrum of inhibition and mode of action
The inhibitory spectrum of AS-48 is remarkably broad, being highly active
against most of gram-positive and some gram-negative bacteria tested (Galvez et al.,
1989b). A low concentration (3 and 4 g/ml) of AS-48 exerted a rapid bactericidal
activity followed by gradual bacteriolysis against all species of Bacillus,
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Streptococcus and Enterococcus tested, and in most Corynebacterium strains. In
contrast, 10g AS-48 /ml induced no bacteriolytic effect in Mycobacterium phlei, M.
smegmatis and Nocardia corallina, although these acid-fast actinomycetes were
among the most sensitive gram-positive bacteria, and the same occurred in
Micrococcus and Staphylococcus species. Clostridium species were also strongly
inhibited by AS-48 (Maqueda et al., 2004), but L. monocytogenes emerged as the
most sensitive bacterium, with a minimum inhibitory concentration (MIC) of 0.1
g/ml at 37 ºC (Mendoza et al., 1999). AS-48 also inhibits some gram-negative
species, but at much higher concentrations. These include Myxococcus strains,
Rhizobium, E. coli, Agrobacterium, Salmonella, Shigella, Pseudomonas and
Klebsiella. Finally, no effect of AS-48 was detected against the eukaryotic organisms
Saccharomyces cerevisiae, Naegleria fowleri and Acanthamoeba, even at
concentrations as high as 100 g/ml (Galvez et al., 1989b), nor against HeLa and
MCDK cell lines nor erythrocytes (Maqueda et al., 2004).
On the basis of the two dimeric forms found during the crystallographic study
(Sanchez-Barrena et al., 2003), a mechanism for the molecular action of AS-48 has
been proposed that does not depend upon membrane potential, but implies an
effective insertion into the membrane consequent to a structural reorganization of a
hydrosoluble dimeric form of AS-48 at the membrane surface (Figure 2c). The strong
dipolar moment of DF-I in solution is suggested to drive the approach of AS-48 to the
membrane. The low pH provided by the membrane interface would destabilise DF-I
due to the protonation of the glutamic side chains. This process would, in turn, allow
the interaction between the carboxylate side chains and the phospholipid polar heads,
and the stabilisation of the hydrophobic moiety of AS-48 via the interaction with the
phospholipid aliphatic chains. The transition from the water soluble DF-I to the
membrane bound DF-II would allow molecules of AS-48 to insert itself into the
bacterial membrane via an accumulation of positive charges at the membrane surface
that would destabilise the membrane potential leading to pore formation and cell
leakage (Maqueda et al., 2004).
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4.4 Applications
Enterocin AS-48 has significant potential as a biopreservative in a large variety
of food systems, although its efficacy is noticeably decreased in the food environment
compared with laboratory media. This has been attributed to the interaction of AS-48
molecules with food components which may result in a higher retention, or slower
diffusion, or irregular distribution of the bacteriocin molecules in the food (Galvez et
al., 2008, Munoz et al., 2007).
Ex-situ application of a semi-purified preparation of AS-48 (40g/g) was shown
to reduce viable counts of S. aureus by 5 logs in a meat sausage model system
(Ananou et al., 2005c). In the same food system, a concentration of 225 AU AS-48 /g
reduced L. monocytogenes counts below the detection level at 3 days of incubation,
but did not prevent listeria re-growth after 9 days. Increasing the AS-48 concentration
to 450 AU/g resulted in complete kill of listeria over the same incubation time
(Ananou et al., 2005b). In yogurt-type soy-based desserts and in gelatin pudding, AS-
48 proved more effective against L. monocytogenes with bacteriocin concentrations
of 87.5 AU/g sufficient to reduce viable counts below detection levels and avoid
regrowth of survivors, whereas a two-fold amount of AS-48 (175 AU/g) reduced
viable counts of S. aureus by only 1.8 log units (Martinez-Viedma et al., 2009). AS-
48 also proved effective in decontaminating raw and processed vegetables and
avoiding listeria proliferation during storage. Application of immersion treatments (5
min at room temperature) with AS-48 solutions (25g/ml) reduced L. monocytogenes
counts by 2.0 to 2.4 logs in sprouts. During storage of vegetable samples treated with
immersion solutions of 12.5 and 25 g of AS-48/ml, listeria counts were reduced
below detection limits in sprouts and green asparagus over 7 days at 15 °C (Molinos
et al., 2005). Addition of 30–60 g/g AS-48 in Russian-type salad significantly
reduced L. monocytogenes counts during 1-week storage at 10 °C (Molinos et al.,
2009a), whereas, in lettuce juice, AS-48 caused strong inhibition of S. aureus and
complete inactivation of L. monocytogenes and B. cereus (Grande et al., 2005b). In
tomato paste supplemented with 6g AS-48/ml and stored at different temperatures,
vegetative cells of Bacillus coagulans were reduced by 2.4 (4 ºC), 4.3 (22 ºC) and 3.0
(37 ºC) logs within 24 h storage, and no viable cells were detected in any sample after
15-days storage. AS-48 was also very active against the same pathogen in juice from
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canned pineapple stored at 22 ºC, and slightly less active in syrup from canned
peaches (Lucas et al., 2006). In apple juice and in commercial apple ciders, 3μg/ml
AS-48 completely inhibited rope-forming B. licheniformis as well as
exopolysaccharide- and acrolein-producing LAB (Grande et al., 2006a, Martinez-
Viedma et al., 2008a), whereas vegetative cells of Alicyclobacillus acidoterrestris
were inactivated by 2.5 μg/ml AS-48 in several types of fruit juices for up to 3
months (Grande et al., 2005a). Interestingly, AS-48 completely eliminated vegetative
cells of B. cereus in boiled rice, in a rice gruel, and in a rice-based infant formula
dissolved in whole milk where it also prevented the pathogen re-growth for at least 15
days at 37 ºC (Grande et al., 2006b). In gelatin and soy pudding, AS-48 (175 AU/g)
reduced viable cell counts of B. cereus below detection levels after 8 h at 10 ºC or
after 48 h at 22 ºC (Martinez-Viedma et al., 2009).
When used in combination with other antimicrobial hurdles, AS-48 showed
increased bactericidal activity or the ability to enhance the efficacy of the selected
hurdle. In skimmed milk, a moderate heat treatment (65 ºC for 5 min) and 20g AS-
48/ml eliminated staphylococci after 6 h of incubation (Munoz et al., 2007). Sub-
lethally heat-injured cells of E. coli O157:H7 were inhibited significantly by AS-48 in
apple juice, providing a means to lower the intensity of juice processing treatments
(Ananou et al., 2005a). AS-48 also significantly increased the heat sensitivity of B.
licheniformis and B. coagulans spores in cider reducing the time for complete
inactivation of intact spores (Grande et al., 2006a, Lucas et al., 2006). In Russian-
type salad, the antilisterial activity of AS-48 (30 g/g) was strongly enhanced by
essential oils, and slightly less in combination with bioactive components from
essential oils and plant extracts, with other natural or synthetic antimicrobials
(Molinos et al., 2009a). In the same food matrix, AS-48 (30 g/g) acted
synergistically with lactic acid, PHBME and Nisaplin™ in reducing below the
detection limit for 7 days a Salmonella enterica cocktail of strains (Molinos et al.,
2009b).
Food biopreservation via application of bacteriocinogenic strains producing AS-
48 in situ has been tested in dairy and meat systems with satisfactory results. In
Taleggio cheese, the activity of AS-48, produced by strain E. faecium 7C5 during
cheese manufacture, remained stable for at least 40 days (Giraffa et al., 1995). In a
non-fat hard cheese, E. faecalis A-48-32 strain produced enough AS-48 to inhibit B.
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cereus and reduce the cell count of bacilli by 5.6 logs after 30 days of ripening
(Munoz et al., 2004), while inhibition of S. aureus proved less effective (Munoz et
al., 2007). Noticeably, growth of starter cultures used in cheese making was not
affected by the bacteriocin-producing strain. In Manchego and Hispano cheeses,
growth of L. monocytogenes was successfully controlled by enterocin 4, a bacteriocin
produced by strain E. faecalis INIA 4 and analogue to AS-48 (Nunez et al., 1997). In
skimmed milk, AS-48 released by E. faecalis A-48-32 effectively inhibited B. cereus
(Munoz et al., 2004) and S. aureus (Munoz et al., 2007) provided that a population of
at least 106 enterococci was used as inoculum. A 107 cfu/g inoculum of AS-48-
producing strains proved also effective in controlling growth of L. monocytogenes
(Ananou et al., 2005b) and S. aureus (Ananou et al., 2005c) in a meat sausage model
system. The antimicrobial efficacy of in situ produced AS-48 is also enhanced by
combination with other hurdles. In apple juice, high-intensity pulsed-electric field
(HIPEF) treatment was shown to enhance bactericidal effect of enterocin AS-48
against S. enterica (Martinez-Viedma et al., 2008b). In raw-milk cheese, the
combination of 300 MPa HHP and AS-48-producing adjunct strain was extremely
effective in tackling E. coli O157:H7, with results varying according to the time of
treatment application (Rodriguez et al., 2005).
5. The potential of lacticin 481 for food biopreservation
5.1 History, isolation and GRAS status of the producing strain
Lacticin 481 is a narrow-spectrum lantibiotic bacteriocin produced by strains of
L. lactis (O'Sullivan et al., 2002a, Piard et al., 1990). Also named lactococcin
(Dufour et al., 1991) and lactococcin DR (Rince et al., 1994) in some early reports,
the bacteriocin was first isolated from L. lactis subsp. lactis CNRZ 481 during a
screening for bacteriocin producers (Piard et al., 1990). Considering the GRAS status
of L. lactis strains, lacticin 481 may be regarded as food-grade and therefore the use
of ex situ or in situ produced lacticin 481 for food preservation do not pose any
legislative issues.
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5.2 Characterization, structure and genetics
Optimal purification of lacticin 481 from broth culture was obtained by
sequential ammonium sulfate precipitation, gel filtration chromatography, and
reversed-phase HPLC leading to a 107,506-fold increase in its specific activity. A
preliminary amino-acid analysis of purified lacticin 481 revealed its lantibiotic nature
(Piard et al., 1992), while a combination of sequencing of the structural gene, amino-
acid analysis, and bidimensional NMR spectroscopy determined the complete amino-
acid sequence and the positions of Lan residues (Piard et al., 1993, van den Hooven et
al., 1996). Lacticin 481 has a molecular mass of 2,901 Da and is ribosomally
synthesized as a prepropeptide containing an N-terminal leader peptide of 24 residues
followed by a 27-residue C-terminal propeptide (Figure 3). The mature lacticin 481
contains the unusual amino-acid dehydrobutyrine, two Lan and one MeLan residues.
Overlapping thioether bridges in the molecule result in a globular structure at the C-
terminal end, whereas the N-terminal part remains linear. As a result of this
conformation, lacticin 481 cannot be strictly defined as a Type A (linear peptides) or
a Type B (globular peptides) lantibiotic, though the C-terminal bicyclic ring structure
makes lacticin 481 more similar to the globular Type B peptides. A lacticin 481
subgroup was therefore proposed which also includes other structurally distinct
lantibiotics such as streptococcin A-FF22, salivaricin A and variacin (Dufour et al.,
2007, Sahl and Bierbaum, 1998).
The genetic determinants for biosynthesis and immunity to lacticin 481 are
encoded on a 70-kb plasmid and are organized as an operon, lctAMTFEG, flanked by
two insertion sequence elements to form a putative transposon (Dufour et al., 2000,
Dufour et al., 1991). The first three genes, lctA, lctM, and lctT, are involved in the
bacteriocin biosynthesis and export (Rince et al., 1994). LctA is the lacticin 481
structural gene encoding the prepropeptide of 51 amino-acids. The gene product of
LctM was shown to interact directly with prelacticin 481, thus suggesting an essential
role for LctM in Lan residue formation in lacticin 481 (Rince et al., 1997, Uguen et
al., 2000). LctT encodes an ABC transporter, containing an N-terminal protease
domain, that has the dual function of cleaving the leader peptide and exporting the
mature bacteriocin (Rince et al., 1994); inactivation of this gene resulted in
production of a truncated form of lacticin 481 (Uguen et al., 2005). The proteins
encoded by lctFEG genes have hydrophobicity profiles and sequence similarities that
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strongly suggest their association into an ABC transporter protecting the lacticin 481
producer strain from its own lantibiotic. Co-expression of the three genes into a
lacticin 481-sensitive L. lactis strain provided the host with immunity to the
bacteriocin; deletion of any of the three genes restored strain sensitivity to lacticin
481 (Rince et al., 1997). No regulatory genes have been identified in the lacticin 481
operon suggesting that this lantibiotic may lack a specific regulator (Dufour et al.,
2000). The observation that increasing osmolarity stimulates lacticin 481 production
suggests that the bacteriocin may be under the influence of global regulation (Uguen
et al., 1999).
5.3 Spectrum of inhibition and mode of action
The inhibitory capacity of lacticin 481 was determined on agar plates using
selected strains of lactic acid and food spoilage bacteria. Lacticin 481 exerted a
bactericidal effect on all species of Lactococcus, some lactobacilli and leuconostocs.
Of particular interest is the sensitivity of Clostridium tyrobutyricum to lacticin 481, as
this spoilage organism is responsible for butyric acid formation and late swelling in
Emmental-type cheese (Piard et al., 1990). During trials for food preservation, in-situ
produced lacticin 481 was also found to control growth of L. monocytogenes
(O'Sullivan et al., 2003b, Rodriguez et al., 2001).
Few studies have addressed the mode of action of bacteriocins of the lacticin 481
group. Recently, Dufour et al. (2007) postulated that these lantibiotics might share a
related mode of action due to their close similarity in terms of sequence and structure;
their self-protection system is thought to expel bacteriocins from the membrane to the
extracellular medium and this supports the idea of a membrane-targeted action.
Lacticin 481 was shown to be membrane-active as judged by interaction with
artificial lipid monolayers and to have higher affinity for zwitterionic lipids than for
anionic lipids (Demel et al., 1996). In another member of the group, nukacin ISK-1,
interaction with artificial lipid monolayers and the role of membrane binding in the
bacteriocin mechanism of action have been demonstrated. Based on structural
similarity, it is conceivable that lacticin 481 acts in a similar manner. However, the
N-terminal lysine of lacticin 481 was shown to be not essential for antimicrobial
activity (Xie et al., 2004) and, even the absence of the five N-terminal residues
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simply reduced but not abolished its biological activity (Uguen et al., 2005). These
observations suggest that although lantibiotics of the lacticin 481 group are likely to
share a similar mechanism by acting at the membrane level, their modes of interaction
with membranes is probably different.
5.4 Applications
A limited number of studies are available in which lacticin 481 has been applied
in food systems. In semi-hard raw milk cheese made with the lacticin 481-producing
strain L. lactis spp. lactis TAB 24, inhibition of L. monocytogenes growth was
observed; the pathogen counts were reduced by 1.6 logs after 8 h from milk
contamination (Rodriguez et al., 2001). The efficacy of lacticin 481 antimicrobial
activity is enhanced in combination with other hurdle treatments. In raw-milk cheeses
artificially inoculated with E. coli O157:H7 (105 cfu/ml), combining HHP at 500 MPa
with the addition of a lacticin 481-producing adjunct strain completely eliminated the
pathogen in 60-day-old cheeses. When pressurization was reduced at 300 MPa,
results varied according to the time of treatment application; a higher reduction in E.
coli O157:H7 counts was obtained when the treatment was applied on day 50 (3.8
logs) than if applied on day 2 (1.3 logs) (Rodriguez et al., 2005). The inhibitory effect
of lacticin 481 was also shown to work synergistically with that of other bacteriocins.
A lactococcal starter derivative producing both lacticins 3147 and 481 reduced the
growth rate of L. monocytogenes by almost fourfold and showed an increased
antilisterial activity compared to the single bacteriocin-producers (O'Sullivan et al.,
2003b).
A recent trend is the application of bacteriocins to enhance the release of
intracellular enzymes from starter culture cells in order to accelerate ripening and/or
improve cheese flavour. Lacticin 481 produced by L. lactis subsp. lactis DPC5552
was shown to increase lysis and release of proteolytic enzymes by starter L. lactis HP
without severely compromising its acid-producing capabilities during a cheddar
cheese–making trial (O'Sullivan et al., 2002a, O'Sullivan et al., 2003a). Similarly,
lacticin 481-producing cultures promoted early lysis of Lactobacillus helveticus cells
in Hispanico cheese and increased the proteolytic activity (Garde et al., 2006).
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6. The potential of variacin for food biopreservation
6.1 History, isolation and GRAS status of the producing strain
Variacin is a lanthionine-containing bacteriocin produced by Kocuria varians
NCC 1482 (formerly referred to as Micrococcus varians). The bacteriocin was
identified in two bacterial strains isolated as part of the natural meat flora from
laboratory production trials of Italian-type raw salami fermentations. Purification and
characterization of the antimicrobial compound produced by both strains revealed the
same bacteriocin, though the strains were not identical and had different plasmid
profiles. Considering the traditional use of K. varians strains as starters in sausage
fermentations, these organisms and/or their metabolites may be applied in food
preservation without posing any safety or regulatory issues (Pridmore et al. , 1996).
6.2 Characterization, structure and genetics
Variacin was purified from cell-free supernatants by hydrophobic interaction
followed by fast protein liquid chromatography (FPLC) (Pridmore et al., 1996). The
bacteriocin is completely inactivated by proteinases pronase E, proteinase K, and
ficin, but retains its activity after incubation with catalase. Variacin is resistant to heat
(100 ºC for 15, 30, and 45 min) and pH values from 2 to 10. Total amino-acid
composition of variacin was determined by means of peptide sequencing and mass
spectrometry analysis of the FPLC active fractions, returning a peptide molecular
weight of 2,658.61 Da. Computer analysis revealed a primary structure sharing
significant homology with that of lacticin 481, especially at the amino-terminal
sequence, and containing the same number of Lan and MeLan residues. At DNA
level, variacin and lacticin 481 share 58.7% overall similarity, basically restricted to
the 144-bp bacteriocin-encoding segment. In contrast, different degrees of homology
exist at the peptide level (Figure 3). The 22-residue leader peptide of variacin is only
60% identical (75% similarity) to that of lacticin 481 (Pridmore et al., 1996) but it
contains the “double-glycine” motif that is typically conserved in bacteriocins of the
lacticin 481 group (Dufour et al., 2007, Piard et al., 1993). These observations led to
postulate that different processing and transport enzymes may have evolved for a
similar bacteriocin in different species (M. varians and L. lactis). In contrast, the 25-
residues pro-peptide of variacin is 84% identical (92% similarity) to that of lacticin
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481 and shows the conserved residues (three cysteine, two serines and a threonine)
potentially involved in the Lan ring formation; mature variacin differs from lacticin
481 for being two amino-acids shorter and having three conservative amino-acid
substitutions (Pridmore et al., 1996). No data has been reported to date regarding the
immunity genes for variacin; however, the observation that a lacticin 481-producing
strain is sensitive to variacin, while natural producers of variacin are both resistant to
lacticin 481 suggests that significant differences probably exist between the immunity
mechanisms of the two bacteriocins (Pridmore et al., 1996).
6.3 Spectrum of inhibition and mode of action
The inhibitory capacity of variacin was determined by the agar well diffusion
method against selected strains of lactic acid and food spoilage bacteria. Variacin
exhibited a wide spectrum of activity inhibiting all gram-positive bacteria tested,
including pathogenic and spoilage organisms such as listeriae, staphylococci, and the
vegetative cells and spores of clostridia and bacilli. Common to most known
bacteriocins produced by gram-positives, variacin did not exhibit inhibitory activity
against gram-negative bacteria (Pridmore et al., 1996).
No data is available to date regarding the mode of action of variacin. However,
considering its sequence and structural similarity with lacticin 481 (Figure 3), the
mechanism of action of variacin most likely resembles that of lacticin 481 (described
in paragraph 4.3 of this chapter) and related bacteriocins (i.e., nukacin ISK-1)
(Dufour et al., 2007).
6.4 Applications
The biopreservative potential of variacin has only been tested in dairy systems so
far (O'Mahony et al., 2001). The authors evaluated the feasibility of applying a spray-
dried, fermented preparation of variacin to control the growth of a cocktail of three
Bacillus cereus strains in chilled dairy foods. These authors obtained a powder
preparation of variacin by growing K. varians in reconstituted skim milk and yeast
extract broth at 30 °C for 18 h, and then spray-drying the cell-free fermentate; the
amount of active variacin in the fermented milk powder was 3.1 g/g (20,000
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AU/ml). Subsequently, they produced a range of chilled dairy food formulations
containing different percentages of fat, carbohydrate and protein to resemble the
composition of commercially available products. These dairy models along with two
commercial products (chocolate mousse and vanilla dessert), included to validate the
experiments, were added with varying amounts of the variacin ingredient and then
challenged with the B. cereus spore cocktail over a range of abuse temperatures.
Addition of 1% variacin inhibited the growth of B. cereus at 8 °C in all products and
models. At 12 °C, addition of 3% variacin was required to inhibit outgrowth of the
spores, whereas a 1% concentration was no longer sufficient to exert long-term
inhibition of the pathogen cocktail. When stored at 30 °C, the use of 3% variacin
inhibited spoilage in only two of eight chilled food models.
7. The potential of sakacin P for food biopreservation
7.1 History, isolation and GRAS status of the producing strain
Sakacin P is a small, class IIa bacteriocin produced by certain strains of the
GRAS organism, Lactobacillus sakei. Production of sakacin P was first reported in
Lb. sakei LTH 673 (Tichaczek et al., 1992) and subsequently in several other
producers (Urso et al., 2006), including Lb. sakei Lb674 where it was initially named
sakacin 674 (Holck et al., 1994). Lactobacillus species have a long history of safe use
as food adjuncts, and some species are also part of the human gut microflora. Their
addition to fermented foods is known to improve the storage stability, flavour, and
texture of the products and, following food ingestion, they exert several beneficial
“probiotic” effects at the intestinal and immune-system levels. Lb. sakei strains are
regularly used as starters in salami fermentations and, recently, a patent application
proposed their use in pharmaceutical, feed, food, and cosmetic compositions (Park et
al., 2009).
7.2 Characterization, structure and genetics
Maximal production of sakacin P may be obtained by growing the producer
strain in a completely defined medium at low temperature without pH control
(Moretro et al., 2000). Amino-acid composition analysis and protein sequencing of
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purified sakacin P revealed a prepeptide of 61 amino-acids containing a typical
“double-glycine” leader peptide (Havarstein et al., 1995), which is enzymatically
removed during bacteriocin maturation. Mature sakacin P is a 43 amino-acids peptide
containing no unusual amino-acids but an N-terminal YGNGVXC consensus motif,
typical of class IIa bacteriocins (Eijsink et al., 1998, Tichaczek et al., 1994). The
three-dimensional structure of sakacin P has been determined by NMR spectroscopy.
The cationic N-terminal region (residues 1-17) has an S-shaped conformation
resembling a three-stranded antiparallel -sheet and contains four positively charged
residues pointing in the same direction. The C-terminal tail (residues 34-43) lacks any
apparent common secondary structural motif, but it is able to fold back onto a central
amphiphilic-helix (residues 18-33), thereby creating a hairpin-like structure (Uteng
et al., 2003).
Biosynthesis and immunity to sakacin P are regulated by seven genes, sppIP,
sspK, sspR, sspA, spiA, sppT and sppE, with chromosomal (Holck et al., 1994,
Tichaczek et al., 1992) or plasmid (Vaughan et al., 2003) location. Uni-directionally
transcribed, these genes are functionally organized in three operons, each one
preceded by typical inducible promoters, PsppIP, PsppA, and PsppT. The first operon,
sppIPKR, contains a three-component regulatory system coupling sakacin P
production to its cell density. SppIP encodes a 19-residue peptide pheromone
responsible for inducing bacteriocin production in non-producing strains. SppK and
sppR encode products homologous to proteins of bacterial two-component signal
transduction systems of the AgrB/AgrA family: the 448-residues SppK is 59% similar
to histidine kinase protein of the plantaricin A operon, whereas the 248-residues
SppR shows 65-68% similarity to response regulator proteins of the same operon
(Brurberg et al., 1997, Huhne et al., 1996). The three-component regulatory system
acts as a quorum-sensing device (Nes and Eijsink, 1999); the increase in extracellular
pheromone consequent to low cell density is registered by the histidine kinase, which
activates the response regulator that in its turn induces the spp promoters. The second
operon consists of the sakacin P structural gene (sppA) and a cognate immunity gene
(spiA) encoding a protein of 98 amino-acids. Finally, the genes of the third operon are
involved in transport and processing of the bacteriocin and pheromone precursors.
SppT encodes a 718-residues peptide homologous to ATP-dependent transporters of
the HlyB family, which are involved in the signal-sequence independent transport of
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proteins across the bacterial membrane. SppE encodes a 458 amino-acids peptide that
probably acts as accessory protein for the SppT ABC-transporter; SppE is indeed
homologous to HlyD-like proteins, which are implicated in the signal-sequence
independent export of haemolysin A in E. coli. SppT and sppE are not only essential
for sakacin P production but also for immunity; the transcription of the immunity
gene spiA is indeed regulated by the extracellular pheromone, whose secretion is
associated with the activity of SppT and SppE (Brurberg et al., 1997, Huhne et al.,
1996). The efficiency of the pheromone-regulated promoter system of sakacin P has
been successfully exploited to obtain high-level inducible gene expression in Lb.
sakei and Lb. plantarum. Plasmid vectors or gene expression systems based on
sakacin P promoters and regulatory genes have been shown to produce some of the
highest levels of regulated gene expression reported so far in lactobacilli (Mathiesen
et al., 2004a, Mathiesen et al., 2004b, Sorvig et al., 2003).
7.3 Spectrum of inhibition and mode of action
The antimicrobial activity of sakacin P was found to inhibit the growth of several
Gram-positive bacteria, including food pathogen (L. monocytogenes and E. faecalis)
and spoilage (Carnobacterium) species (Tichaczek et al., 1992). The mode of action
of this and other pediocin-like bacteriocins has not been fully elucidated to date.
According to NMR studies, the primary structure of pediocin-like bacteriocins is
formed by a hydrophilic, cationic and highly conserved N-terminal region that forms
a three-stranded antiparallel -sheet supported by a conserved disulphide bridge and
an amphiphilic -helix. The less conserved, hydrophobic/amphiphilic C-terminal
stretch has instead a rather extended structure that folds back onto the helical part
when it inserts into the target-cell membrane (Fimland et al., 1996, Fimland et al.,
2000, Nes et al., 2002). The N-terminal region is thought to mediate the initial
binding of pediocin-like bacteriocins to target cells via electrostatic interactions.
Mutational analysis of charged residues in the N-terminus of sakacin P showed
indeed reduced binding to target cells and bacteriocin potency (Fimland et al., 2006,
Kazazic et al., 2002). A mutagenesis approach also highlighted the essential role
played by tryptophan residues in determining membrane interaction and antimicrobial
activity in sakacin P (Fimland et al., 2002). The main role of the C-terminal region
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would be to penetrate into the hydrophobic part of the bacterial membrane, thereby
mediating membrane leakage (Fimland et al., 1996, Fimland et al., 1998). However,
in some pediocin-like bacteriocins (i.e., pediocin PA-1), it also contains a disulfide
bridge capable to influence the target-cell specificity. This bridge is missing in
sakacin P, but its introduction by site-directed mutagenesis made sakacin P mutants
10 to 20 times more potent than the wild-type towards certain indicator strains
(Fimland et al., 2000). Finally, hydrophobic residues located on one side of the C-
terminal amphipathic helix were also suggested to be important for receptor
recognition and specificity toward particular organisms (Kaur et al., 2004).
7.4 Applications
Because of the combination of high anti-listerial activity and a narrow inhibitory
spectrum, sakacin P is one of the most promising bacteriocins for preservation of
foods in which contamination with listeria is a problem (Eijsink et al., 1998).
Addition of purified sakacin P completely eliminated L. monocytogenes in cold-
smoked salmon, despite the bacteriocin being subject to proteolytic degradation in
salmon tissue (Aasen et al., 2003). Sakacin P alone is ineffective against E. coli but it
was shown to enhance synergistically the potency of the fish antimicrobial peptide
pleurocidin against the pathogen. A combination of 32 g/ml sakacin P with 2g/ml
of pleurocidin resulted in complete inhibition of E. coli growth after incubation for
about 18 h (Luders et al., 2003).
Effective inhibition of bacterial pathogens in food products was also achieved by
using sakacin P-producing lactobacilli. A bacteriocinogenic L. sakei strain
significantly decreased listeria, fecal enterococci and total bacterial counts in
sausages, in addition to performing satisfactorily as a starter during meat fermentation
(Urso et al., 2006). In raw beef, the sakacin P producer Lb. curvatus CWBI-B28
successfully inhibited L. monocytogenes. The same strain proved ineffective against
the pathogen in raw chicken meat, but it showed a clear anti-listerial effect when
inoculated together with a sakacin G-producing strain (Dortu et al., 2008). In cold-
smoked salmon, sakacin P released by L. sakei L6790 only had a bacteriostatic
activity on L. monocytogenes; in this case, addition of a sublethal concentration of
purified sakacin P in combination with the bacteriocinogenic culture was necessary to
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obtain partial inactivation of the pathogen (Katla et al., 2001). Similarly, combined
use of a sakacin P preparation and a sakacin P-producing Lb. sakei strain resulted in
good inhibitory activity of L. monocytogenes in vacuum-packaged chicken cuts over a
4-weeks period (Katla et al., 2002).
8. FUTURE PROSPECTS
In response to the growing demand for safer foods free from chemical additives,
research into the application of bacteriocins as biopreservatives in food matrices has
been underway for more than 20 years. Since then, numerous bacteriocins have been
reported to inhibit spoilage and/or pathogen bacteria in several food systems, but only
nisin has been licensed as a food preservative (E234) to date. Currently used in
almost 50 countries, nisin is also the only bacteriocin to have received the GRAS
status for food in the United States. However, several deficiencies of nisin, such as
the instability at neutral to alkaline pH and a spectrum of activity restricted to gram-
positive bacteria, call for other bacteriocins to be examined (Settanni and Corsetti,
2008). Some of the bacteriocins described in this chapter, particularly lacticin 3147
and enterocin AS-48, possess qualities which make them ideal candidates as
alternatives to nisin. Since the effectiveness of bacteriocins in foods is known to
decrease in response to a number of food-related factors (pH, temperature, food
composition, structure, microbiota) (Schillinger et al., 1996), a single bacteriocin-
based technique is unlikely to alleviate the safety issues associated with a large
variety of food products. Therefore, the feasibility of these agents as preservatives
should be tested on a “product by product” basis using specific bacteriocins for
specific tasks. This explains why the use of bacteriocins as part of hurdle technology
has received great attention in recent years. Combination of physico-chemical
treatments (i.e., heat, HHP, HIPEF), antimicrobial agents (i.e., chelators, essential
oils, phenolic compounds) or other bacteriocins with several bacteriocins has been
shown to result in additive or synergistic antibacterial effects (Galvez et al., 2007). Ex
situ–produced bacteriocins may also be exploited to prepare bioactive food inserts
that represent one of the most interesting preservation technologies for foods stored in
modified atmosphere packaging (MAP) at refrigeration temperatures. Many of the
examples presented in this chapter have shown how the combination of bacteriocins
with selected hurdles often results in a more effective form of preservation, providing
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an additional barrier even to the more refractive forms like gram-negative bacteria
endospores. While the search for new bacteriocins, exhibiting different antimicrobial
properties, will certainly continue in the near future, one of the most attractive
directions of future research on food protection remains the exploitation of
bacteriocinogenic cultures or their pure bacteriocins within a hurdle technology
program. In particular, the combination of bacteriocin-activated packaging films and
traditional hurdles holds promise for the extension of shelf-life and improvement of
microbiological safety of food products.
9. FURTHER INFORMATION
A number of public databases are now available for the detection and
structural/functional analysis of bacteriocins during the de novo sequencing of
bacterial genomes. BAGEL is a web-based software tool which enables the
identification of putative bacteriocin gene clusters in novel DNA sequences using a
number of ORF prediction tools and knowledge-based bacteriocin and motif
databases (de Jong et al., 2006). A typical BAGEL search on a genome sequence
results in a set of putative bacteriocin gene clusters ranked according to the presence
of significant features in the amino-acid sequences and their genomic context.
BAGEL is freely accessible at: http://bioinformatics.biol.rug.nl/websoftware/bagel. A
complementary tool to BAGEL for bacteriocin characterization is BACTIBASE, a
web-based database containing the calculated or predicted physicochemical properties
of 123 bacteriocins produced by both Gram-positive and Gram-negative bacteria. The
information in this database allows rapid prediction of relationships structure/function
and target organisms of these antimicrobial peptides. BACTIBASE is freely
accessible at: http://bactibase.pfba-lab-tun.org. Finally, the manually annotated
UniProtKB/Swiss-Prot database stores relevant data regarding the majority of
sequenced bacteriocins that include mode of action, 3D-structure, post-translational
modification of the precursor protein, and interactions with other proteins, other than
cross-references to external databases.
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Figure 1. (a) Primary structure of the lacticin 3147 peptides, LtnA1 and LtnA2.
Thioether aminoacids are shown in dark (Ala-S-Ala, lanthionine) and light grey
(Abu-S-Ala, b-methyllanthionine). Dehydrated amino acids (Dhb, 2,3-
didehydrobutyrine) and D-alanine residues are shown in bold and italics (Adapted
from Wiedemann et al., 2006). (b) Organization of the gene cluster involved in the
production of and immunity to lacticin 3147 (Adapted from McAuliffe et al., 2001a).
(c) Three-step model for the action of the two-peptide lantibiotic lacticin 3147 (I)
Membrane association of the A1 peptide and binding to lipid II. (II) Binding of the
A2 peptide to A1:lipid II and formation of a high-affinity three-component complex.
(III) Translocation of the C-terminus of A2 and formation of a defined pore (Adapted
from Wiedemann et al., 2006).
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Figure 2. (a) Three-dimensional structures of enterocin AS-48, with -helices
represented as cylinders. (b) Organization of the gene cluster involved in the
production of and immunity to AS-48. (c) Schematic representation of the mechanism
for the molecular function of AS-48. The model includes the approach of DF-I to the
membrane and the transition from DF-I to DF-II at membrane surface. Hydrophobic
and polar helices are depicted in light gray and dark gray respectively. The arrow
represents the direction of the intrinsic dipolar moment of DF-I (Adapted from
Maqueda et al., 2004; permission to reproduce material granted by Bentham Science
Publishers Ltd.).
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Figure 3. Sequence comparison of precursor peptides (prepeptides) between lacticin
481 and variacin. Identical residues are shown in bold (Adapted from Dufour et al.,
2007; permission to reproduce material granted by Wiley-Blackwell).
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Chapter II
Genetic response to bacteriophage infection in Lactococcus lactis
reveals a four-strand approach involving induction of membrane
stress proteins, D-alanylation of the cell wall, maintenance of proton
motive force and energy conservation
Submitted to Journal of Virology.
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ABSTRACT
In this study, we have used whole-genome microarrays to gain insights into the
global molecular response of L. lactis IL1403 at the early stages of infection with the
lytic phage c2. The bacterium differentially regulated the expression of 61 genes
belonging to 14 functional categories, including cell envelope (12 genes), regulatory
functions (11 genes), and carbohydrate metabolism (7 genes). The nature of these
genes suggests a complex response involving four main mechanisms: (i) induction of
membrane stress proteins, (ii) D-alanylation of cell wall lipoteichoic acids (LTAs),
(iii) maintenance of the proton motive force (PMF), (iv) and energy conservation.
The phage presence is sensed as a membrane stress in L. lactis IL1403, which
activated a cell-wall targeted response probably orchestrated by the concerted action
of membrane Phage Shock Protein C-like homologues, the global regulator SpxB and
the two-component system CesSR. The bacterium upregulated genes (ddl and
dltABCD) responsible for incorporation of D-alanine esters into LTAs, an event
associated with increased resistance to phage attack in gram-positive bacteria. The
expression of genes (yshC, citE, citF) affecting both PMF components was also
regulated to restore the physiological PMF, which was disrupted following phage
infection. While mobilizing the response to the phage-mediated stress, the bacterium
activated an energy-saving programme by repressing growth-related functions and
switching to anaerobic fermentation, probably to sustain the PMF and the overall cell
response to phage. To our knowledge, this represents the first detailed description in
L. lactis of the molecular mechanisms involved in host response to the membrane
perturbations mediated by phage infection.
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INTRODUCTION
Lactococcus lactis strains are extensively used worldwide for the manufacture of
fermented milk products. The efficiency of industrial fermentations, relying on
lactococcal starters, is however threatened by their sensitivity to bacteriophage
(phage) infection. Lysis of starter bacteria following attack by lytic phages slows
down or arrests the fermentation process, and adversely impacts on product quality.
Severe phage infection can greatly affect production schedules, as investigations must
be carried out to identify the source of the phage and to implement corrective actions,
resulting in significant economic losses for the dairy industry (Emond and Moineau,
2007).
Virulent lactococcal phages are ubiquitous within the dairy industry environment
and, consequently, a great deal of research has been devoted to improving the phage
resistance of L. lactis starters over the past decades. Phages derived from failed
fermentations have been collected and used in pools to screen for new bacterial
strains capable of sustaining such phage challenges. This has led to the selection of
highly resilient bacteria and to the isolation and characterization of a myriad of host-
encoded natural defence mechanisms. According to the phase of the phage life cycle
with which they interfere, these mechanisms have been divided into four groups:
adsorption blocking, DNA ejection blocking, restriction/modification (R/M) systems,
and abortive infection mechanisms. The majority of these mechanisms are encoded
on conjugative or mobilizable plasmids, a feature enabling their transfer to other
strains by conjugation. This has allowed the construction of industrial phage-resistant
systems where isogenic variants of L. lactis, carrying single or multiple natural
defence mechanisms, have been incorporated into rotation programs. The
combination of culture rotation and anti-phage system pairing has greatly improved
the reliability and lifespan of lactococcal starters in the industry (Emond and
Moineau, 2007, Garvey et al., 1996). However, the long-term effectiveness of such
strategies is always challenged by the evolutionary dynamic of phages that, under
protracted selective pressure, are able to evolve and adapt to circumvent the
resistance mechanisms. This requires continuous efforts from researchers to provide
alternative solutions to the phage threat. New and sophisticated anti-phage
approaches may be derived from the wealth of genomic information generated from
bacteria and phages with the recent advent of more affordable DNA sequencing
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platforms. Used in combination with high-throughput technologies for gene
expression profiling such as microarrays, this sequencing data may help to elucidate
the molecular mechanisms of the phage-host interactions in gram-positive bacteria by
identifying targets for the design of novel anti-phage measures for biotechnological
processes.
Lactococcal phages are classified into several groups, but those commonly found
in dairy plants belong to three main species, namely 936, P335, and c2 (Jarvis, 1984).
The phage infection process requires an initial adsorption to the host cell surface via
specific interaction between the phage receptor-binding protein (RBP) and the
bacterial receptor, followed by DNA injection. Once inside the cell, the phage DNA
takes over the cell metabolic machinery to initiate its own replication followed by
packaging of the viral progeny. The early step of the infection process, involving
phage adsorption and DNA injection, is therefore crucial to understand the host
response to phage interaction at the molecular level. A genome-wide transcriptional
profiling of responsive genes may allow for the identification of potential targets (i.e.,
gene networks, promoters, regulatory elements) for the rational design of new anti-
phage strategies for starter cultures.
In this study, we have used whole-genome microarrays to obtain a holistic view
of the L. lactis subsp. lactis IL1403 response at the onset of infection by the lytic
phage c2. Our objective was to gain insights into whether any defence strategy is
activated by this phage-sensitive strain in response to phage infection. L. lactis
IL1403 and phage c2 provide an excellent model system for this study as their
complete genome sequences are known (Bolotin et al., 2001, Lubbers et al., 1995).
Our results suggest that the cell activates a sophisticated response involving induction
of membrane stress proteins, D-alanylation of the cell wall, maintenance of the proton
motive force (PMF) and energy conservation. Regulation and implications of this
response on the chances of cell survival to phage infection are discussed.
Chapter II
54
MATERIALS AND METHODS
Bacterial strains
L. lactis subsp. lactis IL1403 was used for whole genome expression profiling of
the host response to phage infection. L. lactis subsp. cremoris MG1363 served as the
sensitive host for propagation of phage c2 at high titers. Lactococcal strains were
routinely propagated at 30 C in M17 medium (Oxoid, Hampshire, England)
supplemented with 0.5% (wt/vol) glucose (GM17). Solid media contained 1.0%
(wt/vol) bacteriological agar (Oxoid, Hampshire, England). Bacterial strains were
stocked in M17 containing 40% glycerol at -80C. Working cultures were stored at 4
C and transferred periodically.
Preparation of high-titer stock solutions of bacteriophage c2
Phage c2 was propagated to high titres on the sensitive host L. lactis MG1363 as
previously described (Jarvis, 1984). Concentration and purification of the phage
lysate by polyethylene glycol (PEG) precipitation followed by caesium chloride
(CsCl) gradient centrifugation was performed as follows. Briefly, cell debris was
removed from the phage lysate by centrifugation at 11,000 x g for 30 min at 4 °C.
The supernatant was recovered and concentrated by addition of 15% PEG 8000 and 1
M NaCl, followed by slow agitation for 24 h at 4 °C. Phages were then precipitated
by centrifugation at 16,700 x g for 60 min at 4 °C, and the phage pellet resuspended
in 4 ml of TMN buffer (10 mM Tris-HCl, 10 mM MgSO4, 500 mM NaCl) at pH 7.5.
Concentrated phages were purified by centrifugation at 400,000 x g for 3 h at 4 °C
on a discontinuous-step CsCl gradient (1.3, 1.5 and 1.7 g/ml). The high-titer phage
preparation was desalted by dialysis against 10 mM Na3PO4 buffer (pH 7.0) for 24 h
at 4 °C, recovered in 1 ml TMN buffer, and then titrated at 30 °C according to
standard procedures (Terzaghi and Sandine, 1975). This protocol consistently yielded
phage c2 stock solutions with titers in the range of 1013 plaque forming unit (pfu)/ml.
Phage stock solutions were stored at 4 °C.
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Determination of the Multiplicity of Infection (MOI) value for the phage-host
challenge
The phage lytic cycle is estimated to have an average duration of 40 min (Emond
and Moineau, 2007, Garvey et al., 1996). To obtain an accurate and homogeneous
gene expression profile of the L. lactis IL1403 response to phage c2 attack at the
chosen time-point (10 min after infection), we determined the MOI value necessary to
completely lyse a bacterial population within 40 min. To do this, a number of phage-
host challenge tests were performed by infecting a 40-ml culture of L. lactis IL1403,
growing in mid-log phase (OD600 = 0.4), with increasing titers of phage c2. The
clearing of the bacterial population was evaluated by measuring the cell density at
600 nm.
Microarray design
The whole genome sequences of L. lactis IL1403 (2,310 genes) and phage c2 (39
genes) were used to design 50-mer oligonucleotide probes for each gene which were
subsequently spotted onto glass slides in duplicate. Control elements on each array
included negative-control probes from unrelated Arabidopsis thaliana genes.
Oligonucleotide probe design and microarray production were carried out by
Ocimum Biosolutions Ltd. (Hyderabad, India).
Total RNA isolation and mRNA enrichment
Total RNA was isolated as follows. An overnight culture of L. lactis IL1403 was
used to prepare a fresh 0.5% inoculum in 40 ml of GM17 broth, which was
propagated at 30 °C to mid-log phase (OD600 = 0.4). The IL1403 culture was split in
two 20-ml aliquots (experimental and reference), to which were added phage c2
(MOI = 800) (experimental) or TMN buffer (reference), and 10 mM CaCl2 to allow
efficient phage adsorption. Following incubation at 30 °C for 10 min to allow phage
adsorption on IL1403 cells, samples were immersed in a -80 °C ethanol bath for 5
min to prevent any changes in gene expression profiles. After centrifugation at 11,000
x g for 5 min, cell pellets were re-suspended in 200 l of Tris-EDTA buffer (pH 8.0)
containing 6 mg/ml lysozyme and incubated at 37 °C for 10 min. Total RNA was
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extracted by using the RiboPureTM-Bacteria kit (Ambion, USA) and contaminating
DNA was removed with a DNA-free kit (Ambion, USA), according to
manufacturer’s recommendations. Amount and purity of recovered RNA were
determined by reading the absorbance at 260 nm for RNA concentration, and the
absorbance at 230 and 280 nm for solvent and protein contaminations by means of a
NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, USA). RNA integrity
was verified on glyoxal-agarose gels after ethidium bromide staining. Total RNA
samples (50 g) were enriched for mRNA, which provides a superior template for
cDNA synthesis, by using the mRNA-ONLYTM Prokaryotic mRNA Isolation kit
(Epicentre Biotechnologies, USA). This kit uses a 5’-phosphate-dependent
exonuclease enzyme to selectively digest RNA having a 5’-monophosphate.
cDNA preparation and labelling
Reverse transcription of enriched mRNA into single-stranded cDNA was
initiated by adding 9 g of random hexamers (Invitrogen, USA) and 2 l of a 50X
aminoallyl-deoxynucleoside triphosphate stock mixture (25 mM dATP, dGTP, dCTP,
10 mM dTTP, and 15 mM aminoallyl-dUTP). The volume was adjusted to 34l with
RNase-free water before the mixture was incubated at 70 °C for 10 min followed by
10 min at 25 °C to allow primers annealing. After addition of 12l of 5X First Strand
buffer (Invitrogen, USA), 3 l of 0.1 M dithiothreitol (Invitrogen, USA), 3 l of
SUPERase-In (20 U/l; Ambion, USA), and 6 l of SuperScript III Reverse
Transcriptase (200 U/l; Invitrogen, USA), the mixture was first incubated at 25 °C
for 10 min and then at 42 °C for 24 h. cDNA synthesis was stopped by heating at 95
°C for 10 min and the RNA template was removed by alkaline treatment with 20μl of
0.5 M NaOH and 10 μl of 0.5 M EDTA at 65°C for 30 min. Ten microliters of 1 M
HCl were added to neutralize the cDNA mixture, which was then purified by using
the QIAquick PCR purification kit (QIAGEN, Germany) according to manufacturer’s
instructions, except that the free amines-containing wash and elution buffer were
replaced with an ethanol-based phosphate wash buffer (80% ethanol, 5 mM KPO4,
pH 8.5) and a phosphate elution buffer (4 mM KPO4, pH 8.5), respectively. Purified
single-stranded cDNA was dried in a speed vac, resuspended in 60 μl of 0.1 M
sodium bicarbonate buffer (pH 9.0), and labelled by incubation with Cy3 (reference)
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or Cy5 (experimental) mono N-Hydroxysuccinimide (NHS) ester (GE Healthcare,
UK) at room temperature (RT) for 90 min in the dark. Labelling reaction was
quenched by addition of 5 μl of 3 M sodium acetate (pH 5.2) followed by incubation
at RT for 15 min in the dark. Uncoupled dye was then removed using the QIAquick
PCR purification kit (QIAGEN, Germany) and the buffers provided with the kit,
according to manufacturer’s instructions. The efficiency of labelling was determined
by reading the absorbance at 260 nm for cDNA concentration, the absorbance at 550
nm for Cy3 incorporation, and the absorbance at 650 nm for Cy5 incorporation.
Microarray hybridization, scanning, and data analysis.
The two differentially labelled cDNA probes were pooled, dried in a speed vac,
and resuspended in 120 μl of a preheated salt-based hybridization buffer (Ocimum
Biosolutions, India) at 42 °C. Microarray slides were pre-hybridized in a solution
containing 5X saline-sodium citrate (SSC) buffer, 0.1% sodium dodecyl sulphate
(SDS), and 1% bovine serum albumin (BSA) at 42 °C for 60 min. After two washes
with RT double-distilled water for 10 min, arrays were dried by centrifugation at
1,000 rpm for 5 min. The cDNA probe was denatured by heating at 95 °C for 3 min
and cooled on ice for 1 min. After addition of 40 μl of the background blocker
KREAblock (Kreatech Biotechnology, The Netherlands), the hybridization mixture
was heated at 42 °C before application to the microarray. The applied probe was kept
in place with a coverslip, placed in a metal chamber, and incubated in a water bath at
42 °C for 24 h. Following overnight hybridization, slides were washed under gentle
agitation for 1 min in preheated 5X SSC, 0.1% SDS buffer at 42°C, followed by
washes at RT for 2 min in 2X SSC, 2 min in 1X SSC, and 1 min in 0.2X SSC. Slides
were quickly rinsed in RT double-distilled water and dried in 50-ml conical-bottom
tubes by centrifugation at 1,000 rpm for 5 min at RT. Microarrays were scanned with
an Affymetrix 428TM Array Scanner (Affymetrix, USA) by using laser lights at
wavelengths of 532 nm and 635 nm to excite Cy3 and Cy5 dye, respectively. Images
were captured as 16-bit TIFF files by using Affymetrix Array Reader v.1.1
(Affymetrix, USA) and analyzed using ImaGene v.7.5 (BioDiscovery Inc., USA).
This software uses a patented automatic segmentation algorithm to differentiate
between signal and background values, and a complex tool including seven different
criteria for spot fail/pass test to detect and flag low-quality spots. The presence of
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additional poor or empty spots not detected automatically was checked manually and
flagged spots were excluded from quantification analysis. Background correction was
applied globally by using the median of the signal values of all negative-control
spots. A locally weighted regression scatter plot smoothing (LOWESS)-based
procedure (Yang et al., 2002) was applied globally, using all spots, to normalize
background-corrected microarray data. The experiments were biologically replicated
twice. Considering that each biological replicate also contained two technical
duplicates on the array, the two hybridizations generated eight data points from both
channels for each gene. The statistical significance of differential gene expression
was calculated with the Significance Analysis of Microarray (SAM) software (Tusher
et al., 2001) by using a minimal two-fold change in expression ratio and maximal
false discovery rate (FDR) of 1%. The microarray data have been submitted to the
Gene Expression Omnibus (GEO) at the website http://www.ncbi.nlm.nih.gov/geo/
under accession number GSE26042.
Quantitative Real-Time PCR (qRT-PCR).
Enriched mRNA (1g) was reverse transcribed using 6 ng of random hexamers
(Invitrogen, USA), 5 mM dNTP mix, 1X First Strand buffer (Invitrogen, USA), 5
mM dithiothreitol (Invitrogen, USA), 40 U of SUPERase-In (Ambion, USA), and 400
U of SuperScript III Reverse Transcriptase at 55 °C for 1 h. Primers for the qRT-PCR
(Table 1) were designed by using PrimerSelect v.8.0.2 from the Lasergene suite
(DNASTAR Inc., USA). The qRT-PCR was set up by using SYBR Green I Master
mix (Roche, USA), 200 nM of each forward and reverse primer, and 10 ng of cDNA
template. The housekeeping alaS gene was used as internal control and for
normalization of results. The reactions were performed in triplicate by using an ABI
PRISM 7000 detection system (Applied Biosystems). Cycling conditions for all
amplifications were one cycle of 95 °C for 10 min and 45 cycles of 95 °C for 15 sec,
55 °C for 5 sec, and 72 °C for 15 sec. From the qRT-PCR data, an average cycle
threshold (Ct) value was calculated from the triplicate reactions. A mathematical
model based on PCR efficiency and crossing point deviation (Pfaffl, 2001) was used
to determine the relative amount of target and reference gene transcripts and,
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consequently, the average relative expression ratio between phage-treated and
untreated samples.
Computational prediction of protein subcellular localization and function.
Predictions of subcellular localization (SCL) of L. lactis IL1403 proteins were
retrieved from the PSORTdb v.2.0 database. This database includes information from
a manually curated dataset of ~2,000 proteins of experimentally verified localization
as well as SCL computational predictions of 2,165 proteins, from 140 completely
sequenced microbial genomes (96 Gram-negative and 44 Gram-positive organisms),
generated by using the PSORTb program. This predictive tool uses the dataset of
proteins of known SCL to train multiple SCL predictors and relies on a series of
analytical modules to identify typical sequence features known to correlate with
specific localizations. In the case of Gram-positive bacteria, four single (cytoplasm;
cytoplasmic membrane; cell wall; extracellular) and two multiple
(cytoplasm/cytoplasmic membrane; cytoplasmic membrane/cell wall) localization
sites are being predicted by PSORTb and included in PSORTdb (Rey et al., 2005).
Prediction of topology in putative membrane proteins, including a specification of the
membrane spanning segments and the in/out orientation relative to the membrane,
was obtained by using the servers TMHMM v2.0
(www.cbs.dtu.dk/services/TMHMM) and TOPCONS
(http://topcons.cbr.su.se/index.php). This latter tool uses the prediction from five
different topology prediction algorithms (SCAMPI-seq, single sequence mode;
SCAMPI-msa, multiple sequence mode; PRODIV-TMHMM; PRO-TMHMM; and
OCTOPUS) as input to the TOPCONS Hidden Markov Model (HMM), which gives a
consensus prediction for the protein, together with a reliability score based on the
agreement of the included methods across the sequence (Bernsel et al., 2009).
Prediction of function in proteins annotated as hypothetical in the genome of L.
lactis IL1403 was achieved by using the PFAM database (http://pfam.sanger.ac.uk)
(Finn et al., 2010), the Conserved Domain Database (CDD) (Marchler-Bauer et al.,
2009), and the InterProScan service (www.ebi.ac.uk/Tools/InterProScan). This latter
tool predicts the occurrence of functional domains and motifs/signatures in a protein
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by combining 12 different databases and their relative protein signature recognition
methods (Zdobnov and Apweiler, 2001).
Fluorometric determination of membrane potential changes in L. lactis IL1403
following phage adsorption.
Changes in the membrane potential of L. lactis IL1403 cells following phage
adsorption were estimated by using the lipophilic cationic dye rhodamine 123
(Sigma, St. Louis, USA) and flow cytometry. Rhodamine 123 was prepared as a stock
solution of 1 mg/ml in methanol. The uncoupler CCCP (carbonyl cyanide m-
chlorophenol hydrazone) was used as positive control for lack of activity of the
electron transport system. CCCP is a lipophilic weak acid that readily passes through
microbial membranes, binds protons on the acidic side of the membrane, diffuses
through, and releases them inside the cell. As a consequence, the formation of a
proton gradient is blocked, the membrane potential (ΔΨ) is reduced to zero and ATP 
is not synthesized by the electron transport oxidative phosphorylation (Novo et al.,
1999). Cells were grown at 30 °C to mid-log phase (OD600 = 0.4), added of 2 g/ml
rhodamine 123, and then re-incubated for additional 15 min to allow cell uptake of
the dye. At this time-point, a 1-ml aliquot was withdrawn for flow cytometric
analyses, and the remaining sample was infected with phage c2 (MOI = 800) in the
presence of CaCl2 (10 mM) and further incubated at 30 °C to allow phage adsorption
on IL1403 cells. One-ml aliquots were then withdrawn after 10, 15 and 25 min, and
processed for flow cytometric analyses. Aliquots were centrifuged at 20,800 x g for 2
min to remove the growth media. Cell pellets were washed twice in 0.22 m-filtered
50 mM sodium phosphate buffer (pH 7), containing 0.01% Tween-20, and finally re-
suspended in the same buffer to an approximate concentration of 5 x 106-107 cells per
ml. Fluorescence measurements were made with a FACSCanto II flow cytometer
(BD Biosciences, San Jose, USA) equipped with two air-cooled lasers, a 20-mW
solid state (emission, 488 nm) and a 17-mW HeNe (emission, 633 nm), and five
sensors for the detection of forward (FSC) and sideward (SSC) light scatter, green
(FL1, 525 nm), yellow (FL2, 575 nm), and far red (FL3, 695 nm) fluorescence. Cell
samples were delivered at the low flow rate, corresponding to 300 to 500 cells per
sec, until a total number of 10,000 events were acquired by using the FACSDiva
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software v.5.0.2 (BD Biosciences, San Jose, USA). Fluorescence signals were
recorded by using the following detector settings: FSC, 300; SSC, 300; FL1, 400 with
logarithmic amplifications. A threshold was set at FSC and SSC signals of 200 to
reduce background noise deriving from cellular debris.
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RESULTS AND DISCUSSION
Transcriptional profiling of the L. lactis IL1403 response to phage c2 infection.
The life cycle of lytic phages involves different steps that may be organized into
four main phases: (i) infection, (ii) early development, (iii) late development, (iv) and
lysis. The infection stage comprises the steps of phage adsorption to host surface
receptors and injection of the viral DNA, and its duration is phage-dependent (Emond
and Moineau, 2007). In lactococcal phages, appearance of viral DNA into the host
has been detected between 5 and 15 min after adsorption (Garvey et al., 1995, Garvey
et al., 1996, O'Driscoll et al., 2006). Consequently, 10 min after phage addition was
chosen as a representative time-point of an early stage of infection to determine the
response of L. lactis IL1403 to attack by phage c2. In order to obtain an accurate and
homogeneous gene expression profile of the host response, we deemed it necessary to
use infection conditions ensuring complete lysis of the cell population within 40 min,
which is the estimated time for phage c2 to complete its lytic life (Garvey et al., 1995,
Garvey et al., 1996, O'Driscoll et al., 2006). A number of phage-host challenge tests
were performed, and the MOI required to achieve complete lysis within this time
frame was determined to be 800 (Figure 1).
Analysis of the microarray data (Figures 2 and 3) of two independent biological
replicates revealed that L. lactis IL1403 differentially regulated the expression of 61
genes in response to phage c2 challenge (Table 2), with an even distribution between
up- and down-regulated genes. No differential expression of phage c2-related genes
was observed, which is indicative that the chosen sampling time reflects a stage prior
to phage DNA replication. Almost one third of the regulated genes (19 out of 61) and
most of the positively induced genes (17 out of 32) encoded products annotated as
hypothetical proteins. The 61 regulated genes belonged to 14 functional categories,
mostly representing components of the cell envelope (12 genes), regulatory functions
(11 genes), and carbohydrate metabolism (7 genes), which accounted for half of the
regulated genes.
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L. lactis IL1403 increases expression of genes involved in D-alanylation of cell
wall (lipo-)teichoic acids in response to phage infection
Half of the genes regulated by L. lactis IL1403 in response to phage attack
encode proteins whose putative functions are involved to different extents in
biogenesis, modification and regulatory processes of the cell envelope. This finding
suggests that the phage presence is mainly sensed as an extra-cytoplasmic stress by
the cell. Among these, L. lactis IL1403 upregulated three genes (ddl, dltA and dltD)
involved in the peptidoglycan biosynthesis pathway. Ddl encodes the enzyme D-
alanine-D-alanine ligase, which converts D-alanine to its dimer in a reversible
reaction involved in both D-alanine metabolism and cell wall biosynthesis. DltA and
dltD belong to the four-gene operon dltABCD where they overlap with dltB and dltC
genes, respectively. This is indicative of transcriptional coupling and, indeed, RT-
PCR confirmed that dltB and dltC were up-regulated at levels similar to dltA and dltD
during phage attack (Table 3). Induction of the dlt operon leads to increased
incorporation of D-alanine esters (D-alanylation) into cell wall teichoic acids (WTAs)
and lipoteichoic acids (LTAs) in gram-positive bacteria (Koprivnjak et al., 2006,
Neuhaus and Baddiley, 2003). Universally present in these organisms, these
phosphate-rich glycopolymers play crucial roles in protecting, connecting and
controlling the major envelope constituents, and in mediating host-cell adhesion,
inflammation and immune response activation (Weidenmaier and Peschel, 2008).
WTAs and LTAs contain D-alanine esters as their main backbone substitutions and
the extent of this modification is known to exert profound modulatory effects on cell
physiology and host-mediated responses, including a protective function against UV
and acid stress (Boyd et al., 2000, Duwat et al., 1997), autolysins (Steen et al., 2005),
cationic antimicrobials (Kristian et al., 2005), and phage attack (Raisanen et al.,
2007).
As regards this latter function, LTAs have been suggested to serve as phage
receptors in L. lactis (Spinelli et al., 2006, Tremblay et al., 2006) and in many other
organisms including Listeria, Bacillus subtilis, Staphylococcus aureus, and
Lactobacillus (Chatterjee, 1969, Givan et al., 1982, Raisanen et al., 2004, Wendlinger
et al., 1996). There is increasing evidence to suggest that the degree of LTA
substitutions deeply affects phage binding to bacterial cells, either when the receptor
is LTA or a different molecule. Phage-resistant strains of Lb. delbrueckii subsp. lactis
Chapter II
64
were found to contain higher levels of D-alanine esters in their LTAs compared to
phage-sensitive ones (Raisanen et al., 2007), whereas galactosyl-modified LTAs were
suggested to prevent phage adsorption to a L. lactis subsp. cremoris strain by steric
shielding of the actual receptor site (Sijtsma et al., 1990). Lactococcal bacteriophages
are known to use cell wall carbohydrates containing rhamnose, glucose or galactose
moieties as primary receptors for adsorption (Valyasevi et al., 1991, 1994), and for
some, including phage c2, a requirement of a second irreversible binding step to
certain membrane proteins has been demonstrated (Monteville et al., 1994, Valyasevi
et al., 1991). However, the nature of the primary receptor used by phage c2 remains
still unclear. This phage was found to adsorb to rhamnose moieties on the cell wall of
L. lactis subsp. lactis C2 (Monteville et al., 1994), and a similar receptor may be used
to infect other related strains such as L. lactis IL1403. Rhamnose is also a component
of LTAs that have been recently proposed as receptor candidates for other lactococcal
phages of the 936 species (Spinelli et al., 2006, Tremblay et al., 2006). Based on the
above observations, the up-regulation of the dlt operon in L. lactis IL1403 in response
to phage c2 infection adds more weight to the suggestion of a role for LTAs as
receptors for this phage. Indeed, it is tempting to speculate that increased D-
alanylation of LTAs may represent the host attempt to evade phage infection. This
could be achieved via two different mechanisms: D-alanine esters may sterically
impede the already adsorbed phage to access and irreversibly bind the membrane
protein, or they may affect the initial (and reversible) adsorption of other phages to
the cell surface by modifying the primary receptor. This strategy would resemble an
adsorption blocking mechanism and could be very effective at controlling phage
infection by rendering the cell impervious to the phage DNA and leaving the cell and
its biochemical activities unaltered (Emond and Moineau, 2007). While proving
ineffective for most cells of a sensitive host since phage infection would proceed
regardless, such mechanism could allow the survival of a small percent of the cell
population when facing in vivo low titer-phage attacks.
L. lactis IL1403 also regulated the expression of other genes indirectly related to
TAs. Repression of the gene malQ encoding for the enzyme amylomaltase would
switch maltose utilization towards production of D-glucose-1-phosphate, which is the
substrate for the activity of the -phosphoglucomutase (-Pgm) encoded by the up-
regulated gene pgmB. -Pgm catalyzes the reversible transformation of D-glucose-6-
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phosphate to D-glucose-1-phosphate, which is required for the synthesis of uridine
diphosphate-glucose, a precursor of TAs (Weidenmaier and Peschel, 2008) (Levander
et al., 2001). In tune with the up-regulation of the ddl and dlt genes, this would point
to a bacterial activity directed towards strengthening and modifying these surface
glycopolymers. Additionally, the strongest up-regulated gene (yndF) in L. lactis
IL1403 encodes a protein that is likely to interact or to be regulated by the dlt genes.
YndF is a large protein (653 aa) containing the highly conserved LPXTGE motif
(PF00746), common to many Gram-positive surface proteins (Cox et al., 2009). This
cell-wall anchor domain is shared by Internalins of Listeria monocytogenes and M
proteins of Streptococcus pyogenes, which play a key role in host adhesion and
subsequent colonization by these bacteria (Courtney et al., 2002, Sabet et al., 2005).
Interestingly, the expression of the M protein was recently observed to be modulated
by the D-alanylation pathway in a defective dltA mutant of S. pyogenes exhibiting
reduced virulence (Cox et al., 2009).
L. lactis IL1403 also induced at high levels a number of genes encoding
hypothetical proteins with predicted localization on the cytoplasmic membrane. For
some gene products, the presence of conserved domains has allowed for speculation
regarding their putative function. These included the YeeG and YiaI proteins that are
homologous to the LytR family (PF03816) of membrane-bound transcriptional
attenuators involved in peptidoglycan catabolism. In Staphylococcus aureus, lytR
modulates a dicistronic operon that is thought to control peptidoglycan hydrolase
activity (Brunskill and Bayles, 1996), and was also found to be part of the cell wall
stress stimulon induced by a number of antibiotics (Utaida et al., 2003). In contrast,
FloL is a large protein (503 aa) that is predicted to be located in the cytoplasmic
membrane and to contain a flotillin-like domain (cd03399). A member of flotillins,
HlfC (High frequency of lysogenization C) from Escherichia coli, is known to play a
role in the decision between lysogenic and lytic cycle growth during lambda phage
infection (Babuke and Tikkanen, 2007). If FloL plays a similar role in lactococcal
phage infection, its repression by L. lactis IL1403 might be explained by the cell
attempting to deprive phage c2 of a putative host determinant of lysis.
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L. lactis IL1403 restores the physiological PMF altered by phage infection
In any bacterial cell, the electrochemical gradient of protons across the
cytoplasmic membrane, also termed PMF, is a major store of free energy. A
membrane potential (ΔΨ) and a pH gradient (ΔpH) are the two main components of 
the PMF, which are usually generated by the activity of primary ion pumps (e.g.,
F0F1-ATPase) and of secondary transporters (e.g., the citrate/lactate exchanger)
(Lolkema et al., 1995). In response to the phage stimuli, L. lactis IL1403 was found
to repress the expression of yshC and citEF genes, which are actively involved in the
primary and secondary mechanisms of PMF generation, respectively. The yshC gene
encodes a manganese-dependent inorganic pyrophosphatase that plays a key role in
the oxidative phosphorylation pathway and has been shown to be essential to E. coli
growth (Chen et al., 1990). Its activity removes excess pyrophosphate, released in the
cell by numerous metabolic pathways, thus providing the phosphate necessary to the
F0F1-ATPase to generate ATP while driving an influx of protons through the cell
membrane. The down-regulation of this pyrophosphatase activity would limit the
availability of inorganic phosphate in the cell and move the equilibrium of the
reaction catalyzed by F0F1-ATPase towards ATP hydrolysis and consequent use of
the energy released to pump protons out of the cell against their thermodynamic
gradient. The citEF genes encode the beta and alpha chain, respectively, of the three-
subunit enzyme citrate lyase that catalyzes the first step of the citrolactic fermentation
pathway leading to the intracellular conversion of citrate to lactate. In L. lactis, this
pathway is known to generate metabolic energy by a secondary mechanism through
the creation of a PMF that is sufficiently high to drive ATP synthesis via the F0F1-
ATPase (Hugenholtz et al., 1993). The citrate enzymes generate a ΔpH across the cell 
membrane as they consume a cytosolic proton during citrate decarboxylation to
lactate, whereas the secondary transporter generates a ΔΨ of physiological polarity by 
coupling the uptake of divalent citrate to the exit of monovalent lactate.
Consequently, the net result of the down-regulation of yshC and citEF genes
expression would be a collapse of the PMF in L. lactis IL1403 as a result of the
abolished generation of the ΔΨ and ΔpH generally associated with the F0F1-ATPase
activity and the citrolactic fermentation pathway. Phage-induced differential
regulation of other genes (ahrC and argCJD) in L. lactis IL1403 concurred to
confirm this hypothesis. Arginine metabolism in L. lactis is usually modulated by
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ahrC towards repression of the biosynthesis pathway and activation of its catabolism.
This leads to ammonia production which is proposed to maintain pH homeostasis in
L. lactis probably via neutralization of intracellular low pH values (Larsen et al.,
2004, Larsen et al., 2008). In response to the phage stimuli, L. lactis IL1403 was
observed to repress ahrC and induce the biosynthetic genes argCJD, potentially
leading to accumulation of intracellular arginine. This is likely to be consequent to
the F0F1-ATPase-mediated export of protons that, by leaving a more alkaline
intracellular pH, would generate no need for ammonia neutralization.
Why would the cell affect the PMF and switch to anaerobic growth in response
to phage adsorption? In E. coli, adsorption of phages T4 and T5 has been shown to
induce the opening of a channel in the cell membrane, which mediates the transfer of
phage DNA into the host. The open conformation of the channel triggers a strong
efflux of potassium and calcium ions that, in turn, induces a partial and transient
depolarization of the host membrane (Boulanger and Letellier, 1988, Labedan and
Letellier, 1981). The infected bacteria respond by a repolarization that leads to a new
steady state of reduced ΔΨ (Labedan and Letellier, 1981). In L. lactis IL1403, the
changes mediated by the repression of yshC and citEF genes would lead to a
hyperpolarization of the membrane, which is consistent with the repolarization
phenomenon observed in E. coli cells following phage adsorption. This observation
prompted us to investigate putative changes in the ΔΨ of L. lactis IL1403 cells
following adsorption of phage c2 by using flow cytometry and the ΔΨ-sensitive dye
rhodamine 123. This fluorochrome tends to accumulate on the inner side of energized
membranes (i.e. cells maintaining an active ΔΨ) and, consequently, its intracellular
fluorescence intensity decreases following membrane depolarization. Staining of
exponentially growing bacterial cells with rhodamine 123 resulted in active
accumulation of the dye at fluorescence levels averaging around 104 arbitrary units
(Figure 4a). A log decrease in the average intracellular fluorescence was observed 10
min after the addition of phage c2, which was indicative of a depolarization of the
membrane and consequent efflux of the dye out of the cells (Figure 4b). A similar
collapse of the ΔΨ was observed when rhodamine 123-stained cells were incubated in
the presence of the uncoupler CCCP for 10 min (data not shown). A gradual reuptake
of fluorochrome up to pre-infectious levels was then observed between 15 and 25 min
within the infection process (Figure 4c,d), which suggested that bacteria had regained
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an energized membrane thus allowing a reuptake of fluorochrome into the cells.
These data are indicative of an initial dissipation of the ΔΨ followed by a gradual 
restoration of its physiological level, which is consistent with previous findings in E.
coli (Labedan and Letellier, 1981, Letellier and Labedan, 1985). They also suggest
that, regardless of the phage-host system, a strong depolarization of the host
membrane is a common effect induced by phage adsorption. In this context, our
transcriptional data appear to provide insights into the strategy adopted by the cell to
obtain a rapid repolarization of the membrane. By regulating the expression of yshC
and citEF genes, L. lactis IL1403 may simultaneously modulate both components of
the PMF, thus restoring the physiological pre-infectious condition in the shortest
timeframe possible. Increased respiratory rate and proton influx were shown to be
related to the transient depolarization of the membrane in E. coli cells following
adsorption of phages T4 and T5 (Letellier and Labedan, 1985). Consequently, the
“appropriate” regulation of genes involved in the same pathways seems to be the
most logical route for the cell to reverse the phage-induced effect.
L. lactis IL1403 appears to switch to anaerobiosis and to an energy-saving state
to sustain the PMF and the overall response to the phage-induced stress
Transcriptional analyses showed that phage attack triggered the down-regulation
of bacterial genes involved in the metabolism of lipids (pflA, fabG and yebB),
carbohydrates (enoB and adhE), cofactors (coaA), proteins and amino acids (pepXP,
yeiG, yteB), and in DNA replication (ruvB, dnaC, ligA), transcription (rheB, nusG),
and translation (gatA). Expression of genes (ysxL and yphL) encoding for GTP-ases
was also repressed. The activity of these DNA binding proteins is modulated by the
GTP pool in the cell and has been recently demonstrated to link various aspects of the
cell cycle and metabolism with translation by playing key roles in the assembly of
ribosomes in bacteria (Britton, 2009). The results outlined above depict a scenario
where L. lactis IL1403 is globally reducing growth- and development-promoting
activities, to which it generally commits considerable amounts of energy and that are
not needed for coping with the phage-induced stress. The biogenesis of lipid
membrane is an example of such energy-consuming cellular functions, and notably L.
lactis IL1403 repressed three genes (pflA, fabG and yebB) associated with this
pathway. The pflA gene product is required to activate the pyruvate formate-lyase
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enzyme, which catalyzes the non-oxidative cleavage of pyruvate to formate and
acetyl-CoA (Conradt et al., 1984). This latter metabolite is a central intermediate of
the fatty acid biosynthesis pathway, and consequently repression of pflA exerts an
overall rate-limiting action on lipid biogenesis. FabG is an essential gene belonging
to the multi-gene fab cluster involved in fatty acid biosynthesis in bacteria. It encodes
a 3-ketoacyl-acyl carrier protein reductase that is the first enzyme participating in
each cycle of chain elongation, and its essential nature is demonstrated by the fact
that fatty acid biosynthesis and cell growth are arrested in E. coli following
abolishment of fabG transcription (Zhang and Cronan, 1998). Conversely, the yebB
gene is considered nonessential for viability in E. coli but encodes a key enzyme in
the biosynthesis of isoprenoids. These compounds serve numerous essential functions
in eukaryotic and prokaryotic bacteria including structural components of
membranes, mediation of cellular redox chemistry, message relay during signal
transduction, and sugar transport during glycoprotein biosynthesis (Hahn et al.,
1999). In tune with this, L. lactis IL1403 also down-regulated other genes (ywaF and
pmi) associated with the synthesis of the cell wall. YwaF belongs to the ubiquitous
family of glycosyltransferases (PF00534), which are involved in cell envelope
biogenesis and function by transferring activated sugars to an acceptor molecule
localized at the outer surface of the cell membrane. Regulation of ywaF has been
previously reported in L. lactis cultures following treatment with lacticin 972
(Martinez et al., 2007). Mannose-6-phosphate isomerase (Pmi) catalyzes the
interconversion of mannose 6-phosphate and fructose 6-phosphate, which is the first
step in the synthesis of mannose-containing sugar chains. The role of Pmi activity has
not been characterized so far in lactic acid bacteria, but studies in other bacterial
species would suggest a central regulatory role in both cell wall synthesis and energy
production (Lerner et al., 2009).
While repressing energy-consuming functions, L. lactis IL1403 was also found
to induce expression of the nrdDG genes and concomitantly to repress that of nrdE.
The operons nrdEF and nrdDG of L. lactis encode ribonucleotide reductases that are
activated during conditions of aerobiosis and anaerobiosis, respectively. These
enzymes catalyze the reduction of ribonucleoside di- or triphosphates, thereby
providing the building blocks required for DNA replication and repair. During
anaerobic growth, L. lactis switches on the nrdDG operon and relies on the ability of
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NrdG to generate the glycyl radical crucial to the reducing activity of NrdD (Jordan et
al., 1996, Torrents et al., 2000). Repression of the aerobic ribonucleotide reductase
(nrdEF) and induction of the anaerobic enzyme (nrdDG) would therefore suggest a
switch to growth conditions resembling anaerobic fermentation in L. lactis IL1403.
When integrated into the overall picture of cell wall D-alanylation, PMF restoration
and energy conservation, the switch to anaerobic-like growth conditions may be best
explained by the bacterium needing to recover an energetic state favourable to sustain
the PMF and the overall response to the phage stress. In this scenario, up-regulation
of ndrH by L. lactis IL1403 is not fully understood. NrdH belongs to the NrdH-
redoxin family (cd02976) of proteins and is characterized by a glutaredoxin-like
sequence and thioredoxin-like activity profile. It is part of the nrdEF operon and
usually functions as an electron carrier for the aerobic reductase system, which was
found to be repressed in this study. Nonetheless, ndrH induction in L. lactis IL1403
following phage attack might have a different purpose as glutaredoxins/thioredoxins
are also known to be involved as alternative pathways in cellular functions such as
signal transduction and defence against oxidative stress (Fernandes and Holmgren,
2004).
L. lactis IL1403 overall response to phage infection is probably regulated by a
complex cell-envelope stress regulon.
The overall response of L. lactis IL1403 to phage infection is likely to be
orchestrated by a complex regulatory network involving the products of the strongly
up-regulated genes ythB (+7.12), ythC (+4.10), yneH (+7.50), kinD (+4.80) and llrD
(+5.90) (Tables 2 and 3). YthB (67 aa) is identical to a family of conserved
membrane proteins acting as stress-responsive transcriptional regulators (PF04024),
which includes the Phage shock protein C (PspC) from E. coli and Yersinia
enterocolitica. Topology analysis predicted YthB to be an integral membrane protein,
with the N-terminus inserted into the lipid layer and the C-terminus to form a trans-
membrane helix with an in/out orientation relative to the membrane (Figure 5c). The
last seven C-terminal residues are predicted to project out of the membrane which
suggests that they could be involved in stress signal transduction. YthC (371 aa) is
probably a cytoplasmic protein, as no membrane-spanning domains were predicted in
its sequence, and shares homology to a family of conserved proteins of unknown
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function (COG3595). Sequence analysis of the regions surrounding ythB and ythC
revealed a three gene operon-like structure where ythC precedes the genes ythB and
ythA. Similarly to YthB, YthA (154 aa) contains a PspC-like domain that, in this case,
entails only the N-terminal region (0 to 75 aa) of the protein and is predicted to be
located inside the membrane (Figure 5b). The localization of the C-terminus is
uncertain as it is predicted to reside inside the membrane by the TOPCONS model
but outside by the TMHMM model. The ythCBA genes are likely to be transcribed as
a single polycistronic unit as computational analysis retrieved promoter sequences for
efficient gene expression only upstream of ythC as well as a strong rho-independent
terminator signal (ΔG = -7.1) downstream of ythA (Figure 5a).
The Psp system is thought to protect the cell from a variety of extracytoplasmic
stressors affecting membrane integrity and causing dissipation of the PMF and a
likely change in the cell’s redox state (Darwin, 2005, Joly et al., 2010). Interestingly,
recent studies in E. coli identified the Psp system as being involved in regulating the
response to phage-induced stress (Jovanovic et al., 2006, Poranen et al., 2006).
Temporal gene expression analysis of cells during infection with the lytic phage
PRD1 revealed up-regulation of genes involved in anaerobic respiration early in the
infection process (i.e. 5 to 15 min) and induction of the psp system throughout the
whole infection process, with a peak of expression observed coincident with the
production of PRD1 holin protein (Poranen et al., 2006). A psp system response was
also shown to be induced in E. coli by a homologue of protein IV from filamentous
phage and to be directed to adjust and maintain energy usage and PMF by switching
cell metabolism to anaerobic respiration and by sustaining ΔΨ and ΔpH, respectively 
(Jovanovic et al., 2006). These results are strikingly similar to those obtained in our
study and suggest that both Gram-positive and Gram-negative bacteria use a common
mechanism to counteract any stress affecting cell envelope integrity. In L. lactis, psp
homologues have been indeed found to be strongly induced in a nisin-resistant strain
(Kramer et al., 2006), and following exposure to lactococcin 972 (Lcn972), a
bacteriocin that inhibits cell wall synthesis (Martinez et al., 2007). Perturbations of
the host membrane and of the associated PMF, which may be caused by the activity
of pore-forming agents (holins, protein IV, or bacteriocins) or simply by the opening
of a channel for phage DNA delivery (as in our study), induce up-regulation of the
Psp regulon. This system activates a genetic reprogramming of the host cell aimed at
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restoring membrane integrity and a physiological PMF by modulating the expression
of genes affecting both PMF components and switching to anaerobiosis to save
energy and maintain the new steady state.
The psp regulon has a diverse organization in different Gram-negative bacteria,
but only four genes (pspFABC) are always conserved and therefore suggested to
constitute the minimal functional response system (Darwin, 2005). The pspF gene is
transcribed from its own promoter in opposite direction to the pspABC operon. A
basic working model of the Psp response implies that the stress signal is sensed by the
membrane proteins PspB and/or PspC, and then relayed to the PspAF complex that
serves an effector role of the Psp response. In L. lactis IL1403, three genes are
organized in a putative operon (ythCBA) somewhat resembling the organization and
function of the pspABC genes. YthB and YthA are indeed stress-responsive PspC
proteins with predicted localization on the membrane, whereas no function is known
for the cytoplasmic protein YthC. However, no homologues of the pspAF genes are
found upstream of the ythCBA operon. This suggests that L. lactis may have evolved
a novel organization of this responsive system, where cell envelope stress is still
sensed by a PspC-like protein (YthB), but then relayed to a different effector system
than PspAF.
It is tempting to speculate that this effector might correspond to the product of
the spxB (formerly yneH) gene, whose expression was among the most highly
induced in L. lactis IL1403 following phage infection. SpxB is one of seven paralogs
in L. lactis with homology to the highly conserved Spx proteins, known to act as
global transcriptional regulators in many Gram-positive species (Nakano et al.,
2003b). Spx homologues have been shown to fulfil an important role in growth,
general stress protection, and biofilm formation in S. aureus (Pamp et al., 2006), to
regulate the global response to oxidative stress in Bacillus subtilis (Nakano et al.,
2003a), and to mediate the cell-wall stress response in L. lactis. In the latter organism,
SpxB was found to be essential in mediating a multistep response that increases
peptidoglycan resistance to lysozyme hydrolysis (Veiga et al., 2007), and to be
strongly up-regulated in response to the cell wall-targeting antimicrobial peptides
nisin (Kramer et al., 2006) and Lcn972 (Martinez et al., 2007). Spx proteins possess a
bivalent regulatory activity that is suggested to be essential for protection and
maintenance of the general well-being of bacterial cells under stressful conditions.
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They would act as negative regulators to postpone energy-consuming development
and growth-related functions, while using their activator capacities to mobilize the
operations necessary to reverse the stress-induced effects (Nakano et al., 2003a,
Nakano et al., 2003b). This suggests that SpxB might be involved in coordinating the
overall transcriptional response of L. lactis IL1403 to the phage stimuli as observed in
our study, which would include activities related to cell-wall D-alanylation, PMF
maintenance and energy conservation.
SpxB might be therefore the effector protein to which YthB relays the stress
signal. This could be achieved via direct interaction of YthB with SpxB or,
alternatively, via the two-component system CesSR, whose genes were also found to
be highly induced in L. lactis IL1403 following phage exposure (Tables 2 and 3). The
CesSR system has been associated with cell envelope stress response in L. lactis and,
interestingly, it seems to control the expression of both spxB and psp genes via the
regulator CesR (Martinez et al., 2007, Veiga et al., 2007). Based on these findings, it
may be speculated that the stress sensor YthB, the regulator CesR and the effector
SpxB might be part of the same signal transduction pathway leading to activation of a
cell-wall stressosome in L. lactis IL1403 (Figure 6). If this is the case, it is not clear
from our data whether YthB relays the signal directly to CesR or via the histidine
kinase CesS.
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CONCLUSIONS
In this study, we have used a transcriptomic approach to analyze the holistic
response of L. lactis IL1403 at the onset of a phage challenge and to determine any
putative strategy adopted by the host to avoid phage infection. To our knowledge, our
results describe for the first time in L. lactis the molecular mechanisms involved in
the host response to the membrane perturbations mediated by phage infection. The
identity of the regulated genes revealed that L. lactis IL1403 engages in a strong cell
wall-targeted response to phage attack while concomitantly repressing energy-
consuming functions related to development and growth. The phage presence is
clearly sensed as an extra-cytoplasmic stress and, based on our findings, we propose a
putative working model of the cell envelope stress response consequently mounted by
L. lactis IL1403 (Figure 6). The phage-mediated stress would be sensed by the PspC-
like protein YthB, which then relays the stress signal to the effector protein SpxB
presumably via the two-component system CesSR or via direct interaction. Upon
induction, SpxB would use its global regulator capacities to increase the D-alanine
content of cell-wall TAs, to restore a physiological PMF and to activate an energy-
saving programme by postponing growth-related functions and switching cell
metabolism to anaerobiosis in order to sustain the PMF and the overall response to
the phage stress.
In this model, SpxB would play a leading effector role in the bacterial response,
which is deduced from the pleiotropic functions reported for this regulator in various
organisms (Martinez et al., 2007, Nakano et al., 2003a, Nakano et al., 2003b, Pamp et
al., 2006, Veiga et al., 2007). However, it is interesting to note that in our study
phage attack stimulated activation of Psp homologues at levels similar to SpxB, and
also that these proteins might be expected to control and regulate specific responses
(i.e. D-alanylation of LTAs and energy conservation by SpxB; PMF restoration by
Psp proteins). Determining the putative crossover or separation of the regulatory
activities of these proteins is of great interest and will be the subject of future
investigations. Our knowledge to date shows that CesSR seems to control the
expression of both spxB and psp genes in L. lactis (Martinez et al., 2007, Veiga et al.,
2007), thus suggesting that SpxB and the Psp proteins may actually interact and be
part of a common strategy (the CesSR stimulon) aiming at protecting L. lactis from
cell envelope stresses. Considering the nature of the different stressors (lysozyme,
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antimicrobial peptides, phages) stimulating its activation in L. lactis, the CesSR
stimulon probably represents a general defence mechanism committed to preserve not
only cell wall integrity but, ultimately, cell viability. While much is known about this
system in Gram-negative bacteria, very little data is available for Gram-positive
species. As such, we anticipate further investigations to improve our understanding of
this vital defence system in L. lactis and in Gram-positive bacteria, in general.
Another interesting finding of our study is that phage attack could trigger an
increased incorporation of D-alanine into the bacterium cell-wall TAs, thus perhaps
rendering cells more resistant to phage infection. Although the outcome is still a
successful phage infection, we speculate that this strategy is likely to allow the
survival of a small percentage of the cell population when facing in vivo low titer-
phage attacks. The survivors may have retained memory of the strategy adopted
during previous attacks and have gradually generated this sophisticated response.
Theoretically, the efficiency of this strategy could be enhanced through genetic
manipulation by over-expression of the dlt operon. However, findings from a recent
study seem to negate this hypothesis. In Lb. delbrueckii, phage inactivation by D-
alanyl-substituted LTAs was found indeed to be less effective when high levels of D-
alanine residues were present in the LTA backbone (Raisanen et al., 2007).
Considering that this result may be related to the specific phage-host system
examined, the application of such a genetic approach in L. lactis may still prove
successful.
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TABLES
Table 1. Primers used in this study for qRT-PCR validation of microarray results
Gene Primer Sequence 5' - 3' Position Size (bp)
ddl forward GTTTTTGAAGCGGTTGGTGT 400-419 187
reverse TTAGCGCAGGTTGAAGGTCT 586-567
dltA forward AAGCGATTAATGCGGTGACTT 198-218 283
reverse GGTGATTCGGTAGCCAAAGGT 480-460
dltB forward AGAAGCTTGGGTGTATTGTTGC 555-576 161
reverse ACTAAAAGCGCCAGTTGTCAC 715-695
dltC forward GAACGCGTGCTGCTATTTTAT 24-44 163
reverse CGTGAAGACTTAGACATGGATTTAT 186-162
dltD forward GGGTGGTGGTATTTTCTTTAGGA 783-805 228
reverse GTTTTACGCCATTCTTAGTAGGAC 1010-987
nrdG forward GTGCGCTGCTCACTTTATGTG 97-117 398
reverse AATCCGCTGATTTGATGACCC 495-475
yhbF forward CTACAATCGGGCGGTTAGAGC 195-215 394
reverse TTTCAAATTGCCATTTTCATCAG 588-566
yndF forward CAGTCGTTGCAAGCCCTAAAGT 1530-1551 383
reverse AACAAACAGCACCAACAAGTCAAA 1835-1812
yneH forward GGAGACGCCAAGGAATAAAGG 6-23 154
reverse GGAATCAAAAGCACCCAAACT 198-179
ythB forward GTGTGTCATCAATAGACTCGCA 23-46 145
reverse GGACTTGGTGAATACTTTGGCT 167-151
ythC forward AATATTTCCGTTTACGAGTGAGACA 286-310 185
reverse TTATGAACGGAAATGCTGAAGTG 470-448
kinD forward GGATTACTTGCGCTGATTTTTACCC 178-202 395
reverse AAGAGTGCTCGCATTTCATTTTGTG 572-548
llrD forward CCCGATATCGAAGTGGTTGG 79-98 256
reverse CAGCGGCTTGTGATGTTTTA 334-315
yhbE forward GAACGTTCAGTAGGCAGTTTCTTA 172-195 129
reverse AGGTTCGGCGATTTCTTTTT 300-283
ywaF forward GTGACAGCTGCCCTTTATTTTA 493-514 215
reverse GCAGATGACATGGCTCCTTC 707-688
yveF forward TTTTCTCCCTTCTGCTCACTCAAT 17-40 138
reverse CCCCGCTCGAAAATGGTATC 154-135
alaS forward AGTAAGCGACGTAAAACATAACCAC 1691-1715 207
reverse TCAAGGCGGAAAAACAAACT 1897-1878
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Table 2.
Functional category / Pathway a Gene
Expression
ratio (n-fold) Gene product / Putative function
b Subcellular localizationc
Carbohydrate metabolism
Citrate (TCA) cycle citE -2.25 Citrate lyase beta chain (EC:4.1.3.6) Cytoplasmic
Citrate (TCA) cycle citF -2.28 Citrate lyase alpha chain (EC:4.1.3.6) Cytoplasmic
Glycolysis/Gluconeogenesis enoB -2.26 Phosphopyruvate hydratase (EC:4.2.1.11) Cytoplasmic
Glycolysis/Gluconeogenesis adhE -2.35 Acetaldehyde-CoA / alcohol dehydrogenase (EC:1.2.1.10) Cytoplasmic
Starch and sucrose metabolism malQ -2.18 4-alpha-glucanotransferase (EC:2.4.1.25) Cytoplasmic
Amino sugar and nucleotide sugar metabolism pmi -2.05 Mannose-6-phosphate isomerase (EC:5.3.1.8) Cytoplasmic
Starch and sucrose metabolism pgmB 2.08 Beta-phosphoglucomutase (EC:5.4.2.6) Cytoplasmic
Cell envelope
Surface (lipo-)polysaccharides and antigens yndF 3.16 Hypothetical protein Cell wall
Surface (lipo-)polysaccharides and antigens floL -2.72 Flotillin-like protein Cytoplasmic membrane
Surface (lipo-)polysaccharides and antigens ywaF -2.34 Glycosyltransferase Cytoplasmic
Peptidoglycan biosynthesis dltA 2.11 D-alanine-poly(phosphoribitol) ligase (EC:6.1.1.13) Cytoplasmic
Peptidoglycan biosynthesis dltD 2.11 D-alanine transfer protein Unknown
Peptidoglycan biosynthesis ddl 2.18 D-alanine-D-alanine ligase (EC:6.3.2.4) Cytoplasmic
ABC transporters optS -2.13 Oligopeptide ABC transporter substrate binding protein Cell wall
Unknown yfbG 2.09 Hypothetical protein Cytoplasmic membrane
Unknown ybfC 2.08 Hypothetical protein Cytoplasmic membrane
Unknown yghD 2.54 Hypothetical protein Cytoplasmic membrane
Unknown ythB 2.46 Putative stress response protein, PspC-like Cytoplasmic membrane
Unknown ythC 2.83 Hypothetical protein Cytoplasmic
Energy Metabolism
Oxidative phosphorylation yshC -2.51 Putative Mn-dependent inorganic pyrophosphatase (EC:3.6.1.1) Cytoplasmic
Electron transport ndrH 2.18 Glutaredoxin-like protein NrdH Cytoplasmic
Lipid Metabolism
Fatty acid biosynthesis fabG1 -2.23 3-oxoacyl-acyl carrier protein reductase (EC:1.1.1.100) Cytoplasmic
Fatty acid biosynthesis acpD 2.04 Acyl carrier protein phosphodiesterase [EC:3.1.4.14] Unknown
Pyruvate metabolism pflA -2.29 Pyruvate-formate lyase activating enzyme (EC:1.97.1.4) Cytoplasmic
Terpenoid backbone biosynthesis yebB -2.00 Isopentenyl-diphosphate delta-isomerase (EC:5.3.3.2) Cytoplasmic
Metabolism of Cofactors and Vitamins
Pantothenate and CoA biosynthesis coaA -2.55 Pantothenate kinase (EC:2.7.1.33) Cytoplasmic
Riboflavin metabolism ribC 2.29 Riboflavin kinase (EC:2.7.1.26 Cytoplasmic
Protein and Amino Acid metabolism
Amino acid transport and metabolism yteB -2.54 Putative D-amino acid oxidase protein Cytoplasmic
Amino acid transport and metabolism yeiG -2.67 Aminotransferase (EC:2.6.1.-) Cytoplasmic
Arginine and proline metabolism argC 2.27 N-acetyl-γ-glutamyl-phosphate reductase (EC:1.2.1.38) Unknown
Arginine and proline metabolism argJ 2.06 Ornithine acetyltransferase (EC:2.3.1.35) Cytoplasmic
Arginine and proline metabolism argD 2.22 acetylornithine aminotransferase (EC:2.6.1.11) Cytoplasmic
Degradation of proteins and (glyco-)peptides pepXP -2.10 X-prolyl dipeptidyl aminopeptidase (EC:3.4.14.11) Cytoplasmic
Purines, Pyrimidines, Nucleosides and Nucleotides
Purine metabolism; Pyrimidine metabolism nrdE -2.29 Ribonucleoside-diphosphate reductase alpha chain (EC:1.17.4.1) Unknown
Purine metabolism; Pyrimidine metabolism nrdD 2.65 anaerobic ribonucleoside triphosphate reductase (EC:1.17.4.2) Cytoplasmic
Purine metabolism; Pyrimidine metabolism nrdG 2.87 Anaerobic ribonucleoside-triphosphate reductase activating
protein (EC:1.97.1.4)
Cytoplasmic
Regulatory functions
Transcription factors rliA -2.85 Transcription regulator, LacI family Cytoplasmic
Transcription factors yddC 2.23 Putative transcription regulator Cytoplasmic
Transcription factors yveF 2.24 Putative PadR family transcriptional regulator Cytoplasmic
GTP-binding proteins ysxL -2.17 GTPase EngB Cytoplasmic
GTP-binding proteins yphL -2.04 GTP-binding protein EngA Cytoplasmic membrane
GTP-binding proteins yyaL 2.10 GTP-dependent nucleic acid-binding protein Cytoplasmic
General yeeG -2.28 Transcription regulator Cytoplasmic membrane
General ahrC -2.04 Transcription regulator of arginine metabolism Cytoplasmic
General yjaI 2.27 Hypothetical protein Unknown
Unknown yneH 2.72 Putative transcription regulator Unknown
Two-component systems kinD 2.11 Sensor protein kinase KinD Cytoplasmic membrane
Replication and Repair
DNA replication; Nucleotide excision repair ligA -2.45 NAD-dependent DNA ligase (EC:6.5.1.2) Cytoplasmic
DNA replication dnaC -2.05 Replicative DNA helicase (EC:3.6.1.-) Cytoplasmic
DNA repair ywaC 2.81 Hypothetical protein Cytoplasmic
Homologous recombination ruvB -2.26 DNA helicase RuvB (EC:3.1.22.4) Cytoplasmic
Transcription
RNA processing rheB -2.62 ATP-dependent RNA helicase Cytoplasmic
RNA synthesis/modification; DNA transcription nusG -2.32 Transcription antitermination protein Cytoplasmic
Aminoacyl-tRNA biosynthesis gatA -2.11 Aspartyl/glutamyl-tRNA amidotransferase subunit A (EC:6.3.5.6
6.3.5.7)
Cytoplasmic
Aminoacyl-tRNA biosynthesis argS 2.04 Arginyl-tRNA synthetase (EC:6.1.1.19) Cytoplasmic
Unknown
Unknown yhfA 2.02 Hypothetical protein Cytoplasmic
Unknown yveE 2.10 Hypothetical protein Cytoplasmic
Unknown ywaH 2.11 Hypothetical protein Cytoplasmic
Unknown yccL 2.34 Hypothetical protein Cytoplasmic
Unknown yhbF 2.34 Hypothetical protein Cytoplasmic
Unknown yhbE 2.46 Hypothetical protein Cytoplasmic
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Table 2. Transcriptional response of L. lactis IL1403 following infection by the lytic
phage c2.
Captions:
aPathway assignment is based on the KEGG GENES database
(www.genome.jp/kegg/genes.html).
bPutative function is based on homology to conserved domains and motifs/signatures
by using the InterProScan tool (Zdobnov and Apweiler, 2001).
cSubcellular localization is based on predictions retrieved from the PSORTdb v.2.0
database (Rey et al., 2005).
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Table 3. qRT-PCR validation of microarray data for selected genes differentially
expressed in L. lactis IL1403 following infection by phage c2.
Gene qRT-PCR microarrays
ddl 2.42 2.18
dltA 2.80 2.11
dltB 2.50 nsd1
dltC 3.78 nsd1
dltD 2.94 2.11
nrdG 15.88 2.87
yhbF 5.18 2.34
yndF 3.26 3.16
yneH 7.50 2.72
ythB 7.12 2.46
ythC 4.10 2.83
kinD 4.82 2.11
llrD 5.96 nsd1
yhbE 11.02 2.46
ywaF - 2.90 - 2.34
yveF 2.40 2.24
1nsd = not significantly different
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Figure 1. Phage-host challenges to determine the multiplicity of infection (MOI)
necessary to lyse completely a bacterial population within 40 min. Effects of the
addition of phage c2 (indicated by an arrow) at an MOI of 0 (■), 200 (▲), 400 (●), 
600 (◊) and 800 (□) on the viability of L. lactis IL1403 cells growing in log phase.
Chapter II
89
Figure 2. Microarray image of Cy3-labelled cDNA of L. lactis IL1403 vs. phage c2
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Figure 3. Microarray image of Cy5-labelled cDNA of L. lactis IL1403 vs. phage c2
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Figure 4. Flow cytometric analysis of membrane potential in rhodamine 123-stained
cells of L. lactis IL1403 before (a) and after addition of phage c2: (b) 10 min; (c) 15
min; (d) 25 min.
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Figure 5. Sequence analysis of the putative ythCBA operon and of the PspC-like
products YthA and YthB. (a) Putative regulatory elements of the ythCBA operon. The
ribosome binding site (RBS) and -10 sequences in the promoter region upstream of
ythC and the rho-independent terminator signal downstream of ythA are shown
underlined. The start codon of ythC is shown in bold. (b, c) Membrane topology
prediction for the YthA (b) and YthB (c) proteins by using the TMHMM and
TOPCONS models (i = inside ; M = trans-membrane; o = outside).
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Figure 6. Putative working model of the cell-wall stressosome of L. lactis IL1403
in response to phage infection. The predicted sequence of events in the host cell
triggered by phage infection is indicated by broken arrows, and by numbers
within brackets as regards the putative steps leading to SpxB induction. D-alanine
esters incorporated into LTAs or WTAs are indicated by small squares. Inhibition
of metabolic reactions or pathways is indicated by black crosses. Gene up-
regulation and down-regulation is indicated by arrows pointing up and down,
respectively. Abbreviation are as follows: LTAs, Lipoteichoic acids; WTAs, cell
wall teichoic acids; RNAP, RNA Polymerase; ATP, Adenosine Triphosphate;
ADP, Adenosine Diphosphate; Pi, inorganic phosphate; PPi, inorganic
pyrophosphate; F0F1-ATPase, ATP synthase.
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Novel conjugative plasmids from the natural isolate Lactococcus
lactis subsp. cremoris DPC3758: a repository of genes for the
potential improvement of dairy starters
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ABSTRACT
A collection of 20 natural lactococcal isolates from raw milk cheeses were
studied in terms of their plasmid distribution, content and diversity. All strains in the
collection harboured an abundance of plasmids, including L. lactis subsp. cremoris
DPC3758, whose 8-plasmid complement was selected for sequencing. The complete
sequences of pAF22 (22,388 bp), pAF14 (14,419 bp), pAF12 (12,067 bp), pAF07
(7,435 bp) and pAF04 (3,801 bp) were obtained, whereas gene functions of
technological interest were mapped to pAF65 (65 kb) and pAF45 (45 kb) by PCR.
The plasmids of L. lactis DPC3758 were found to encode many genes with the
potential to improve the technological properties of dairy starters. These included
three anti-phage restriction/modification (R/M) systems (one of type I and two of type
II) and genes for immunity/resistance to nisin, lacticin 481, cadmium and copper.
Regions encoding conjugative/mobilization functions were present in 6 of the 8
plasmids, including those containing the R/M systems, thus enabling the food-grade
transfer of these mechanisms to industrial strains. Using cadmium selection, the
sequential stacking of the R/M plasmids into a plasmid-free host provided the
recipient with increased protection against 936- and c2-type phages. The association
of food-grade selectable markers and mobilization functions on L. lactis DPC3758
plasmids will facilitate their exploitation to obtain industrial strains with enhanced
phage protection and robustness. These natural plasmids also provide another
example of the major role of plasmids in contributing to host fitness and preservation
within its ecological niche.
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INTRODUCTION
Forty years of studies on plasmid biology have widely shown the crucial
contribution of these extra-chromosomal entities to the performance, fitness and
genomic evolution of Lactococcus lactis. Strains belonging to this genus have
become an essential component of modern industrial starters, mostly as a result of
plasmid-encoded features promoting efficient growth in milk (i.e. metabolism of
lactose, milk proteins, citrate and other complex nutrients), resistance to
environmental stresses (e.g. bacteriophages, heavy metals, temperature/osmotic
stresses), and competitive advantages (i.e. production of bacteriocins and
exopolysaccharides). Plasmids encoding these phenotypes are often mobilizable,
facilitating their spread among bacteria occupying the same ecological niche. This
feature has greatly contributed to the genome plasticity and evolution of lactococci,
enabling them to become adapted and specialized to the dairy environment (Mills et
al., 2006).
In addition to being commonly found in milk, L. lactis strains are naturally
present on plants and thus it is highly likely that dairy strains actually originate from
plant-derived strains transferred from forage plants and meadow grasses to milk via
cattle (Nomura et al., 2006, Salama et al., 1995). Compared to milk-derived strains,
natural lactococcal isolates are thought to possess additional capabilities that enable
them to compete and survive to multiple selections deriving from the environment,
farm and traditional milk processing. Dairy strains have probably lost these traits in
favour of those required for adaptation to the milk environment (Mills et al., 2006,
Nomura et al., 2006, Salama et al., 1995). An example is the greater tolerance of
stress demonstrated by natural isolates as a result of a variety of protection
mechanisms developed to resist the numerous cytotoxic compounds and organisms
(antibiotics, heavy metals, bacteriocins and bacteriophages) present in the plant and
animal environments (Ballesteros et al., 2006, Leelawatcharamas et al., 1997,
Nomura et al., 2006, Schirawski et al., 2002, Tanous et al., 2007). These phenotypes
are encoded by genes often carried by plasmids, which, again, reaffirms the role
played by these genetic elements in determining the uniqueness, fitness and
performance of L. lactis strains. Based on these observations, the analysis of plasmid
distribution and diversity appears to be an essential tool to evaluate the genetic
potential and variability in both dairy and natural lactococcal strains.
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Only a relatively limited number of L. lactis strains belonging to the subspecies
lactis and cremoris are used in modern large-scale processes due to the need to
maintain consistent quality over a vast range of products manufactured worldwide. It
is thus arguable that the intensive exploitation of these few cultures has contributed to
narrow flavour diversity in dairy products and favoured the emergence of host-
specific lytic bacteriophages (phages) (Coffey and Ross, 2002, Cogan et al., 1997,
Nomura et al., 2006). There is therefore a renewed interest in the isolation and
characterization of new strains in order to replace or complement the starter cultures
currently used in dairy industry. Novel genes encoding for phage-defence systems,
bacteriocin production/immunity, flavour-forming abilities and good technological
properties are particularly sought. These phenotypes are often encoded on plasmids
that are easily mobilizable via natural conjugation, thus enabling the use of a food-
grade approach to obtain novel starter formulations with enhanced robustness and
long-term efficiency or to allow the manufacture of new and safer products (Coffey
and Ross, 2002, Forde and Fitzgerald, 1999, Mills et al., 2006).
We have recently focused our attention towards the isolation, identification and
characterization of L. lactis strains from natural ecological niches and good quality
artisanal products, particularly cheese. Artisanal cheeses generally possess unique
sensory characteristics compared to large scale industrial products, that may
attributed to the activity of the natural milk microflora, left intact by the absence of
pasteurization and probably derived from the plant and animal environments
(Ballesteros et al., 2006, Cogan et al., 1997, Delgado and Mayo, 2004). In this study,
we describe a preliminary analysis of the plasmid complement of 20 lactococcal
isolates from artisanal cheeses for traits with potential for the improvement of starter
cultures, followed by the sequencing and functional analyses of the 8-plasmid
complement of the isolate L. lactis subsp. cremoris DPC3758. Our results suggest a
significant contribution by the plasmid pool in protecting the host from several
environmental stresses by means of three anti-phage restriction/modification (R/M)
systems, and genes for resistance to bacteriocins and heavy metals. These genetic
traits are located on plasmids carrying conjugative/mobilization regions, which is
suggestive of a high level of genome plasticity for L. lactis DPC3758. We
demonstrate that these regions are functional and allow the exploitation of these
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natural plasmids to obtain lactococcal strains with enhanced phage protection and
robustness.
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MATERIALS AND METHODS
Bacterial strains, bacteriophages and media
A collection of 20 natural lactococcal isolates was used in this study (Table 1),
which were isolated during a previous screening of artisanal raw milk cheeses from
around Europe (Spain, France, Italy and Greece) with a view to identifying strains
with the potential as starters for commercial dairy fermentations (Cogan et al., 1997).
Bacterial strains were routinely propagated at 30 C in M17 medium (Oxoid, UK)
supplemented with 0.5% (wt/vol) glucose (GM17) or lactose (LM17). Solid media
contained 1.0% (wt/vol) bacteriological agar (Oxoid, UK). Lactococcal
bacteriophages (Table 1) were propagated on sensitive hosts and phage preparations
were titrated at 30 °C according to standard procedures (Terzaghi and Sandine, 1975).
Bacterial strains were stocked in M17 containing 40% glycerol at -80 C. Working
cultures were stored at 4C and transferred periodically.
Screening for natural lactococcal isolates
A combination of phenotypic and genotypic techniques was used to confirm the
preliminary assignment of isolates to the Lactococcus genus (Cogan et al., 1997), or
to support a new identification. Phenotypic tests were as follows. Gram staining and
catalase reaction using 3% (v/v) H2O2 were performed on single colonies grown
overnight on LM17 agar at 30 C, while cell morphology was determined from a
loopful of culture grown overnight in LM17 broth at 30 C. Growth of isolates at
different temperatures (10 and 45 °C) and in presence of different salt levels (4 and
6.5%) was tested in 10 ml LM17 broth (1% inoculum) over a 5-days period, after
which the pH of each culture was measured and a pH difference of 1 units between
the test isolate and the uninoculated control was considered indicative of growth.
Ability to hydrolize aesculin was assessed by growing isolates on kanamycin aesculin
azide (KAA) agar (Oxoid, Hampshire, England) for 24 to 48 h. Acid production from
lactose was assessed after streaking isolates onto lactose indicator agar (LIA)
containing 0.004% (w/v) bromocresol purple. Genotypic tests involved the use of
genus-specific primers, designed within conserved regions of the lactococcal and
enterococcal 16S rRNA genes, and PCR conditions as described elsewhere (Deasy et
al., 2000). Definitive genus confirmation of presumptive lactococcal isolates was
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obtained by using the universal 16S rRNA primers CO1 (5’-
AGTTTGATCCTGGCTCAG-3’) and CO2 (5’-TACCTTGTTACGACT-3’) and the
PCR conditions as described elsewhere (Beresford and Condon, 1991). Aliquots (20
l) of the amplified products were subjected to electrophoresis in 1% agarose (Sigma,
St. Louis, USA) gels and stained with ethidium bromide. PCR products were purified
by using the QIAquick PCR Purification Kit (Qiagen GmbH, Germany) and
sequenced by single run primer extension (Beckman Coulter Genomics, USA).
Sequencing data were searched for regions of similarity against DNA sequences
available in public databases (GenBank, EMBL, DDBJ, PDB) by using the nucleotide
MegaBLAST algorithm of the Basic Local Alignment Search Tool (BLAST) (Zhang
et al., 2000).
Classification of natural lactococcal isolates
Isolates identified as belonging to the Lactococcus genus were selected for the
rest of the study. Differentiation and classification of lactococcal isolates at species
and subspecies level was obtained by using traditional phenotypic and genotyping
methods in combination with chemometric analyses. The fermentation profiles of 49
sugars and polyalcohols were determined on fully grown lactococcal cultures by
using the API 50 CH kit and API 50-CHL medium (bioMerieux SA, France)
according to the manufacturer’s instructions. L. lactis subsp. lactis IL1403, L. lactis
subsp. lactis biovar. diacetylactis DRC3, and L. lactis subsp. cremoris HP were
included in the analysis as internal references. Chemometric analyses of carbohydrate
fermentation profiles of lactococcal isolates were performed by using Minitab
v.15.1.1 (Minitab Inc., USA). The fermentation profiles typical of the subspecies
lactis, cremoris and hordniae, and of L. raffinolactis, as reported by the API 50 CH
kit’s manufacturer, were also included in the analysis as external references.
Biochemical tests showing no change in percent of carbohydrate fermentation among
all test and reference bacteria were removed from the analysis. Results of the
remaining tests were converted to a five-grade score, corresponding to different
percents (0, 25, 50, 75 and 100%) of substrate utilization. Hierarchical cluster
analysis (HCA) on the converted data was obtained by using the unweighted pair
group method with arithmetic averages (UPGMA) and the squared Euclidean
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distance. Principal components analysis (PCA) was performed standardizing the
variables (mean = 0; SD= 1) (Fallico et al., 2004).
Genomic DNA was extracted from 1 ml-aliquots of overnight cultures (Hoffman
and Winston, 1987). Randomly amplified polymorphic DNA (RAPD)-PCR profiles
of lactococcal isolates were obtained by using the primer 5’-ATGTAACGCC-3’ and
the PCR conditions described elsewhere (Jayarao and Oliver, 1994). Aliquots (5 l)
of the amplified products were subjected to electrophoresis in 1% agarose gels. The
reproducibility of RAPD-PCR patterns was checked in duplicate assays. HCA
analysis of RAPD-PCR profiles was performed by using BioNumerics v.2.00
(Applied Maths, Belgium). Band patterns were normalized before being subjected to
HCA by using the Pearson correlation coefficient and the UPGMA method.
Plasmid DNA analysis
Plasmid DNA of the lactococcal isolates was extracted as described elsewhere
(O'Sullivan and Klaenhammer, 1993) and analyzed by electrophoresis on horizontal
0.6% agarose gels in TAE buffer (40 mM Tris–HCl, 20 mM Acetic acid, 2 mM
EDTA, pH 8.0) for 4 h at 80 V. The large plasmids (65-, 51- and 36-kb) of L. lactis
DRC3 (McKay and Baldwin, 1984) and the Supercoiled DNA ladder (2 to 16 kb)
(Invitrogen, USA) were used as markers of DNA molecular size.
Antimicrobial production and cross-sensitivity assays
Antimicrobial production by the lactococcal isolates was estimated by agar well
diffusion assay (Ryan et al., 1996) using L. lactis subsp. cremoris HP as the indicator
strain. The bacteriocin-like nature of the antimicrobials was determined by sensitivity
assays to proteases (trypsin, -chymotrypsin, and proteinase K, 50 mg/ml each) and
temperature (50, 70, 90, and 110C) as described elsewhere (Ryan et al., 1996). The
anti-listerial activity of bacteriocins was tested against Listeria innocua DPC3572 in
agar well diffusion assays. Cross-sensitivity of antimicrobial producers L. lactis
DPC3758 and L. lactis DPC3694 versus known bacteriocin producers was
determined as follows. Agar plates were seeded with 200 l of L. lactis DPC3758 or
L. lactis DPC3694 overnight cultures, inoculated with 50 l of neutralized
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supernatant from L. lactis DPC5558 (nisin producer), L. lactis DPC5552 (lacticin 481
producer), L. lactis DPC938 (lactococcins A, B and M producer), and L. lactis
DPC3147 (lacticin 3147 producer) into pre-formed wells, incubated overnight at 30
C and then examined for zones of growth inhibition.
Phage resistance analyses
Rapid screening of lactococcal strains for phage resistance/sensitivity was
performed by using the spot test technique (Sanders and Klaenhammer, 1983).
Briefly, GMI7 agar plates were overlaid with top lawns of soft GM17 agar (0.7%,
w/v) containing 100 l of overnight culture, 5 mM CaCl2, and 0.75% (w/v) glycine.
Lactococcal lawns were spotted with 20l of purified phage lysates at a suitable titre
(108-1010 pfu/ml), incubated overnight at 30 C and then examined for zones of
clearance. Glycine was added during all spot and plaque assay tests to improve
visualization of plaques in poor plaque-producing phages (Lillehaug, 1997).
Additionally, the plasmid complement of lactococcal strains was screened for the
presence of a type I R/M hsdS gene by using a degenerate PCR approach. The amino
acids sequences of 20 HsdS subunits from lactococcal plasmids were aligned by
using T-Coffee (Notredame et al., 2000). Regions of homology within the N-terminal
and central conserved domains of the HsdS proteins were used to design the
degenerate primers 5’-GGNTTYACNGAYGAYTGGTAR-3’ and 5’-
GCRAANCGNAGRTCNGGNAC-3’ in order to amplify the variable region, or
target recognition domain (TRD), located in the middle of these conserved domains.
By using total plasmid DNA as template, PCR amplicons of ca. 640 bp were
obtained. These were purified by the QIAquick PCR Purification kit (Qiagen GMBH,
Germany) and sequenced by double strand primer extension (Beckman Coulter
Genomics, USA). Sequencing data were searched for regions of similarity against
DNA sequences available in public databases (GenBank, EMBL, DDBJ, PDB) by
using the nucleotide MegaBLAST algorithm of the Basic Local Alignment Search
Tool (BLAST) (Zhang et al., 2000).
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Sequencing and annotation of the plasmid complement of L. lactis subsp.
cremoris DPC3758
Plasmid DNA was prepared as described elsewhere (O'Sullivan and
Klaenhammer, 1993). Any residual genomic DNA was removed by treatment with
Plasmid-Safe ATP-Dependent DNase (Epicentre, Madison, USA) which selectively
hydrolyzes linear double-stranded DNA to deoxynucleotides without affecting closed
circular supercoiled or nicked circular dsDNAs. The eight purified plasmids were
sequenced as a pool on a 454 Genome Sequencer FLX System, after preparation of a
sonication library, barcoding of the library with the Roche multiplex identifier
system, and emPCR amplification (Beckman Coulter Genomics, USA). Automatic
de-novo assembly of data resulted in 92 large (> 500 bp) contigs (ca. 203 kb) and 115
small (< 500 bp) contigs (ca. 31 kb) providing a total of ca. 234 kb of sequence data.
Gap closure was performed by PCR using primers designed with PrimerSelect v.8.0.2
(DNASTAR, USA), followed by sequencing of the PCR products (Beckman Coulter
Genomics, USA). Putative open reading frames (ORFs) were automatically predicted
and annotated using Glimmer 2.0 (Delcher et al., 1999). Annotated DNA sequences
were examined manually using the Artemis viewer (Rutherford et al., 2000) and
BLASTX and BLASTP analyses (Altschul et al., 1998) were used to examine
intergenic regions for putative ORFs not identified by Glimmer, to identify putative
frameshifts, and to refine the start codon assignments. The InterProScan tool
(www.ebi.ac.uk/Tools/InterProScan), the PFAM (Finn et al., 2010) and Conserved
Domain Database (CDD) (Marchler-Bauer et al., 2009) were used to predict protein
function. InterProScan predicts the occurrence of functional domains and
motifs/signatures in a protein by combining 12 different databases and their relative
protein signature recognition methods (Zdobnov and Apweiler, 2001).
Association of genetic traits to pAF65 and pAF45 of L. lactis DPC3758
A PCR-based approach was used to associate traits of interest (phage resistance,
conjugation and stress response) with one of two of the unclosed plasmids, pAF65
(65kb) or pAF45 (45 kb) (Figure 2). The individual plasmids were gel extracted,
purified by the Geneclean II kit (QBiogene, USA), and used as template DNA in PCR
reactions containing primers specific for each selected genetic trait (Table 1).
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Functional analyses of the cadmium and copper resistance operons of L. lactis
DPC3758
To evaluate the functionality of the cadmium resistance operon, L. lactis
DPC3758 was grown at 30C for 18 h in LM17 containing increasing concentrations
(0 to 0.3 mM) of cadmium chloride (CdCl2). Similarly, the functionality of the copper
resistance operon was evaluated by growing L. lactis DPC3758 at 30 C for 18 h in
LM17 containing increasing concentrations (0 to 6 mM) of cupric sulphate (CuSO4).
In both experiments, L. lactis MG1363 was used as a reference strain due to its
sensitivity to cadmium and copper.
Conjugative studies and phage sensitivity assays
A conjugation study was designed using L. lactis DPC3758 (cadmium resistant,
CdR; rifampicin sensitive, RifS), and the plasmid-free L. lactis MG1614 (cadmium
sensitive, CdS; rifampicin resistant, RifR) as donor and recipient strains, respectively.
Overnight cultures of donor and recipient strains were used to prepare 2% inoculums
that were grown at 30 C for 4 h. Cells from 1-ml aliquot of each culture were
harvested (14,000 rpm, 1 min, 4 C), resuspended in 200 l of GM17, mixed in a
recipient-to-donor ratio of 1:2 and then spotted onto the centre of a non-selective
GM17 agar plate. Donor and recipient controls were prepared in a similar manner.
Following an overnight incubation at 30 C, the mating mix was recovered from the
plate, resuspended in 10 ml of GM17 broth containing 0.3 mM cadmium chloride
(CdCl2) and 100 g ml-1 rifampicin, and then incubated a further overnight at 30C
to enrich for CdR RifR transconjugants. Donor and recipient controls were recovered
from the plates, resuspended in 1 ml of GM17 broth, and directly plated onto LIA,
containing 0.3 mM CdCl2, 100 g ml-1 rifampicin, and 0.004% bromocresol purple.
Following overnight incubation, cells from 1-ml aliquot of the mating mix were
harvested, resuspended in 1 ml of GM17, and then plated onto selective media.
Putative transconjugants, appearing as white colonies, selected and plasmid DNA
profile analyzed to verify the acquisition of the plasmids. Confirmed transconjugant
strains were examined for their sensitivity to phages c2 and 712 by using the plaque
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assay technique (Terzaghi and Sandine, 1975). Efficiency of plaquing (EOP) was
determined by dividing the phage titer on the test strains by the titer on the
homologous host L. lactis MG1614.
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RESULTS AND DISCUSSION
Screening for natural Lactococcus lactis isolates
All twenty isolates were found to be gram-positive, catalase-negative, coccus-
shaped bacteria that existed in pairs or short chains; they were all growing in 4%
NaCl and producing acid from lactose. Enterococci are found in a wide range of dairy
products, especially those made from raw milk, at a magnitude comparable to
lactococci (Cogan et al., 1997, Delgado and Mayo, 2004). Consequently, bacterial
isolates were subjected to a number of phenotypic tests (growth at 10 °C and in 6.5%
NaCl; esculin hydrolysis on KAA medium) commonly used for the identification of
the genus Enterococcus (Deasy et al., 2000, Delgado and Mayo, 2004). Four isolates
(DPC3694, DPC3901, DPC3758 and DPC3912) showed a positive response to all
tests, which is typical of enterococci, whereas four other isolates (DPC3757,
DPC3776, DPC3907 and DPC3749) exhibited negative responses, typical of
lactococcal strains (Table 3). The remaining twelve isolates showed undefined
intermediate reactions, a finding that confirms the inaccuracy of traditional tests in
clearly differentiating lactococci from enterococci. There are indeed numerous reports
of lactococcal strains, especially those isolated from natural ecosystems, exhibiting an
Enterococcus-like phenotype and vice versa. Consequently, researchers now prefer to
use molecular techniques for both classification and typing purposes (de la Plaza et
al., 2006, Deasy et al., 2000, Delgado and Mayo, 2004, Nomura et al., 2006). A
genotyping approach involving genus-specific 16S rRNA gene sequencing was thus
used to obtain a reliable and definitive discrimination between lactococci and
enterococci in our bacterial collection. Seventeen isolates produced an amplicon only
in presence of the Lactococcus-specific primers, whereas three isolates gave reaction
only with the Enterococcus-specific primers (Table 3).
Chemometrics of carbohydrate fermentation profiles is a valid tool for
differentiation and classification of lactococcal strains
The 17 isolates identified as belonging to the Lactococcus genus were selected
for the remaining part of this study. Differentiation and classification of these bacteria
at species and subspecies level was attempted by chemometric analysis of
carbohydrate fermentation profiles. All lactococcal isolates were able to fully ferment
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ribose, galactose, glucose, fructose, mannose, esculin, maltose, lactose and trehalose,
but unable to utilize glycerol, erythritol, D-arabinose, L-xylose, adonitol, methyl-D-
xylopyranoside, L-sorbose, L-rhamnose, dulcitol, inositol, D-sorbitol, methyl-D-
mannopyranoside, methyl-D-glucopyranoside, D-mellibiose, inulin, D-melezitose,
D-raffinose, glycogen, xylitol, D-turanose, D-lyxose, D-tagatose, D- and L-fucose, D-
and L-arabitol, and potassium 2- and 5-ketogluconate.
A sub-dataset of 26 tests, showing the actual inter-strains differences, was
subjected to cluster analysis by the UPGMA method (Figure 1). Levels of similarity
greater than 80% in the homology tree dendrogram were considered indicative of
strain homology. With the exceptions of L. lactis DPC3749 and DPC3758, the
isolates shared high similarity (greater than 90%) and were grouped into three main
clusters. The two larger clusters (I and III) were composed of 12 isolates that are
likely to belong to the lactis subspecies as they grouped together with reference
standards L. lactis subsp. lactis 1 and 2. However, clusters I and III were clearly
separated in the dendrogram and shared less than 80% homology, which is indicative
of a phenotypic diversity between members of the two groups. PCA results (Figure 2)
revealed that these differences consisted in the ability of cluster I members to ferment
D-mannitol, D-saccharose, D-xylose, gentibiose, arbutin, salicin, potassium
gluconate, amygdalin, N-acetylglucosamine, D-lactose, L-arabinose, and D-
cellobiose at a greater extent than strains of cluster III. Within this cluster, L. lactis
DPC3776, DPC3778 and DPC3926 shared virtually identical fermentation profiles.
The smallest cluster (II) included three isolates (L. lactis DPC3901, DPC3880 and
DPC3911) sharing greater than 90% similarity with the experimentally obtained
profile of the reference strain L. lactis subsp. lactis biovar. diacetylactis DRC3.
Interestingly, L. lactis DPC3749 and DPC3758 were not grouped in any of the above
clusters. L. lactis DPC3749 shared less than 80% similarity with clusters II and III
and with the reference strain L. lactis subsp. lactis IL1403. This suggested an atypical
subspecies lactis phenotype for this isolate. Similarly, L. lactis DPC3758 is likely to
represent an atypical cremoris isolate as it was found to share less than 80% similarity
to L. lactis subsp. cremoris 1 but only 40% similarity to L. lactis subsp. cremoris HP.
The 16S rRNA gene of five strains (L. lactis DPC3694, DPC3749, DPC3901,
DPC3776 and DPC3758), including a representative of each cluster and both outliers,
was amplified and sequenced in order to confirm the reliability of this classification.
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BLAST analysis confirmed the cremoris genotype for L. lactis DPC3758 and the
lactis genotype for the other isolates, with L. lactis DPC3694 and DPC3901
exhibiting strong similarity to the 16S rRNA gene of the biovariant diacetylactis.
Among the 17 natural isolates, L. lactis DPC3758 was the only one to belong to the
cremoris subspecies. This finding is consistent with the observation that most natural
isolates of lactococci belong to the lactis subspecies, whereas the subspecies cremoris
is only rarely isolated (Cogan et al., 1997, Salama et al., 1995). Interestingly, L. lactis
DPC3758 exhibited a cremoris genotype but it was found to grow at high
temperatures and NaCl concentrations, properties that are typical of the subspecies
lactis. This is consistent with the reports of strains with a lactis phenotype that may
fall either into the lactis or in the cremoris genotype (de la Plaza et al., 2006, Delgado
and Mayo, 2004). In this study, data generated by carbohydrates fermentation tests
provided a differentiation of the isolates at the subspecies level that was further
confirmed by 16S rRNA gene sequencing. In contrast to previous reports (Delgado
and Mayo, 2004), our results therefore support the use of chemometric analysis of
fermentation profiles as a valid and reliable tool for the classification and typing of
novel lactococcal isolates.
Following the phenotypic characterization, the lactococcal isolates were
differentiated at the strain level by using HCA of RAPD-PCR profiles (Figure 3). All
isolates exhibited different profiles, with the exceptions of L. lactis DPC3776,
DPC3778, and DPC3926 that were already found to share identical fermentation
profiles (Figure 1). These isolates were collected from the same dairy batch and,
therefore, they are likely to represent the same strain. HCA of RAPD-PCR profiles
separated the lactococcal isolates into three main clusters (Figure 3). The smallest one
included three isolates (L. lactis DPC3757, DPC3780 and DPC3694) sharing each
other low genetic similarity (60 to 70%) but high phenotypic relatedness as they were
grouping together (cluster I) in the HCA dendrogram of fermentation profiles (Figure
1). The remaining two clusters included isolates with high genetic homology (greater
than 80%) but varied phenotypic relatedness as these isolates were grouping in
different fermentation clusters (Figure 1). These results are not surprising as it is
widely recognized that phenotypic and genotypic groupings do not necessarily match
in L. lactis strains (de la Plaza et al., 2006, Delgado and Mayo, 2004, Nomura et al.,
2006).
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Preliminary characterization of the natural lactococcal strains
Natural L. lactis isolates are thought to possess a broader genetic makeup
compared to industrial strains, with plasmid-encoded functions generally reflecting
host adaptation to different ecological niches (Mills et al., 2006). Based on this
rationale, the 17 natural lactococcal strains were characterized for the diversity and
genetic content of their plasmids with the aim of identifying novel plasmid-encoded
genes for the technological improvement of dairy starters. A rich and heterogeneous
content of plasmids was found in all investigated strains, with each one harbouring
between 2 and 10 plasmids with sizes ranging from 2 kb to 80 kb (Figure 4a). This
latter finding was especially intriguing as large plasmids are expected to contain most
of the genetic information providing a competitive advantage to the lactococcal host
to flourish in its natural ecosystem (Siezen et al., 2005).
A number of preliminary tests were undertaken to identify genetic traits of
potential interest (i.e. antimicrobial production and phage resistance) on the plasmid
complement of these isolates. Firstly, the supernatant from an overnight culture of
each strain was assayed for antimicrobial activity. Three strains (L. lactis DPC3758,
DPC3694 and DPC3901) were found to produce narrow-spectrum antimicrobial
compounds, which inhibited the growth of the indicator strain L. lactis HP (Figure
4b) but not the growth of indicators such as Listeria innocua, Lactobacillus paracasei
and Pediococcus acidilactici. The antimicrobials produced by L. lactis DPC3758 and
DPC3694 were sensitive to proteases and thermal treatments, which is indicative of a
bacteriocin-like nature, whereas the compound produced by L. lactis DPC3901 was
unaffected by such treatments. Results of cross-sensitivity tests (data not shown)
suggested that L. lactis DPC3758 and DPC3694 were likely to produce a lacticin 481-
or a lactococcin-like protein and to harbour immunity to nisin, lacticin 481 and
lactococcins A, B and M. Despite these similarities, differences in RAPD-PCR
patterns (results not shown), plasmid profiles and bacteriocin potency excluded that
L. lactis DPC3758 and DPC3694 are different isolates of the same strain.
Secondly, spot assays with a number of c2-type (c2, ml3, eb1) and 936-type
(sk1, 712, hp) phages revealed that 3 isolates (L. lactis DPC3776, DPC3874, and
DPC3778) were exclusively sensitive to c2-type phages, whereas the remaining
strains were resistant to all phages tested (Figure 4c). In L. lactis, host protection from
phage attack is often afforded by its plasmid complement via one or more of four
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mechanisms of resistance known to date: (i) inhibition of phage adsorption, (ii) phage
DNA injection blocking, (iii) phage DNA restriction/modification (R/M), (iv)
abortive phage infection. Of these, R/M systems are the most interesting as their
phage inactivation strategy has no deleterious effects on host viability, and, in the
case of type I R/M, they can modulate the level of phage restriction by homologous
recombination of HsdS specificity subunits (Mills et al., 2006, Schouler et al.,
1998b). Consequently, we investigated our collection of natural lactococcal strains for
the presence of type I R/M hsdS genes by using degenerate primers designed to target
the N-terminal TRD (Figure 4d). Thirteen of the 17 isolates produced an amplicon of
the expected size (ca. 640 bp), indicating the presence of at least one hsdS gene and
possibly, of a complete type I R/M system in their plasmid complement.
Sequence analysis of the plasmid complement of L. lactis subsp. cremoris
DPC3758
These initial findings prompted a deeper investigation of the genetic properties
of these natural isolates by sequencing the entire plasmid complement of L. lactis
subsp. cremoris DPC3758. This strain was chosen as it exhibited a number of
technologically interesting characteristics: (i) complete resistance to c2- and 936-type
phages, (ii) the presence of a hsdS gene and putatively of an associated type I R/M
system, (iii) antimicrobial production, (iv) and a rich extra-chromosomal complement
composed of 8 plasmids, with sizes ranging from 2 kb to 80 kb. Additionally, L. lactis
DPC3758 was the only strain in the investigated collection to belong to the
subspecies cremoris, which is highly suitable for the manufacture of Cheddar and
other cheese varieties (Nomura et al., 2006, Salama et al., 1995).
High-throughput sequencing of L. lactis DPC3758 plasmids generated 234 kb of
data distributed over 207 contigs. Following initial BLAST analysis and gene
annotation, a PCR-mediated gap closure strategy was adopted to complete each of the
plasmid sequences. This approach was successful in the case of five plasmids, namely
pAF22, pAF14, pAF12, pAF07 and pAF04 (Figure 5; Tables A1-A5 in Appendix).
These plasmids displayed a GC content ranging from 32 to 36%, which is consistent
with the 31-36% range described for lactococcal plasmids (Siezen et al., 2005).
However, the presence of numerous secondary structures and many homologous
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insertion sequences (IS) rendered the primer walking strategy unsuccessful in closing
the largest plasmids, pAF65 (65 kb) and pAF45 (45 kb). In these cases, gap closure
focused on those regions containing traits of technological interest (phage resistance
systems, conjugation/mobilization regions, and stress response/selectable markers),
which were then associated with either pAF65 or pAF45 using a PCR approach
(Figure 5; Tables A6-A12 in Appendix). The sequencing data revealed that the
antimicrobial produced by L. lactis DPC3758 is a lactococcin-like bacteriocin whose
genetic determinants are located on the chromosome.
A battery of three R/M systems protects L. lactis DPC3758 against phage attack
The plasmid complement of L. lactis DPC3758 harbours a significant array of
defence mechanisms against phage attack, including one type I R/M and two type II
R/M systems, which confirms suggestions that the latter mechanisms are the most
common in lactococci (Mruk et al., 2003). Type I R/M systems are typically made up
of three genes (hsdRMS), transcribed in the same direction, and coding for three
subunits which are responsible for DNA restriction (HsdR), modification (HsdM) and
specificity (HsdS), respectively (Murray, 2000). The type I R/M system (R/M-I) of L.
lactis DPC3758 is located on pAF65 (Figure 5; Table A7 in Appendix). The hsdR
gene encodes a restriction endonuclease (REase, 995 aa) containing conserved
helicase-like (COG0610) domains, while the 515-aa long product of hsdM is a typical
N6-adenine -class methyltrasferase (MTase, pfam02384). Both proteins are 99%
identical to the HsdR and HsdM enzymes encoded by homologous genes present on
the chromosome of L. lactis IL1403 (Schouler et al., 1998a). In contrast, the
specificity protein (428 aa) encoded by R/M-I hsdS of pAF65 is 61% similar to
listerial HsdS subunits and shares only 36% identity with its homolog from L. lactis
IL1403. Low similarities among HsdS subunits is generally common and reflects the
large variability existing within their TRDs, which are responsible for imparting
target sequence specificity to both the restriction and modification activities of the
type I R/M complex (Murray, 2000). However, amino acid sequence alignments
revealed that the HsdS of pAF65 mostly diverges from that of L. lactis IL1403 and
other lactococci at the C-terminal TRD (aa positions 281-399), where the sequence
identity drops to as low as 18% (Figure 6). Indeed, this region is 84% similar to a
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TRD shared by some Listeria, Enterococcus and Lactobacillus organisms, a finding
that would suggest a putative shuffling of hsdS TRDs. Such an event has been
reported to have generated the co-integrated plasmid pAH90 from the native plasmids
pAH33 and pAH82 in L. lactis DPC721 (O'Sullivan et al., 2000). In pAH90, the
recombination event formed two novel hybrid hsdS genes that had interchanged the
N- and C-terminal TRDs of the parent subunits and sequence analysis revealed that
the site of recombination involved a 19-aa sequence
(KVPELRFAGFADDWEERKL) located in the conserved central domain of both
HsdS proteins (O'Sullivan et al., 2000). Interestingly, this exact sequence is present at
the end of the conserved central domain (aa positions 256-276) of the HsdS of L.
lactis DPC3758, just preceding the C-terminal TRD and exactly marking the start of
the divergence of sequence from the HsdS of L. lactis IL1403 (Figure 6). These
findings support the hypothesis that a homologous recombination event may have
promoted the acquisition of a novel TRD, possibly from a Listeria, Enterococcus or
Lactobacillus strain, and of a likely novel specificity in the R/M-I HsdS of L. lactis
DPC3758. Such an event is highly feasible as members of these genera usually
coexist in the rich and diverse microflora typical of raw milk cheeses. O’Sullivan et
al. (2000) aligned the variable regions of all known HsdS proteins of L. lactis and S.
thermophilus and found evidence of putative domain shuffling events occurring
between members of these two genera. This led the authors to speculate that the
generation of new specificities via homologous recombination is a widespread
strategy used by Lactococcus to enhance its natural defences against phages. Indeed,
the formation of pAH90 occurred in a background of high-titre phage challenge for L.
lactis DPC721 (O'Sullivan et al., 2000). In the case of pAF65, it is tempting to
speculate that its raw milk origins would favour the establishment of a resilient
microflora and, in turn, the likely emergence of a reservoir of homologous phages.
Phages are able to overcome the restriction systems of the host by mutating the
restriction sites in their genomes (Coffey and Ross, 2002, Forde and Fitzgerald,
1999). Consequently, the acquisition of novel restriction specificities by genetic
recombination may represent the evolutionary response of lactococci to the
mutational capacity of phages to avoid the host anti-phage mechanisms.
In addition to R/M-I, L. lactis DPC3758 also contains the type II R/M systems
R/M-IIa and R/M-IIb, located on pAF45 and pAF22 (Figure 5; Tables A1 and A6 in
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Appendix), respectively. Type II R/M systems are typically composed of two
enzymes: a REase that recognizes and cleaves a specific short DNA sequence (4–8
bp), and a MTase that modifies the same sequence in order to protect the host DNA
against the action of the cognate restriction enzyme (Mruk et al., 2003). The upstream
gene in R/M-IIa encodes a protein of 296 aa containing typical N6-adenine -class
MTase (pfam01555) and DNA modification methylase (COG0863) domains, while
the downstream gene encodes a protein of 335 aa containing an HindIII restriction
endonuclease domain (pfam09518). These proteins are virtually identical to the
MTase (99%) and REase (96%) enzymes of the LlaCI system found on plasmid
pAW153 from L. lactis subsp. cremoris W15 (Madsen and Josephsen, 1998a).
Similar to the LlaCI system, the R/M-IIa genes of L. lactis DPC3758 are arranged in
a convergent fashion and are separated by a 94-bp sequence. The second type II R/M
system, R/M-IIb, consists of a 180-aa REase, belonging to the Bsp6I superfamily
(pfam09504), and a 317-aa cytosine-C5 specific DNA methylase (cd00315)
belonging to the superfamily of S-adenosylmethionine-dependent MTases (cl12011).
In this case, both genes are transcribed in the same direction and their gene products
are virtually identical to the REase (98%) and MTase (99%) enzymes of the LlaDII
system found on the naturally occurring 8.9-kb plasmid pHW393 in L. lactis subsp.
cremoris W39 (Madsen and Josephsen, 1998b). Taken individually, these R/M-II
systems have limited restriction efficiency (Madsen and Josephsen, 1998a, b).
However, the most likely benefit for L. lactis DPC3758 in harbouring these systems
is in their cooperative activity with R/M-I, which confers the strain with wider and
greater protection against different phage types. Phages attacking this strain will be
sequentially challenged by three systems possessing different R/M specificities; those
that will be uncut or restricted with low efficiency by one system will still have to
face two other systems before being able to proliferate within the cell. The additive
restriction phenomenon and enhanced host protection afforded by the stacking of
anti-phage mechanisms is well documented (Coffey and Ross, 2002, Josephsen and
Klaenhammer, 1990, Madsen and Josephsen, 1998a, Mills et al., 2006, O'Sullivan et
al., 1998). L. lactis DPC3758 may have naturally opted to stack multiple R/M
systems to resist phage invasion as this strategy could prove crucial in providing
protection against existing and forthcoming phages, thus allowing the strain to
survive and become established in the challenging habitat of raw milk cheeses.
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The majority of L. lactis DPC3758 plasmids contain genes for
conjugative/mobilization functions
Conjugative plasmids are commonly found in lactococci and play a fundamental
role in their evolution as they allow the transfer of genome-size segments (Mills et
al., 2006). In terms of starter improvement, this feature is extremely important as the
conjugal transfer of naturally occurring plasmids is the most widely accepted
approach for the genetic improvement of dairy starters designed for human
consumption (Coffey and Ross, 2002, Forde and Fitzgerald, 1999, Mills et al., 2006).
Six of the 8 plasmids in L. lactis DPC3758 contain genetic regions associated with
predicted conjugative/mobilization functions. Firstly, pAF45 contains a 17,264 bp
conjugal transfer region (tra1) (Figure A5; Table 8 in Appendix) composed of 18
genes, which is virtually identical (99% at DNA level, and 97 to 100% at protein
level) to the tra operon of the lactococcal plasmid pMRC01 (Dougherty et al., 1998),
a finding that may be indicative of a genetic exchange event between these plasmids.
This region renders pMRC01 self-transmissible, a characteristic that has allowed the
efficient transfer of the plasmid to more than 30 different lactococcal strains,
including derivatives of commercial starters (Coffey and Ross, 2002, Ryan et al.,
1996). Similarly, tra1 could mediate the transfer of pAF45 and of the associated anti-
phage mechanism (R/M-IIa). A second large conjugal region, tra2, is present on
pAF22, whose overall genetic makeup is completed by the R/M-IIb system, a
replication region and two genes encoding for putative site-specific
resolvase/invertase (cd03768) enzymes (Figure 5; Table A1 in Appendix). Tra2
consists of ten genes (traABCDEFGJKL) encoding proteins with 43 to 78% similarity
to homologs present on plasmids plca36 from Lactobacillus casei Zhang (Zhang et
al., 2008), pLgLA39 from Lb. gasseri LA39 (Ito et al., 2009) and pWCFS103 from
Lb. plantarum WCFS1 (van Kranenburg et al., 2005). The third conjugal region, tra3,
of L. lactis DPC3758 is located on pAF65 (Figure 5; Table A9 in Appendix), also
carrying the R/M-I system. Data for seven (traCDEFJKI) of the 12 putative genes
composing tra3 were obtained from the original sequencing, but further attempts to
close gaps within this region were unsuccessful. Tra3 genes encode for products with
31 to 64% similarity mainly to conjugation proteins from Carnobacterium sp. AT7.
Homology to Tra proteins from plca36 (Zhang et al., 2008), pLgLA39 (Ito et al.,
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2009), pWCFS103 (van Kranenburg et al., 2005), and pMRC01 (Dougherty et al.,
1998) is much lower, in the region of 30-40%.
In addition to the conjugative abilities of pAF65, pAF45 and pAF22, a
mobilization gene cluster (mobC1ABC2) is located on pAF14 (Figure 5; Table A2 in
Appendix). This mob region is 99% identical at the nucleotide level to the
corresponding region in pNZ4000 (van Kranenburg et al., 2000). MobC1 (164 aa)
and MobA (410 aa) belong to the relaxase family (pfam05713) of enzymes and are
likely to be involved in DNA strand separation and nicking of the nic site of the oriT
sequences, respectively (van Kranenburg and de Vos, 1998). Both proteins are 98%
identical to their homologues from lactococcal plasmids pNZ4000 (van Kranenburg
et al., 2000) and pCI528 (Lucey et al., 1993). MobB (207 aa) and MobC2 (200 aa)
share 89% and 99% identity with MobB and MobC from pNZ4000, respectively.
These proteins are also thought to be involved in plasmid mobilization but their role
is unclear (van Kranenburg et al., 2000), as no canonical mobilization domains are
found in their sequence. BLAST analysis showed that the mobC2 gene is recurrent
among the Bacillus, Streptococcus and Enterococcus genera while returning a single
hit (pNZ4000) from the Lactococcus genus. This suggests that mobC2 has been
probably acquired during a recent horizontal gene transfer. Finally, genes encoding
mobilization proteins were also found on pAF12 (mobCD1D2) and on pAF07
(mobCA) (Figure 5; Tables A3-A4 in Appendix).
L. lactis DPC3758 harbours various stress response determinants that may be
used as food-grade selection markers
L. lactis DPC3758 plasmids were found to contain a number of stress response
genes conferring immunity/resistance to the bacteriocins nisin and lacticin 481, and to
the heavy metals cadmium and copper. In addition to their primary role of enhancing
the robustness and survival capabilities of the host, these genes also represent four
well documented markers of selection for transfer of plasmids in lactococci. As
indigenous genotypes, they are considered food-grade and are therefore acceptable
for use in dairy cultures designated for human consumption. All have been previously
exploited to produce phage resistant derivatives of L. lactis cultures and/or to
construct food-grade cloning vectors that are central to future programs of starter
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improvement (Coffey and Ross, 2002, Khunajakr et al., 1999, Liu et al., 2002, Liu et
al., 2005, Mills et al., 2002, Trotter et al., 2001).
In L. lactis DPC3758, nisin resistance is afforded by a 956-bp gene present on
pAF65 that is 99% identical to the resistance gene nsr present on the 60-kb
conjugative plasmid pNP40 from L. lactis DRC3 (O'Driscoll et al., 2006). NSR (318
aa) contains an N-terminal membrane-spanning domain and a C-terminal processing
peptidase domain (cd06567) typical of serine proteases. A recent study showed that
lactococcal Nisin Resistance Protein (NSR) confers the host with nisin resistance by
using a novel mechanism involving proteolytic removal of the C-terminal tail of
nisin. The peptidase/protease domain of NSR has been suggested to reside on the
extracellular side of the membrane, where it might contact and degrade nisin (Sun et
al., 2009). Plasmid pAF65 also carries the classical immunity determinants lctFEG
conferring resistance to lacticin 481, which are generally organized within an operon
also containing genes (lctAMT) involved in lacticin 481 biosynthesis and export
(Rince et al., 1994). However, these latter genes are missing in L. lactis DPC3758.
The proteins encoded by lctFEG genes have hydrophobicity profiles and sequence
similarities that strongly suggest an ABC transporter protecting the lacticin 481
producer strain from its own lantibiotic (Rince et al., 1997). A copper resistance
operon, lcoRSABC, (Figure 5; Table A12 in Appendix) identical to corresponding
homologues on lactococcal plasmids pND306 (Khunajakr et al., 1999, Liu et al.,
2002) and pSK11P (Siezen et al., 2005) is also present on pAF65. As observed in
pSK11P, the operon is flanked by two copies of IS-LL6 transposase A to form a
putative composite transposon (Siezen et al., 2005). The operon confers copper
resistance in L. lactis by reducing the intracellular accumulation of copper ions via a
two-component regulatory system composed of a DNA-binding response regulator
(LcoR, 223 aa) and a signal transduction histidine kinase (LcoS, 465 aa), which
regulate the copper-inducible transcription of downstream genes lcoABC. All
LcoABC proteins are required for copper resistance, but none of them contain any
putative copper-binding motifs. This suggests that LcoABC proteins play an indirect
role in the cell to achieve copper homeostasis (Khunajakr et al., 1999, Liu et al.,
2002). LcoA (269 aa) is a putative prolipoprotein diacylglyceryl transferase (cl00478)
and contains seven membrane-spanning hydrophobic regions, which suggests an
intra-membrane location. LcoB (451 aa) is an abundantly secreted protein of L. lactis
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but its function remains unknown. The C-terminal cysteine, histidine-dependent
amidohydrolase/peptidase (CHAP) domain (PF05257) of LcoB would suggest a
putative role as amidase involved in peptidoglycan metabolism (Siezen et al., 2005).
It is probably attached to the cell membrane through the N-terminal spectrin repeat
(cd00176) domain, which might also provide binding sites to favour the assembly of
large multi-protein regulatory or resistance complexes (Djinovic-Carugo et al., 2002).
LcoC (464 aa) is highly homologous to multicopper oxidases (COG2132) and
contains a lipoprotein signal motif which suggests a likely translocation across the
membrane to the outside of the cell to be covalently anchored by LcoA to membrane
lipids (Siezen et al., 2005). Analysis of growth in the presence of copper showed the
functionality of the lco operon in L. lactis DPC3758 (Figure 7c, d). While the growth
of L. lactis MG1363 was strongly inhibited by CuSO4 concentrations above 1 mM, L.
lactis DPC3758 was able to grow relatively well even at copper concentrations of 6
mM.
Resistance to cadmium in L. lactis DPC3758 is conferred by two overlapping
genes present on pAF14 (Figure 5; Table A2 in Appendix), which are 99% identical
to the cadmium resistance cassette cadAC present in lactococcal plasmids pAH82
(O'Sullivan et al., 2001), pGdh442 (Tanous et al., 2007) and pNP40 (O'Driscoll et al.,
2006), and in several other gram-positive bacteria (Schirawski et al., 2002). These
genes are organized as an operon, and their transcription is cadmium dependent in
vivo. The complete cassette has been shown to confer cadmium and zinc resistance to
both S. thermophilus and L. lactis, but expression of cadA alone is sufficient to give
resistance (Schirawski et al., 2002). CadA (705 aa) is a cation-translocating P-type
ATPase (COG2217, COG4087) that allows efflux of cadmium, thus resulting in
reduced accumulation of the toxic cation. CadC (119 aa) is highly similar to ArsR-
type regulatory proteins and has been shown to act as a repressor of the cadmium-
dependent expression of cadA by binding to its own promoter region, an interaction
that is lost in the presence of cadmium (Schirawski et al., 2002, Yoon et al., 1991).
The functionality of the cadAC cassette of pAF14 was tested by comparing the
growth of DPC3758 to that of the CdS strain L. lactis MG1363, in presence of
increasing concentrations of CdCl2 (Figure 7a, b). L. lactis DPC3758 was able to
tolerate CdCl2 concentrations of up to 0.3 mM, whereas L. lactis MG1363 was
inhibited by concentrations as low as 0.05 mM.
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In L. lactis DPC3758, three markers (nisin, lacticin 481 and copper resistance)
are contained on a plasmid (pAF65) also carrying conjugative proteins (Tra3) and a
phage resistance mechanism (R/M-I). This represents the ideal situation as it
overcomes the known difficulties encountered in delivering natural anti-phage
systems to industrial strains (Coffey and Ross, 2002, Forde and Fitzgerald, 1999,
Mills et al., 2006).
The R/M systems of L. lactis DPC3758 are transmissible and their stacking
increases the phage resistance of the host
L. lactis DPC3758 plasmids are of significant interest for programmes of starter
improvement as the presence of multiple transfer regions and food-grade selectable
markers would facilitate their delivery to industrial strains. Therefore, a series of
conjugation experiments were undertaken to evaluate the transmissible nature of these
plasmids. In agreement with previous reports (O'Sullivan et al., 2001, Trotter et al.,
2001), cadmium resistance proved to be a very effective selectable marker for
plasmid transfer to the chosen recipient, L. lactis MG1614. Analysis of the plasmid
profiles of 20 random transconjugants showed that all had acquired a plasmid of
approximately 14 kb, similar in size to pAF14 which contains the cadmium
determinants. Interestingly, only few transconjugants contained pAF14 on its own,
whereas the majority had acquired one or more additional plasmids, giving rise to a
total of seven major plasmid patterns (Figure 8a). Based on plasmid profile analysis,
it was deduced that the transconjugants Tc5, Tc6 and Tc7 harboured different
combinations of the three L. lactis DPC3758 R/M systems, a finding that was
confirmed using primers specific to each of these mechanisms (Figure 8b). This
allowed the evaluation of the restriction efficiency afforded by each R/M system
against phages c2 and 712, representatives of the predominant phage types found in
dairy industry, in a plasmid-free background (Figure 8c).
R/M-IIa and R/M-IIb were shown to restrict the 936 phages more efficiently than
the c2 phages, presumably due to the larger genome and correspondingly higher
number of recognition sites in the former. The phage EOP is known to decrease
exponentially as the number of sites in the viral genome increases (Forde and
Fitzgerald, 1999). The presence of R/M-IIa in MG1614-Tc6 resulted in a 2-log
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decrease of the EOP of phage 712 whereas it proved almost ineffective against phage
c2. These results are in agreement with the restriction efficiency reported for the
LlaCI system, which is homologous to R/M-IIa and was shown to confer L. lactis
strains with decreased sensitivity to phages of the 936 or P335 but not to the c2
species (Madsen and Josephsen, 1998a). The inefficacy against these latter phages
was associated with the lack of HindIII/LlaCI restriction sites in their genomes
(Madsen and Josephsen, 1998a). Superimposition of R/M-IIb on R/M-IIa (MG1614-
Tc7) resulted in additive restriction of phage 712 by causing a further 2.5-log EOP
reduction and increasing the efficiency of restriction to close to 10-5. Conversely,
R/M-IIb stacking did not improve host resistance against phage c2. These results are
less than what expected from the additive restriction afforded by a LlaDII
homologous, as this mechanism was reported to reduce by 2- and 4-fold the EOPs of
phage species c2 and 936, respectively (Madsen and Josephsen, 1998b).
While the chromosomally-encoded type I R/M system of L. lactis IL1403 is
known to restrict c2-type phages with low efficiency (2 logs) (Schouler et al., 1998b),
its homolog in L. lactis DPC3758 (R/M-I) was found to possess a broader and greater
restriction ability. Indeed, the superimposition of R/M-I on the low efficiency R/M-
IIb system (MG1614-Tc5) provided the L. lactis MG1614 host with complete
protection against both phages c2 and 712. These results confirm that the novel TRD
of R/M-I HsdS compared to that of the L. lactis IL1403 homolog is able to provide
the system with altered specificity and restriction activity. HsdS subunits determine
the target sequence specificity of type I R/M systems via both TRDs, each one
responsible for recognizing half of a bipartite target site (Murray, 2000). It is
therefore obvious that the acquisition of a different TRD, which may occur via
recombination of hsdS genes as observed in pAH90 (O'Sullivan et al., 2000), is able
to generate a new R/M specificity.
Results of the conjugation study reveal that most of L. lactis DPC3758 plasmids,
including those containing the R/M systems, are self-conjugative and may be co-
mobilized alongside other plasmids even in the absence of specific selection. This
feature has important commercial implications as it may be exploited to develop
industrial cultures with improved phage resistance through targeted delivery of anti-
phage mechanisms. Theoretically, all R/M systems of L. lactis DPC3758 may be
sequentially or concomitantly transferred to phage-sensitive industrial starters, thus
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providing the host with enhanced protection against phage attack as a result of the
additive resistance mediated by the stacking of three different restriction specificities.
Such strategies are generally limited by the lack of a suitable marker on the plasmid,
which would facilitate the selection of transconjugants harbouring the newly acquired
trait. This limitation should not affect the delivery of L. lactis DPC3758 plasmids as
they encode four phenotypes with well-documented application as food-grade
selectable markers (Liu et al., 2002, Mills et al., 2002, Trotter et al., 2001).
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CONCLUSION
In this study, we have investigated the plasmid distribution and diversity of a
collection of natural L. lactis isolates from raw milk cheeses for the presence of
genetic traits with potential application in programmes of dairy starters’
improvement. Natural lactococci are expected to possess a heterogeneous range of
properties, which are mostly plasmid-encoded and provide the host with a
competitive advantage to adapt and become established within its ecological niche
(Mills et al., 2006). The results of this study support the assumption and confirm the
value of the approach targeting natural isolates. An intriguing abundance and
diversity of plasmids was observed in all investigated strains. Moreover, when the 8-
plasmid complement of the natural isolate L. lactis DPC3758 was sequenced and
functionally analysed, a wealth of genetic traits encoding multiple anti-phage
systems, resistance genes/selectable markers and functional conjugative/mobilization
regions was found. The identification of such natural plasmids is of tremendous
benefit for the successful outcome of any programme of starter improvement. Indeed,
the association of food-grade selectable markers and mobilization functions on many
of these plasmids will facilitate their exploitation to obtain lactococcal industrial
strains with enhanced phage protection and robustness.
L. lactis DPC3758 plasmids also provide another example of the major role
played by these genetic elements in contributing to host fitness and preservation
within its ecological niche. Raw milk is likely to prove an extremely challenging
habitat to live in due to the presence of a large and heterogeneous microflora and,
putatively, of related phages. Harbouring multiple conjugative plasmids containing
three separate R/M systems and various stress resistance determinants clearly
provides L. lactis DPC3758 with a competitive advantage to survive in this
environment. The observation that 6 out of 8 plasmids carry mobilization functions is
suggestive of their likely acquisition by horizontal transfer from organisms occupying
the same habitat, and also indicative of the high level of genome plasticity of the
strain.
In conclusion, our study provides the gene knowledge base to exploit single
plasmids from L. lactis DPC3758, although the whole strain might be well and safely
employed as a component of novel starter formulations. L. lactis DPC3758 has been
indeed genotyped as a cremoris strain, which is highly desirable in the manufacture of
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Cheddar and other cheese varieties (Delgado and Mayo, 2004, Salama et al., 1995),
and also does not contain any undesired virulence or antibiotic resistance genes. The
wealth of potentially useful genetic traits found in L. lactis DPC3758 plasmids also
reaffirms the importance of ongoing screening aimed at isolating and characterizing
new lactococcal strains from natural non-dairy ecosystems. If pursued, this strategy
will provide a whole new range of natural starters or properties to develop novel or
improved starter formulations with enhanced robustness and long-term efficiency.
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TABLES
Table 1. Bacterial strains and lactococcal bacteriophages used in this study (Chopin
et al., 1984, Jarvis et al., 1991, Mckay and Baldwin, 1984, Ryan et al., 1996)
Description Source a or reference
Natural bacterial isolates
L. lactis DPC3758 Isolated from a French raw milk cheese: contains 8 plasmids TFRC culture collection
L. lactis DPC3776 Isolated from a Spanish raw milk cheese: contains 10 plasmids TFRC culture collection
L. lactis DPC3874 Isolated from a French raw milk cheese: contains 6 plasmids TFRC culture collection
L. lactis DPC3749 Isolated from a Spanish raw milk cheese: contains 9 plasmids TFRC culture collection
L. lactis DPC3880 Isolated from a French raw milk cheese: contains 6 plasmids TFRC culture collection
L. lactis DPC3694 Isolated from a Spanish raw milk cheese: contains 6 plasmids TFRC culture collection
L. lactis DPC3754 Isolated from a French raw milk cheese: contains 4 plasmids TFRC culture collection
L. lactis DPC3756 Isolated from a French raw milk cheese: contains 5 plasmids TFRC culture collection
L. lactis DPC3783 Isolated from a Italian raw milk cheese: contains 7 plasmids TFRC culture collection
L. lactis DPC3901 Isolated from a Greek raw milk cheese: contains 4 plasmids TFRC culture collection
L. lactis DPC3780 Isolated from a Italian raw milk cheese: contains 2 plasmids TFRC culture collection
L. lactis DPC3757 Isolated from a French raw milk cheese: contains 4 plasmids TFRC culture collection
L. lactis DPC3778 Isolated from a Spanish raw milk cheese: contains 10 plasmids TFRC culture collection
L. lactis DPC3881 Isolated from a French raw milk cheese: contains 7 plasmids TFRC culture collection
L. lactis DPC3907 Isolated from a Italian raw milk cheese: contains 2 plasmids TFRC culture collection
L. lactis DPC3911 Isolated from a Italian raw milk cheese: contains 7 plasmids TFRC culture collection
L. lactis DPC3926 Isolated from a Spanish raw milk cheese: contains 5 plasmids TFRC culture collection
L. lactis DPC3898 Isolated from a Greek raw milk cheese TFRC culture collection
L. lactis DPC3904 Isolated from a Spanish raw milk cheese TFRC culture collection
L. lactis DPC3912 Isolated from a Italian raw milk cheese TFRC culture collection
Bacterial strains
L. lactis MG1363 Plasmid-free derivative of L. lactis subsp. cremoris 712 TFRC culture collection
L. lactis MG1364 Rifampicin and streptomycin-resistant derivative of L. lactis MG1363 TFRC culture collection
L. lactis IL1403 Plasmid-free derivative of L. lactis IL594; representative of subspecies lactis (Chopin et al. , 1984)
L. lactis HP Cheese starter; indicator strain; representative of subspecies cremoris TFRC culture collection
L. lactis DRC3 DNA size marker strain; contains 8 plasmids (2, 3.4, 4.8, 5.2, 35.8, 51, 65 and 78
kb); representative of subspecies diacetylactis
(Mckay and Baldwin, 1984)
L. lactis DPC3147 Lacticin 3147 producer (Ryan et al. , 1996)
L. lactis DPC5558 Nisin producer TFRC culture collection
L. lactis DPC5552 Lacticin 481 producer TFRC culture collection
L. lactis DPC938 Lactococcins A, B and M producer TFRC culture collection
L. innocua DPC3306 Indicator strain TFRC culture collection
P. acidilactici DPC5492 Indicator strain TFRC culture collection
Lactobacillus paracasei 43338 Indicator strain TFRC culture collection
Bacteriophages
c2 lytic phage; member of the c2-type phage specie (Jarvis et al. , 1991)
ml3 lytic phage; member of the c2-type phage specie (Jarvis et al. , 1991)
eb1 lytic phage; member of the c2-type phage specie (Jarvis et al. , 1991)
sk1 lytic phage; member of the 936-type phage specie (Jarvis et al. , 1991)
712 lytic phage; member of the 936-type phage specie (Jarvis et al. , 1991)
hp lytic phage; member of the 936-type phage specie (Jarvis et al. , 1991)
a TFRC: Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland
Strains or bacteriophages
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Table 2. Primers used in this study to map gene features of technological importance
to either plasmid pAF65 or pAF45 of L. lactis DPC3758
Primer Sequence (5'-3') Size (bp) Target
R/M-I (Fa) ACTACTTTAAGGAACTGGGAGTG 850 R/M-Ic
R/M-I (Rb) TGCGTAAAACCTTCAACATAATCT
R/M-IIa (F) TTGCTAATAAACTAAATAATGTGCTAAG 693 R/M-IIad
R/M-IIa (R) TTTCTAAATTATATGCTCCTACACCA
tra1 (F) AAAAACCTTGAATAAATACCAT 659 tra1e
tra1 (R) TTAAACTTACTCAAAAATCTACACA
tra3 (F) CAAGTAGGAGATTAGGTTATAGTCGCAGTT 292 tra3f
tra3 (R) AAATTTTCTAAGGTGGCATATCAAGTCAAG
lco (F) GATGTCGGCTTTCTTCTCGGATGATG 660 lcog
lco (R) ATGTAGTTTTGATGGAAGAAGGTAGTAGT
nsr (F) GCAGTATGTGCTTTATTTTTAGG 650 nsrh
nsr (R) CTTAAAGCACAAAGCGGTT
lc481 (F) AGGTGACATTTTTGGCTTTCT 544 lc481i
lc481 (R) TTCTCCCTTTTTAATAATTGCTACTG
aF = forward primer; bR = reverse primer; cR/M-I = type I restriction/modification system; dR/M-IIa =
type II restriction/modification system; etra1 = conjugation region tra1 ; ftra3 = conjugation region
tra3; glco = copper resistance operon; hnsr = nisin resistance gene; i lc481 = lacticin 481 immunity
genes
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Figure 1. Hierarchical cluster analysis (HCA) of the carbohydrates fermentation
profiles of natural Lactococcus lactis isolates (DPC #) and of representative strains L.
lactis subsp. lactis IL1403, L. lactis subsp. lactis biovar. diacetylactis DRC3, and L.
lactis subsp. cremoris HP. The fermentation profiles reported by the API 50 CH kit’s
manufacturer to be typical of the subspecies lactis (1 and 2), cremoris (1 and 2) and
hordniae, and of L. raffinolactis are included in the analysis as external references.
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Figure 2. Principal component analysis (PCA) of the carbohydrates fermentation
profiles of natural Lactococcus lactis isolates (DPC #) and of representative strains L.
lactis subsp. lactis IL1403, L. lactis subsp. lactis biovar. diacetylactis DRC3, and L.
lactis subsp. cremoris HP. The fermentation profiles reported by the API 50 CH kit’s
manufacturer to be typical of the subspecies lactis (1 and 2), cremoris (1 and 2) and
hordniae, and of L. raffinolactis are included in the analysis as external references.
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Figure 3. HCA of randomly amplified polymorphic DNA (RAPD)-PCR profiles of
natural lactococcal isolates.
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Figure 4. Preliminary characterization of the natural lactococcal isolates (DPC#). (a)
Distribution and diversity of the plasmid DNA complement. The plasmid profile of L.
lactis DRC3 provides reference plasmids of large sizes (36, 51 and 65 kb) as a
complement to the 2 to 16 kb molecular size ladder. (b) Antimicrobial production on
agar well diffusion assays by using L. lactis HP as indicator strain. Icon=positive;
nd=not detected. (c) Resistance/sensitivity to c2-type phages (c2, ml3, eb1) by using
the spot test technique. R=resistant; Icon=sensitive. (d) PCR detection of type I
restriction/modification hsdS subunits.
Chapter III
139
Figure 5.
TraJ
0
traK
tr. lla
dI
I
M.
lla
tra
C
o
tr
aD
pAF22
22,388 bps
GC% 34.9
or
f13
ad A
50
bA
o r
f7
m
pAF14
14,419 bps
GC% 34.1
0
C
pAF12
12,067 bps
GC% 33.3
pAF04
3,801 bps
GC%32.0
0
pAF07
7,435 bps
GC%36.4
Phage
resistance
Conjugation Stress
resistance
pAF65 R/M-I tra3 lco, nsr, lc481
pAF45 R/M-IIa tra1
Major gene features
Plasmid
Chapter III
140
Figure 5. Physical and genetic maps of plasmids pAF22, pAF14, pAF12, pAF07 and
pAF04 of L. lactis DPC3758. Position and orientation of genes is indicated by
arrows. Inner circles show the nucleotide numbering. The table shows the features of
technological interest mapped to plasmids pAF65 and pAF45 by PCR. Features
acronyms are as indicated in Table 2.
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Figure 6. Multiple alignment of the amino acid sequence of the type I R/M HsdS of
L. lactis DPC3758 and top BLAST hits. The GenInfo Identifier for each organism is
indicated within brackets. Orange-to-red areas are indicative of high similarity,
whereas green-to-yellow-to-blue areas are indicative of low similarity. The 19-aa
sequence of the type I R/M HsdS of L. lactis DPC3758, in common with the HsdS of
pAH90 and potentially involved in TRDs recombination, is indicated by the dotted
arrow.
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Figure 7. Functional analyses of the cadmium (a, b) and copper (c, d) resistance
operons in L. lactis DPC3758 compared to the sensitive strain L. lactis MG1363.
Growth curves of L. lactis DPC3758 (a) and MG1363 (b) in media containing 0 (●), 
0.05 (■), 0.1 (▲), 0.15 (x), 0.2 (○), 0.25 (□) and 0.3 mM (∆) cadmium chloride. 
Growth curves of L. lactis DPC3758 (c) and MG1363 (d) in media containing 0 (●), 1 
(■), 2 (▲), 3 (◊), 4 (○), 5 (□) and 6 mM (∆) cupric sulfate.
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Figure 8. (a) Plasmid profiles of the plasmids donor strain L. Lactis DPC3758 and of
L. Lactis MG1614 transconjugants (Tc1 to Tc7) obtained by using cadmium
resistance as selectable marker. (b) PCR detection of R/M systems in selected
transconjugants. (c) Efficiency of plaquing (EOP) of phages c2 and 712 on selected
transconjugants harbouring different combinations of R/M systems.
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Chapter IV
Plasmids of raw milk cheese isolate L. lactis subsp. lactis biovar.
diacetylactis DPC3901 suggest a plant-based origin for the strain
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ABSTRACT
The four plasmid-complement of the raw milk cheese isolate L. lactis subsp.
lactis biovar. diacetylactis DPC3901 was sequenced and some genetic features
functionally analyzed. The complete sequences of pVF18 (18,977 bp), pVF21
(21,739 bp) and pVF22 (22,166 bp) were obtained whereas 49 of the predicted 50 kb
of pVF50 were assembled in three contigs. Each plasmid encoded genes not
previously described in Lactococcus, in addition to genes associated with plant-
derived lactococcal strains. Most of the novel genes were found on pVF18 and
encoded functions typical of bacteria associated with plants, such as activities of plant
cell wall modification (orf11 and orf25). In addition, a predicted high-affinity
regulated system for the uptake of cobalt was identified (orfs19-21), which has a
single database homolog on a plant-derived Leuconostoc plasmid and whose
functionality was demonstrated following curing of pVF18. Additional metal
transporters are encoded by pVF21 and pVF22. Along with orfs19-21 of pVF18,
these transporters could enhance host ability to uptake growth-limiting amounts of
biologically essential ions within the soil. In addition, pVF50 and pVF21 share 35 kb
of highly homologous sequence with the plant-derived 68 kb lactococcal plasmid
pGdh442, which suggests extensive horizontal transfer between these plasmids and a
common plant niche for their hosts. Phenotypes associated with these plasmids
include glutamate dehydrogenase activity and Na+ and K+ transport. The presence of a
wealth of plant-associated markers in L. lactis DPC3901 suggests a plant origin for
the raw milk cheese isolate and provides for the first time the genetic basis to support
the concept of the plant-milk transition for Lactococcus strains.
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INTRODUCTION
Lactococcus lactis strains belonging to the lactis and cremoris subspecies are
essential components of industrial starters for the manufacture of fermented dairy
products and have great biotechnological and economical importance. The success of
many L. lactis strains in food fermentations is largely due to plasmid-encoded traits
promoting efficient growth in milk (i.e. metabolism of lactose, milk proteins, citrate
and other complex nutrients), resistance to environmental stresses (e.g.
bacteriophages, heavy metals, temperature/osmotic stresses), and selective
colonization advantages (i.e. production of bacteriocins and exopolysaccharides).
Plasmids encoding these phenotypes are often mobilizable, which has greatly
contributed to the genome plasticity of lactococci, enabling them to become adapted
and specialized to the dairy environment (Mills et al., 2006).
However, L. lactis is also naturally present on plants and on cows’ skin (Klijn et
al., 1995, Nomura et al., 2006). In particular, plant environments are the second most
important ecosystem occupied by L. lactis, and, although this has never been
demonstrated, it is likely that plant-derived strains are the natural source of dairy
strains as they can transfer from forage plants and meadow grasses to milk via cattle
(Salama et al., 1995). A recent genotypic and phenotypic diversity analysis of a large
collection of dairy and plant lactococcal isolates showed that the latter mostly belong
to the subspecies lactis and exhibit a molecular diversity not observed within dairy
strains (Rademaker et al., 2007). A subsequent genome-scale analysis confirmed that
plant strains exhibit an array of metabolic phenotypes exceeding that of dairy strains
and including traits associated with the adaptation to grow on diverse plant cell walls
substrates, but also genes for defence and stress response (Siezen et al., 2008).
Natural isolates often demonstrate greater tolerance of stress as a result of specific
protection mechanisms developed to resist the numerous cytotoxic compounds and
organisms (i.e. antibiotics, heavy metals, bacteriocins and bacteriophages) present in
the plant and animal environments (Rodionov et al., 2006, Siezen et al., 2005, Teuber
et al., 1999). They also exhibit phenotypes of industrial interest that can be utilized in
dairy and other food fermenting applications such as amino acids conversion to ﬂavor 
compounds (i.e. -keto acid decarboxylase and glutamate dehydrogenase) or the
production of broad-spectrum bacteriocins (Klijn et al., 1995, Smit et al., 2005,
Tanous et al., 2006). As in the case of dairy strains, many of these phenotypes are
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often plasmid-encoded in plant-derived strains, a finding that reaffirms the crucial
contribution of these extra-chromosomal entities to the performance, fitness and
ability of L. lactis strains to colonize specific biotopes.
Based on these observations, the analysis of plasmid gene content is therefore
essential to evaluate the genetic potential and variability existing in dairy and natural
lactococcal strains. Using this approach, novel genotypes useful to the dairy industry
can be found, but also, niche-specific traits determining the uniqueness and adaptive
capabilities of the strain can be uncovered. Assuming the validity of the plant origin
hypothesis for dairy strains, this also implies that L. lactis strains recently transferred
to the milk, and therefore potentially still carrying plant-specific traits, could
theoretically be retrieved in artisanal products such as raw milk cheeses where the
natural milk microflora, in turn derived from the grass, remains intact (Florez et al.,
2008, Salama et al., 1995).
In this study, we have sequenced and functionally analyzed the four plasmid-
complement of the raw milk cheese isolate L. lactis subsp. lactis biovar. diacetylactis
DPC3901, which was isolated and phenotypically characterized during previous
studies aimed at identifying novel strains or genetic traits to be used in programmes
of starter improvement (Cogan et al., 1997). These plasmids were found to contain a
number of gene functions not previously described in Lactococcus and typical of
bacteria associated with plants, as well as several other genes displaying homology
only to single genes found on the plant-derived lactococcal plasmids pGdh442 or
pKF147A (Siezen et al., 2010, Tanous et al., 2007). Additionally, two L. lactis
DPC3901 plasmids exhibited high levels of homology over many loci with pGdh442,
which is indicative of extensive horizontal gene transfer (HGT) and implies that L.
lactis DPC3901 may have originated from a plant niche.
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MATERIALS AND METHODS
Lactococcal strains and media.
The natural strain L. lactis DPC3901 was isolated and partially characterized in
previous studies (Cogan et al., 1997). Lactococcal strains were routinely propagated
at 30 C in M17 medium (Oxoid, UK) supplemented with 0.5% (wt/vol) glucose
(GM17) or lactose (LM17). Solid media contained 1.0% (wt/vol) bacteriological agar
(Oxoid, UK). Bacterial strains were stocked in M17 containing 40% glycerol at -80
C. Working cultures were stored at 4C and transferred periodically.
Classification of L. lactis DPC3901
L. lactis DPC3901 was genotyped by using the universal 16S rRNA primers CO1
(5’-AGTTTGATCCTGGCTCAG-3’) and CO2 (5’-TACCTTGTTACGACT-3’)
using PCR conditions described elsewhere (Beresford and Condon, 1991). Aliquots
(5 l) of the amplified products were subjected to electrophoresis in 1% agarose
(Sigma, USA) gels and stained with ethidium bromide. PCR products were purified
by using the QIAquick PCR Purification Kit (Qiagen GmbH, Germany) and
sequenced by single run primer extension (Beckman Coulter Genomics, USA).
Sequencing data was searched for homology against sequences available in public
databases (GenBank, EMBL, DDBJ, PDB) by using the nucleotide MegaBLAST
algorithm of the Basic Local Alignment Search Tool (BLAST) (Zhang et al., 2000).
Confirmation of the genotypically predicted citrate-fermenting phenotype was
obtained by streaking a freshly grown culture of L. lactis DPC3901 on KMK medium
and checking for the appearance of blue colonies after 48-h incubation at 30 °C (Drici
et al., 2010).
Plasmid DNA sequencing, assembly and annotation.
Plasmid DNA was prepared as described elsewhere (O'Sullivan and
Klaenhammer, 1993). Any residual genomic DNA was removed by treatment with
Plasmid-Safe ATP-Dependent DNase (Epicentre, Madison, USA) which selectively
hydrolyzes linear double-stranded DNA to deoxynucleotides without affecting closed
circular supercoiled or nicked circular dsDNAs. The purified plasmids were
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sequenced as a pool on a 454 Genome Sequencer FLX System, after preparation of a
sonication library, barcoding of the library with the Roche multiplex identifier
system, and emPCR amplification (Beckman Coulter Genomics, USA). Automatic
de-novo assembly of data resulted in 56 large (> 500 bp) contigs providing ca. 135 kb
of sequence data. Gap closure was performed by PCR using primers designed with
PrimerSelect v.8.0.2 (DNASTAR, USA), followed by sequencing of the PCR
products (Beckman Coulter Genomics, USA). Putative open reading frames (ORFs)
were automatically predicted and annotated using Glimmer 2.0 (Delcher et al., 1999).
Annotated DNA sequences were examined manually using the Artemis viewer
(Rutherford et al., 2000) and BLASTX and BLASTP analyses (Altschul et al., 1998)
were used to examine intergenic regions for putative ORFs not identified by
Glimmer, to identify putative frameshifts, and to refine the start codon assignments.
The InterProScan tool (www.ebi.ac.uk/Tools/InterProScan), the PFAM (Finn et al.,
2010) and Conserved Domain Database (CDD) (Marchler-Bauer et al., 2009) were
used to predict protein function. InterProScan predicts the occurrence of functional
domains and motifs/signatures in a protein by combining 12 different databases and
their relative protein signature recognition methods (Zdobnov and Apweiler, 2001).
Prediction of topology in putative alpha-helical membrane proteins, including a
specification and the in/out orientation of the membrane spanning segments, was
obtained by using the TOPCONS hidden Markov model
(http://topcons.cbr.su.se/index.php), which uses five different topology prediction
algorithms (SCAMPI-seq; SCAMPI-msa; PRODIV-TMHMM; PRO-TMHMM; and
OCTOPUS) to generate a consensus prediction for the protein (Bernsel et al., 2009).
Putative Ribosome Binding Sites (RBS) and terminator sequences were automatically
identified by using the RBSFinder+TransTerm programme (http://nbc11.biologie.uni-
kl.de/). Manual identification of terminator sequences was achieved by following
three main criteria: (i), a ∆G of less than -6; (ii), a stem loop structure rich in GC;
(iii), a T-rich sequence following the stem loop structure.
Growth inhibition assays.
Bacterial sensitivity to cadmium (Cd2+), cobalt (Co2+), tetracycline, streptomycin
and kanamycin (Sigma, USA) was assessed by using a micro-plate procedure. Two-
hundred microliters of GM17 or LM17 broth containing either CdCl2 (0 to 0.3 mM)
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or CoCl2 (0 to 6 mM) or tetracycline (0 to 10 g/ml) or streptomycin (10 to 500
g/ml) and kanamycin (10 to 500 g/ml) were inoculated at 1% with overnight
cultures on 96-wells micro-plates (Sarstedt, Newton, USA). Bacterial growth was
assessed over 18 h at 30 °C by measuring absorbance at 600 nm with a GENios Plus
reader (Tecan, Switzerland).
Determination of glutamate dehydrogenase (GDH) activity.
GDH activity was determined in cell-free extracts (CFEs) as previously described
(Kieronczyk et al., 2003), with some modifications. Briefly, cell cultures (200 ml)
growing in mid-log phase (OD = 0.4) were harvested by centrifugation (4,100 x g, 15
min, 4 °C) and washed twice with 50 mM triethanolamine buffer (TEA, pH 7). Pellets
were resuspended in 5 ml of TEA containing lysozyme (1.6 mg/ml) and saccharose
(0.2 mg/ml), incubated at 30 °C for 2 h, harvested by centrifugation and resuspended
in hypotonic buffer TEA to provoke spheroplast lysis. Cell debris was eliminated by
centrifugation at 20,000 x g for 30 min, and the supernatants were filtered through a
0.45m filter (Millipore, USA) and used as CFEs. The protein concentration of CFEs
was determined by the Bradford method by using bovine serum albumin as the
standard (Bradford, 1976). Determination of GDH activity in CFEs was based on a
modification of a colorimetric glutamic acid assay (Boehringer Ingelheim GmbH,
Germany), where the reduced cofactor (NADH or NADPH), produced by oxidative
deamination of glutamate by GDH at pH 9, reacts with iodonitrotetrazolium in the
presence of diaphorase to produce a colorimetric product (formazan), which is
measured by absorbance at 492 nm. A 300 l-reaction mixture consisted of 40 l of
50 mM potassium phosphate–50 mM TEA buffer (pH 9.0) containing 1% of Triton
X-100 (Promega Corporation, USA), 20 l of 100 mM glutamic acid, 20l of 2 mM
iodonitrotetrazolium, 20l of diaphorase (1.76 U/ml), 20l of NAD+ (17.33 mM) or
NADP+ (13.8 mM), and 180 l of water. The colorimetric reaction was started by
adding 30 l of CFEs to the reaction mixture, and the changes in concentration of
NADH were measured after incubation for 1 h at 37°C, by measuring the absorbance
at 492 nm. A control test lacking glutamic acid was prepared for each strain in order
to subtract for non-specific reactions that might produce the reduced cofactors. The
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GDH activity was expressed by the increase in absorbance (Abs) at 492 nm, per mg
of protein of CFE, and per min of reaction.
Plasmid curing
Plasmid curing experiments were performed by growing strains at 37 °C in
LM17 lacking the buffering agent -glycerophosphate-GP) for 50 generations
before being transferred to fresh media. The strain was plated on LM17 agar at each
transfer in order to analyze plasmid profiles of individual colonies.
Measurement of bacterial growth rate and acidification capacity
The growth rates and acidification capacities of L. lactis DPC3901 and of its
pVF18/pVF22-cured derivative (L. lactis DPC3901-c2) were compared with those of
cheese starter strains L. lactis subsp. cremoris DPC4268 and L. lactis subsp. lactis
SK1 as previously described (Fallico et al., 2009). Briefly, growth rate parameters
(max growth rate, max, and generation time, G) were determined after growth in
LM17 at 30C, whereas the acidification capacities (starter activity) were evaluated,
based on final pH, after growth in 11% reconstituted skim milk (RSM) over a 5-h
incubation time through a simulated Cheddar cheese making temperature profile (32
°C for 70 min; 40°C for 190 min; 32 °C for 40 min).
PCR analysis
Detection of specific genes within the plasmid complement of L. lactis DPC3901
and its cured derivatives DPC3901-c1 and DPC3901-c2 was obtained by PCR
analysis using the primers listed in Table 2.
Atomic Force Microscopy (AFM) imaging
L. lactis DPC3901 was diluted in distilled water (1:100) prior to imaging. Ten l
of diluted sample were deposited on freshly cleaved mica disc and subsequently dried
in a desiccator. Samples were imaged using AC mode (MFP-3D atomic force
microscope, Asylum Research, UK). An aluminium reflex coating cantilever with a
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tetrahedral tip (AC 240, spring constant: 1.8 N/m, resonant frequency: 79.58 kHz)
(Olympus Optical Co., Japan) was used at a scan rate of 1 Hz.
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RESULTS AND DISCUSSION
Sequencing of the 16S rRNA gene of the natural isolate L. lactis DPC3901
revealed a subsp. lactis biovar. diacetylactis genotype, thus confirming the
phenotypic data obtained from growth on KMK medium and showing the strain’s
ability to ferment citrate. Biovariant diacetylactis strains isolated from raw milk and
plant surfaces have been shown to be of significant technological interest due to their
abilities to grow rapidly in milk, to ferment a wide range of carbohydrates and to
tolerate high pH (9.6) and temperature (50 °C) values, features that are mostly
plasmid-encoded (Drici et al., 2010, Nomura et al., 2006). In a previous study, L.
lactis DPC3901 was shown to harbour four plasmids greater than 10 kb, and to be
completely resistant to a number of 936- and c2-type phages (Chapter II, this thesis).
In this study, the entire plasmid complement of L. lactis DPC3901 was sequenced to
investigate the genetic contribution of these extra-chromosomal entities to the
technological capacities of the strain. Sequencing of the four plasmids of L. lactis
DPC3901 returned 135 kb of data organized in 56 large contigs. The complete
circular sequences of plasmids pVF22 (22,166 bp), pVF21 (21,728 bp) and pVF18
(18,977 bp) were obtained (Figure 1; Tables 1-3 in Appendix) by using a PCR-based
gap closure strategy. The GC content of these plasmids ranged from 33.6 to 35.1%,
which is similar to that of other lactococcal plasmids (Siezen et al., 2005). Attempts
to obtain the complete sequence of pVF50 were unsuccessful, probably due to the
presence of a large number of transposases and secondary structures. However, three
large contigs (contig1 of 23 kb; contig2 of 18 kb; and contig3 of 8 kb), accounting for
49 of the predicted ca. 50 kb of pVF50 sequence, were assembled (Tables 4-6 in
Appendix). All plasmids appear to replicate according to a theta mechanism as each
one is characterized by an origin of replication (ori), located upstream of the rep gene
encoding the replication initiator protein RepB (383 to 441 amino acids (aa); in
pVF18, pVF21, pVF22) or RepA (450 aa; in pVF50), containing highly conserved
structural motifs typical of theta replicons (Figure 2) (Seegers et al., 1994). The most
significant genetic features of L. lactis DPC3901 plasmids are discussed below.
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The presence of plasmid pVF18 suggests a plant-based origin for L. lactis
DPC3901
Plasmid pVF18 contains 25 orfs encoding predicted proteins with no obvious
dairy-associated functions, eight of which (orf8 , orf11, orfs18-21, orf23, orf25) have
been rarely if ever described in Lactococcus (Figure 1; Table 3 in Appendix). An
example is orf11, which encodes a putative polysaccharide deacetylase (432 aa)
belonging to a family of conserved proteins (PFAM01522) involved in hydrolysis of
the plant cell wall. Members of this family include the chitooligosaccharide
deacetylase NodB from Rhizobium (Freiberg et al., 1997), chitin deacetylases from
Saccharomyces cerevisiae (Mishra et al., 1997), and microbial endoxylanases
(Millwardsadler et al., 1994). These latter enzymes share sequence similarity with the
NodB deacetylase (Millwardsadler et al., 1994), whose activity enables Rhizobium to
associate symbiotically with leguminous plants thus allowing them access to mineral
nitrogen necessary for their growth. The nodB gene is plasmid-encoded in Rhizobium
sp. NGR234, and this was suggested to be the result of a recent horizontal gene
transfer (HGT) from Agrobacterium (Freiberg et al., 1997). Orf11-like proteins are
highly conserved in Enterococcus faecium, Staphylococcus aureus and in some
Ruminococcus and Clostridium members, but no homologues have been found to date
in Lactococcus.
Similarly, homologues of the product of orf25 can be found in various
environmental subspecies of Streptococcus, Carnobacterium, Enterococcus,
Corynebacterium, Bacillus, Geobacillus and Clostridium, but not in Lactococcus or
other milk-derived bacteria. Orf25 is a 140-aa protein containing the conserved barrel
domain typical of cupins (PFAM07883). The functions of these proteins range from
isomerase and epimerase activities involved in the modification of cell wall
carbohydrates in bacteria and plants, to non-enzymatic germins and plant seed storage
proteins, which provide the major nitrogen source for the developing plant (Dunwell,
1998).
The genes described above encode products whose functions are irrelevant to
bacteria growing in milk but clearly important to those associated or striving to
become established within the natural plant ecosystem. In addition, pVF18 lacks any
trait favouring colonization of the dairy environment and, interestingly, it was the first
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plasmid to be cured from the host during growth at 37 °C in absence of-GP. Taken
together, these observations provide indications that L. lactis DPC3901 might have
originally occupied a grass plant niche, where pVF18-encoded genes conferred the
host with a selective advantage, before transferring to the dairy environment probably
via cattle. Such an event is likely to have occurred recently as the bacterium still
retains plasmid traits that are dispensable for growth in milk and are indeed
immediately lost during growth under stress conditions in synthetic media.
Functional Co2+ transport mechanisms – another link to the plant environment
Cobalt (Co2+) is an essential component of many enzymes and must be
transported into cells in appropriate amounts when needed. Despite its importance for
bacterial metabolism, Co2+ uptake must be tightly regulated to avoid toxic effects
(Rodionov et al., 2006). Plasmid pVF22 of L. lactis DPC3901 is predicted to carry
two copies of the corA gene (COG0598), corA1 and corA2, which encodes the
principal transporter of Mg2+ in prokaryotes but also functions in the uptake of Co2+
(Niegowski and Eshaghi, 2007). The presence of two CorA transporters is likely to
enhance L. lactis DPC3901 ability to uptake Co2+ in environments (e.g. the soil)
where its presence in trace amounts might be growth-limiting for the strain but also
increases the strain’s sensitivity to the heavy metal. Additionally, pVF18 of L. lactis
DPC3901 carries a putative polycistronic operon (orfs19-21) that may play a role in
the high-affinity and regulated uptake of Co2+. Two 4-bp overlaps between orf20 and
its neighbour genes, coupled to the presence of putative promoter sequences upstream
of orf19 and of a strong Rho-independent terminator (ΔG = -7.9 kcal/mol)
downstream of orf21 (Figure 3a), suggest that orf19, orf20 and orf21 are transcribed
as a single mRNA. This three-gene operon is uncommon to L. lactis and can only be
found, with high similarity at DNA (99%) and protein (92-99%) level, on the recently
sequenced plasmid LkipL4726 from Leuconostoc kimchii IMSNU 11154 (Oh et al.,
2010). Orf19 encodes a small protein (75 aa) of unknown function exhibiting 92%
identity to its only significant match, a hypothetical protein from LkipL4726 (Oh et
al., 2010). Orf20 and orf21 encode proteins containing features typical of the ATPase
and permease components of ATP-binding cassette (ABC) transporters (Figure 3b,c),
which use the energy of ATP hydrolysis to transport specific substrates across the
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cellular membrane. Homologs of Orf20 are widespread in Lactococcus, whereas
Orf21 has a single lactococcal match on pGdh442 (Tanous et al., 2007). A putative
role for the Orf20-21 transporter is suggested by the presence in Orf20 of a conserved
domain (cd03225) found in the CbiO component of CbiMNQO, which is the most
widespread transport system for the high-affinity uptake of Co2+ in prokaryotic
genomes (Rodionov et al., 2006). Functional analyses of the CbiMNQO system have
shown that the integral membrane protein CbiM and the cobalt-binding periplasmic
protein CbiN are the minimal requirements for a functional transporter exhibiting
significant cobalt uptake activity (Rodionov et al., 2006). In the putative pVF18-
encoded Co2+ transporter, it is possible that Orf20 may act as the ATPase-like protein
CbiO whereas Orf21 functionality might resemble that of CbiM, which also contains
seven trans-membrane helices. Orf19 is probably a cytoplasmic protein but lacks any
conserved Co2+ binding motifs (Thilakaraj et al., 2007), which discards the option
that it might be a CbiN homolog. CbiMNQO transporters are generally controlled on
the level of translation initiation by B12 riboswitch elements (Rodionov et al., 2006).
In pVF18, expression of the orfs19-21 operon might be controlled by the upstream
orf18, which encodes a transcriptional regulator belonging to the XRE family
(cd00093). Putative promoter sequences but no termination signal could be identified
for orf18 (Figure 3a), suggesting that it might be co-transcribed with orf19-21 and
possibly regulate the activity of this operon. If functional, the putative Co2+ transport
system encoded by orfs18-21 should endow L. lactis DPC3901 with the ability to
uptake Co2+ with high-affinity and in a regulated manner, allowing its efflux outside
the cell in order to maintain metal homeostasis.
To verify this, the growth of L. lactis DPC3901 in presence of increasing
concentrations of Co2+ was compared to that of L. lactis MG1363, which lacks any
high-affinity Co2+ uptake system but possesses a chromosomally-encoded CorA
transporter. L. lactis DPC3901 was able to grow relatively well in presence of 4 mM
Co2+ and to tolerate concentrations as high as 6 mM (Figure 4a). In contrast, the
growth of L. lactis MG1363 was affected by the presence of 1 mM Co2+ and totally
inhibited by concentrations of and above 2 mM (Figure 4b). These results are
indicative of L. lactis DPC3901 ability to regulate Co2+ uptake in order to avoid its
toxic effects. To further confirm these indications, pVF18 and pVF22 were
sequentially cured from L. lactis DPC3901 in order to first remove orfs18-21 and
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then the corA genes. Growth curves analysis showed that the pVF18-cured derivative,
named DPC3901-c1 (orfs18-21- corA+), could not grow at Co2+ concentrations higher
than 1 mM (Figure 4c), whereas the derivative cured of both pVF18 and pVF22,
DPC3901-c2 (orfs18-21- corA-), exhibited an ability to tolerate Co2+ very similar to
that of the parent strain (Figure 4d). These results confirm the involvement of the
orfs18-21 genes in mediating uptake and homeostasis of the potentially toxic metal
Co2+ in L. lactis DPC3901.
To date, the orfs19-21 operon has been only found on plasmids from Leuconostoc
kimchii IMSNU 11154 (Oh et al., 2010) and L. lactis DPC3901 (this study).
Interestingly, a recent and comprehensive comparative and functional analysis of
cobalt transporters in prokaryotic genomes retrieved no homologues of cbi genes in
both Leuconostoc and Lactococcus (Rodionov et al., 2006). Thus, bacteria from these
genera may have evolved a novel plasmid-encoded uptake system to ensure an
efficient homeostasis of the metal. Leuconostoc kimchii IMSNU 11154 was isolated
from a traditional Korean fermented food made from cabbage (Oh et al., 2010),
whereas L. lactis DPC3901 derives from a raw milk cheese where the absence of
pasteurization preserves the natural milk microflora, mostly derived from grass plants
(Salama et al., 1995). It is thus likely that LkipL4726 and pVF18 hosts have inhabited
natural environments where perhaps the presence of trace amounts of Co2+ may have
promoted the development of an appropriate high-affinity uptake system (Rodionov
et al., 2006). The observation that lactococcal homologs of the Orfs20-21 transporter
can only be found on pGdh442, a plasmid recently isolated from a plant L. lactis
strain (Tanous et al., 2007), further supports the link between this Co2+ uptake system
and the plant environment.
Plasmid pVF18 also contains genes (orf8 and orf23) that have been rarely found
in Lactococcus. Both encode putative GCN5-related N-acetyltransferases (GNAT;
cd04301) that are much conserved among Streptococcus, Clostridium, Enterococcus
and Staphylococcus, but have a single lactococcal homolog on the chromosome of L.
lactis MG1363 (Wegmann et al., 2007). GNAT enzymes catalyze the transfer of an
acetyl group to the cognate substrate and are thought to be implicated in a variety of
functions, ranging from antibiotic (aminoglycosides) resistance to regulation of cell
growth and development (Vetting et al., 2005). To test the possible involvement in
antibiotic resistance of Orf8 and Orf23, L. lactis DPC3901 and the sensitive strain L.
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lactis MG1363 were grown in presence of increasing concentrations of streptomycin
and kanamycin (data not shown). Both strains were similarly sensitive to both
aminoglycosides, which suggests that the GNAT-like proteins encoded by pVF18 are
not involved in resistance to these antibiotics.
Plasmid pVF21 confers phage resistance and potential flavour-forming ability to
L. lactis DPC3901
Traces of a putative plant origin can also be linked to pVF21 (Figure 1; Table 2
in Appendix), which includes orf15 encoding a 105-aa hypothetical protein identical
to its only database match encoded by the plant-derived lactococcal plasmid
pKF147A (Siezen et al., 2010), and a 5.6 kb region sharing 97% identity to its only
homologue found on the plant-derived pGdh442 (Tanous et al., 2007). In addition to
containing genes responsible for cadmium resistance and transposition, this region
encodes a glutamate dehydrogenase (GDH) enzyme, an activity that is rare in L. lactis
and thus far only identified in strains of plant and animal origin (Tanous et al., 2007,
Tanous et al., 2002). In pGdh442, this region is part of a remnant Tn3-like
transposon, also containing a resolvase gene and delimited by two 28-bp IR (Tanous
et al., 2005). These latter features are missing in pVF21, which might imply that the
transposon is not functional and is therefore stably maintained in this plasmid. The
gdh gene of pVF21 encodes a putative 448-aa protein identical to the NAD(P)-
dependent GDH of pGdh442 (Tanous et al., 2005). GDH enzymes catalyze the
reversible oxidative deamination of glutamate to α-ketoglutarate and ammonium by
utilising NAD, NADP or both as a cofactor. GDH of pGdh442 has been shown to
function mainly in glutamate biosynthesis, but also to be able to stimulate its
conversion to aroma compounds in L. lactis strains that had acquired the plasmid by
conjugation (Tanous et al., 2006). We tested the functionality of the gdh gene of
pVF21 by using L. lactis IL1403 as a GDH-negative reference strain. No GDH
activity was registered for L. lactis IL1403, whereas L. lactis DPC3901 exhibited
NAD+- and NADP+-dependent specific activities of 0.028 and 0.01, respectively,
which are similar to those reported for a cremoris strain used in the manufacture of
Gouda and Cheddar type cheeses (Kieronczyk et al., 2003). These results suggest that
pVF21 encodes a functional GDH enzyme providing L. lactis DPC3901 with the
potential to produce aroma compounds from glutamate catabolism and/or to
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synthesize glutamate from -ketoglutarate and ammonia. This latter capacity has
been suggested to be important for bacteria living on plants as it allows more efficient
elimination of the high levels of ammonia present in this environment (Tanous et al.,
2005). In pVF21, the gdh gene is followed downstream by a gene encoding a
truncated IS1216-like transposase and by the cadAC operon, which is identical to
those found on lactococcal plasmids pAH82 (O'Sullivan et al., 2001), pGdh442
(Tanous et al., 2007) and pNP40 (O'Driscoll et al., 2006), and in several other gram-
positive bacteria (Schirawski et al., 2002). This operon encodes a two-component
system composed of an efflux ATPase (CadA) and a resistance regulator (CadC),
which has been shown to confer resistance to both cadmium and zinc (Schirawski et
al., 2002).
Upstream of the Tn3-like region, pVF21 carries genes encoding a restriction-
modification (R/M) system of type I, which is one of the many molecular
mechanisms developed by L. lactis strains to defend themselves against
bacteriophage (phage) attack. Susceptibility to infection by lytic phages is indeed
common in lactococci and a major concern for the dairy industry as it affects strains
ability to perform efficiently in large-scale fermentations. Type I R/M systems are
typically made up of three genes (hsdRMS), overlapping and transcribed in the same
direction, which encode subunits responsible for DNA restriction (HsdR),
modification (HsdM) and specificity (HsdS), respectively (Mills et al., 2006). In
pVF21, hsdR encodes a restriction enzyme (1025 aa) containing conserved helicases-
related domains (cd00046; COG0610), while the 537-aa product of hsdM is a typical
N6-adenine methyltransferase (pfam02384). Both proteins are virtually identical
(99%) to the HsdR and HsdM enzymes encoded by genes on the lactococcal plasmid
pAH82 (O'Sullivan et al., 2001). In contrast, the HsdS specificity protein (414 aa) of
pVF21 shares only 38% identity with the homolog encoded by pAH82. Low
similarities among HsdS subunits are common and reflect the large variability
existing within their target recognition domains (TRDs), which impart target
sequence specificity to both restriction and modification activities of the type I R/M
complex (Mills et al., 2006). Novel specificities may be generated by recombinational
shuffling of TRDs between different HsdS subunits, which confers the host with the
ability to alter its phage restriction level (O'Sullivan et al., 2000, Schouler et al.,
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1998). This makes type I R/M systems one of the most effective mechanisms of
defence against phages.
Other interesting genes present on pVF21 are orf5 and orf16. Orf5 encodes a
protein of 365 aa containing the pentapeptide DGQHR motif, the QR pair and the
FxxxN motif, which are typical conserved residues of the highly divergent and
uncharacterized DGQHR domain (TIGR03187). Orf5 has no homologues in
Lactococcus or other lactic acid bacteria. The most similar matches (27 to 32%) are
proteins from two Bacillus cereus strains, whereas lower similarity is shared with
proteins from several environmental species. While the function of proteins
containing the DGQHR domain is unknown, members of this family occur in
contexts that suggest extensive HGT and, interestingly, several of them have been
annotated as putative bacteriophage proteins. The 111-aa product of orf16 contains an
Enterocin A immunity domain (pfam08951) and is 90% identical to hypothetical
proteins of pNP40 (O'Driscoll et al., 2006) and pGdh442 (Tanous et al., 2007). This
domain is found in immunity proteins protecting food-associated LAB strains from
the bactericidal activity of their own class IIa or pediocin-like bacteriocins. Immunity
genes belonging to this family, which are plasmid-encoded and not associated with
bacteriocin genes, have been already described (Chikindas et al., 1993).
Plasmid pVF22 encodes antibiotic resistance
Plasmid pVF22 (Figure 1; Table 1 in Appendix) is predicted to carry a gene
(orf14) encoding a Tet(S)-like tetracycline resistance protein (cd04168) identical to
those found on pKL0018 from the fish pathogen L. garvieae (Maki et al., 2008) and
on pK214 from a L. lactis isolate from raw milk soft cheese (Teuber et al., 1999).
This protein functions through ribosomal protection and its gene is typically found on
mobile genetic elements, such as transposons or plasmids. In pVF22, tet(S) is inserted
within a genetic context resembling a transposon-like structure as it is flanked by two
IS1216 transposases and by genes responsible for site-specific recombination (pinR
and orf17) and for conjugal transfer (mobC1ABC2). However, the genetic organization
of this region is different from that of transposon Tn916, which usually carries tet(S)
in a broad range of gram-positive and gram-negative bacteria (Celli and Trieu-Cuot,
1998). Lactococcus strains are known to be susceptible to most antimicrobial agents
Chapter IV
171
but, recently, many isolates resistant to chloramphenicol, erythromycin, streptomycin
and tetracycline have been reported (Delgado and Mayo, 2004, Florez et al., 2008,
Teuber et al., 1999). This has been associated with the fact that lactococci can be
naturally present as saprophytes in cow's membrane surfaces, where they could
acquire resistance during antibiotic treatments to cure or prevent mastitis (Florez et
al., 2008). The absence of pasteurization in the manufacture of raw milk cheeses
allows then these bacteria to be transferred from raw milk into the final product.
Plasmid pVF50 contributes to L. lactis DPC3901 adaptation to the dairy
environment
Annotation of genes contained in the assembled contig1, contig2, and contig3
(Tables 4-6 in Appendix) reveal that pVF50 is largely similar to the plant-derived
plasmid pGdh442 (Tanous et al., 2007), with whom it shares five gene modules
spanning over 30 kb of sequence and exhibiting 97 to 100% homology at both DNA
and protein levels. Plasmid pGdh442 contains 20 IS elements that are likely to have
mediated the acquisition of its numerous gene modules (Tanous et al., 2007), and can
therefore promote their transfer to plasmids of a different organism. A 20-kb
sequence of the 23-kb contig1 of pVF50 is identical to the adjacent modules orfs55-
64 and orfs1-3 of pGdh442, whereas a 10-kb region of the 18-kb contig2 is highly
homologous to three flanking modules in pGdh442 spanning orf15 to orf23. Adjacent
modules in pVF50 exhibit a swapped organization compared to their arrangement in
pGdh442, which would confirm previous suggestions regarding the ability of these
gene blocks to be mobilized by the flanking IS elements (Tanous et al., 2007). The
observation that one of these shared gene blocks is to date exclusive to pGdh442 in L.
lactis further supports the hypotheses of large-scale HGT occurring between the two
plasmids and, consequently, of a plant origin for the pVF50 host. This region is
composed of three genes encoding membrane components of Na+ and K+ transport
systems, which are virtually identical in pVF50 (contig2.gene1-3) and in pGdh442
(orfs15-17) but share only 41 to 45% identity to other homologues found in
Clostridium (Tanous et al., 2007).
Genes on pVF50 related to growth on milk components have certainly facilitated
the adaptation of L. lactis DPC3901 to the dairy environment. The ability of the strain
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to grow well in milk and to utilize lactose is encoded by the lacXGEFDCBA operon,
or the lactose phosphotransferase system (contig3.gene1-8), which is negatively
regulated by the product of the divergently transcribed lacR gene (contig3.gene9)
(Vanrooijen and Devos, 1990, Vanrooijen et al., 1991). The lacXGEFDCBAR region
of pVF50 is 98 to 100% identical at both DNA and protein level to that present on
pSK11L (Siezen et al., 2005). A further contribution to lactose utilization in L. lactis
DPC3901 might also be afforded by the dld gene (contig2.gene14), which is
predicted to encode a D-lactate dehydrogenase (D-LDH) of 559 aa and might
function in D-lactate utilization under aerobic conditions (Siezen et al., 2005).
However, experiments by Tanous et al. showed that L. lactis strains containing a
pGdh442-encoded dld gene, identical to that on pVF50, were unable to grow in M17
containing D-lactate as carbon source, and also that the gene was not over-expressed
when the same strains were grown in GM17 (Tanous et al., 2007).
Plasmid pVF50 also encodes a neutral oligoendopeptidase PepO and the
complete oligopeptide permease (Opp) system OppDFBCA, which endow L. lactis
DPC3901 with the ability to utilize proteins as carbon source. The corresponding
genes are part of a gene block (contig1.gene7-19), containing the flp operon and
flanked by transposases of the IS3 (tnp-IS3) and IS6 (tnp-IS946) families, that is 98%
identical to the homologous region on pGdh442 (orfs55-64) (Tanous et al., 2007).
The Opp system allows the efficient uptake of oligopeptides generated from casein
degradation by the cell wall proteinase (Tynkkynen et al., 1993), whereas PepO is
reported to hydrolyze oligopeptides ranging in length from 5 to 35 residues
(Christensen et al., 1999). To date, the combination of pepO and Opp system has
been found only on plasmids pSK11L (Siezen et al., 2005) and pGdh442 (Tanous et
al., 2007), and has been suggested to be beneficial for the optimal utilization of milk
caseins as a nitrogen source, thus resulting in a fast milk coagulation phenotype
(Siezen et al., 2005). A further contribution to this process in L. lactis DPC3901 may
also derive from the oligoendopeptidase F encoded by pepF (contig2.gene20), which
is known to be part of the complex proteolytic system essential for growth of L. lactis
in milk. This enzyme hydrolyzes oligopeptides of 8-9 residues and plays a potential
role in protein turnover under nitrogen limiting conditions (Christensen et al., 1999).
The presence of these determinants led us to evaluate the strain’s ability to grow and
acidify milk under conditions resembling the manufacture of Cheddar cheese. Growth
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rates and acidification capacity of L. lactis DPC3901 were slightly lower than those
of the widely used cheese starters L. lactis DPC4268 and L. lactis SK1, but still
sufficient for cheese manufacturing (Table 3).
Plasmid pVF50 is predicted to carry various stress response genes that may have
enhanced the robustness of L. lactis DPC3901 within the dairy environment. These
include a number of genes encoding putative cold shock proteins including CspA,
CspC and CspB homologues. These proteins are identical to the only lactococcal
Csps found to date on the plant-associated plasmid pKF147A (Siezen et al., 2010), on
pSK11P (Siezen et al., 2005) and on L. lactis MG1363 chromosome (Wegmann et
al., 2007). It has been suggested that the presence of multiple plasmid-encoded Csps
might enhance the survival capability of the L. lactis host at low temperatures (Siezen
et al., 2005).
pVF50 is the only L. lactis DPC3901 plasmid to contain a replication and
maintenance region composed of a typical lactococcal theta-type ori site (Seegers et
al., 1994), a repA gene (contig1.gene2) encoding the replication initiator, and two
genes (contig1.gene3-4) encoding the partition proteins ParA and ParB. This region is
identical to homologous regions present on plant-derived lactococcal plasmids
pKF147A (Siezen et al., 2010) and pGdh442 (Tanous et al., 2007), and on pSK08
from L. lactis ML3 (accession no. AF300944). The similarity of the ori regions of
pGdh442 and pSK08-like plasmids, which include the lactose/protease plasmid
pLP712 (Gasson, 1983), has been associated with the instability of pGdh442 within a
strain containing pLP712 (Tanous et al., 2007). Plasmid pVF50 carries an ori region
identical to that of pGdh442 and is predicted to contain determinants for lactose
fermentation but no protease-associated genes. This suggests that pGdh442-like
plasmids are probably incompatible with protease genes in co-resident plasmids, and
also that the transfer of pVF50 to strains capable of growing in milk cannot be ruled
out as suggested for pGdh442 (Tanous et al., 2007). The partition genes parA and
parB are likely to provide pVF50 with a maintenance system counteracting plasmid
loss at cell division. ParA is a DNA-binding protein similar to a conserved family of
ATPases (cd02042), which includes the RepA protein of the repABC operon involved
in replication and partition of the Rhizobium etli CFN42 symbiotic plasmid (Cevallos
et al., 2002). ParB (242 aa) contains a nuclease-like domain (PF02195) belonging to a
highly conserved set of chromosomal and plasmid partition proteins. Shortly
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following the initiation of DNA replication, ParB localizes to opposite cell poles
where it binds to DNA sequences adjacent to ori and regulates the ParA ATPase
activity by promoting nucleotide exchange (Easter and Gober, 2002). During plasmid
partitioning, ParA polymerizes into filaments forming a mitotic-like apparatus, which
is initially located at the centre of the nucleoid and then gradually migrates towards
the cell quarters. Plasmid DNA is constantly co-localized with the ParA spot, which
therefore acts as a pulling motor determining the destination of the partitioning
plasmid (Hatano and Hironori, 2010). In L. lactis, the ParAB maintenance system has
only been found on pSK08, pCI2000, pGdh442 and pKF147A to date (Kearney et al.,
2000, Siezen et al., 2010, Tanous et al., 2007). These plasmids share with pVF50 a
large size (over 50 kb) and a low copy number, which make them more at risk of
being lost during cell division. The ParAB maintenance system presumably increases
the stability of these plasmids within the host by ensuring their faithful segregation at
each cell division. In the case of pVF50, this would allow the stable maintenance of
lactose and peptide utilization abilities that are essential to L. lactis DPC3901 for a
successful adaptation to the dairy environment.
A pVF18/pVF22-cured derivative of L. lactis DPC3901 retains phage-resistance
and potential starter and flavour-forming capacities
The plasmid-encoded capacities of resistance to phages and various stresses,
coupled to the starter and flavour-forming potential, render L. lactis DPC3901 an all-
round candidate for the preparation of starter formulations with enhanced robustness
and novel technological attributes. However, the presence of tet(M) on the
conjugative pVF22 would impede the potential use of L. lactis DPC3901 in foods for
human consumption due to concerns regarding the spread of antibiotic resistance
genes from food-borne LAB to pathogenic organisms (Teuber et al., 1999). In the
past, antibiotic resistance genes have been removed from probiotic strains by using
methods that did not genetically modify the organism and retained the original
probiotic characteristics (Rosander et al., 2008). We took a similar approach and
cured pVF22 from the pVF18-cured derivative of L. lactis DPC3901 (L. lactis
DPC3901-c1) (Figure 5a). The strain lost pVF22 after ca. 100 generations but
retained pVF50 and pVF21, as also confirmed by PCR (Figure 5b). Compared to the
parent strain, the new derivative (L. lactis DPC3901-c2) exhibited unaltered
Chapter IV
175
acidification capacities and slightly better growth rates (Table 3), probably as a result
of the loss of two metabolically-burdening plasmids. Such a strain might be safely
employed to generate novel starter formulations with improved protection against
phage attack and ability to diversify and widen the flavour profile of the final product.
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CONCLUSION
It is thought that plant-associated strains are the original source of many dairy
strains as they can transfer from forage plants and meadow grasses to milk via cattle
(Salama et al., 1995). However, to the best of our knowledge, no clear evidence of
such an origin has ever been found for any of the lactococcal genomes or plasmids
sequenced to date. Plasmids are of great interest as these mobile elements often
mediate extensive HGT, thus enabling strains to acquire traits conferring a selective
advantage to colonize specific biotopes (Mills et al., 2006). Some of these traits can
be as specific to a particular niche as to be reasonably considered equivalent to
traceability markers, thus enabling the plasmid complement to be used as a sort of
bar-coding system of the organisms’ origin. Retrieval of strains containing such
traceable traits is feasible within raw milk cheeses where the absence of
pasteurization allows the transfer of plant-derived bacteria to cheese via the cow-milk
network.
In this study, we found that the four-plasmid complement of the raw milk cheese
isolate L. lactis subsp. lactis biovar. diacetylactis DPC3901 encodes a number of
gene functions that have not been previously described in Lactococcus and are
generally typical of bacteria associated with the plant ecosystem (Table 4). These
include activities of modification of the plant cell wall and a functional system for the
high-affinity and regulated uptake of Co2+. Additionally, these plasmids carry several
other genes, encoding transporters with a confirmed or predicted role in the uptake of
a variety of metal ions, which have single lactococcal homologues on plant-derived
plasmids (Table 4). Considering that none of these traits are required for growth in
milk, their presence in a dairy strain may be inferred as genetic traces of the previous
niche inhabited by the organism where they conferred the host with a real
colonization advantage.
The plant-origin hypothesis is further supported by the observation that vast
regions of pVF50 and pVF21 share high degrees of homology to regions of the plant-
derived lactococcal plasmid pGdh442 (Tanous et al., 2007), and that these regions
encode phenotypes (i.e. glutamate dehydrogenase, Na+ and K+ transporters) so far
unique to pGdh442 in L. lactis (Tanous et al., 2007, Tanous et al., 2002). This is
indicative of large HGT occurred between pVF65/pVF21 and pGdh442, which again
links L. lactis DPC3901 with the plant biotope. Based on these considerations, we
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have found plasmid-encoded markers that potentially trace L. lactis subsp. lactis
biovar. diacetylactis DPC3901 back to a plant origin and provide for the first time the
genetic basis to support the concept of the plant-milk transition for L. lactis strains.
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TABLES
Table 1. Bacterial strains used in this study
Bacterial strain Relevant characteristic(s) Sourcea or reference
L. lactis subsp. lactis biovar.
diacetylactis DPC3901
Raw milk cheese isolate; contains four plasmids of 18, 21, 22
and 65 kb
TFRC culture collection
L. lactis subsp. lactis biovar.
diacetylactis DPC3901-c1
pVF18-cured derivative of L. lactis DPC3901 This study
L. lactis subsp. lactis biovar.
diacetylactis DPC3901-c2
pVF22-cured derivative of L. lactis DPC3901-c1 This study
L. lactis subsp. cremoris
MG1363
Plasmid-free derivative of L. lactis subsp. cremoris 712 Gasson (1983)
L. lactis subsp. lactis biovar.
diacetylactis DRC3
DNA size marker strain; contains eight plasmids with sizes
from 2 to 78 kb
McKay and Baldwin
(1984)
L. lactis subsp. lactis SK1 Cheese starter TFRC culture collection
L. lactis subsp. cremoris
DPC4268
Cheese starter TFRC culture collection
aTFRC, Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland
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Table 2. Primers used in this study to map gene features of L. lactis DPC3901
plasmids
Primer Sequence (5'-3') Productsize (bp) Target Plasmid
orfs18-21 (Fa) GAAAACATCAAGAAGAACGCAGAGT 1,858 orfs18-21 pVF18
orfs18-21 (Rb) TGGCAATCGAAGCATCAAGTAGAC
gdh (F) GTGGGTCGACGATGCTGGTAAAGTT 822 gdh pVF21
gdh (R) TGGACGCCGCTGGAAATCAATA
corA (F) TTTATGTGTATGGTGACGAACGAGAAT 812 corA pVF22
corA (R) CAGCACAGCAAAAACACCATAAGAAGAT
ldh (F) GTGCTGCCAAATATAGATGCCCAACA 484 ldh pVF50
ldh (R) ATGCCAAAGCGGTTAGATGATTATTACGA
aF = forward primer; bR = reverse primer. Table columns indicate primer’s name and
sequence, expected size of the PCR product, gene(s) target and its plasmid location.
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Table 3. Comparison of the growth rate parameters and acidification capacities of L.
lactis DPC3901 and its pVF18/pVF22-cured derivative (DPC3901-c2) with those of
selected lactococcal cheese starters
L. lactis
strain m max
a (h-1) Generation time (h -1) 11% RSM GM17
DPC3901 0.90 (± 0.08) 1.17 (± 0.10) 5.37 (± 0.18) 6.06 (± 0.04)
DPC3901-c2 0.99 (± 0.10) 1.09 (± 0.12) 5.25 (± 0.01) 5.90 (± 0.05)
SK1 1.18 (± 0.01) 0.85 (± 0.01) 4.91 (± 0.24) 5.67 (± 0.03)
DPC4268 1.10 (± 0.13) 0.92 (± 0.11) 4.78 (± 0.13) 5.41 (± 0.01)
Growth rate Starter activity (pH)
amax = maximum growth rate.
Chapter IV
188
P
la
sm
id
G
en
e(
s)
P
ro
du
ct
(s
)
P
re
di
ct
e
d
fu
nc
tio
n/
ro
le
(s
)
B
e
st
h
om
ol
og
fo
un
d
in
Id
en
tit
y
N
o
ve
li
n
L.
la
ct
is
pV
F
18
or
f1
1
P
o
ly
sa
cc
ha
rid
e
de
a
ce
ty
la
se
H
yd
ro
ly
si
s
o
fc
el
lw
a
ll
ca
rb
oh
yd
ra
te
s
in
pl
an
ts
;
ut
ili
za
tio
n
of
m
in
er
a
ln
itr
og
en
E
n
te
ro
co
cc
us
fa
ec
iu
m
PC
4.
1
99
%
pV
F
18
or
f2
5
C
up
in
-d
om
ai
n
co
nt
a
in
in
g
is
om
e
ra
se
/e
p
im
er
as
e
o
rg
e
rm
in
/p
la
nt
st
o
ra
ge
pr
o
te
in
M
o
di
fic
at
io
n
of
ce
ll
w
al
lc
ar
bo
hy
dr
at
es
in
pl
an
ts
;
ut
ili
za
tio
n
of
m
in
er
a
ln
itr
og
en
S
tr
ep
to
co
cc
us
ub
e
ris
01
40
J
92
%
pV
F
18
or
fs
19
-2
0-
21
X
R
E
fa
m
ily
tra
ns
cr
ip
tio
na
lr
eg
ul
at
or
;
H
yp
ot
he
tic
al
p
ro
te
in
;A
B
C
tr
an
sp
or
te
r,
A
T
P
as
e
a
nd
pe
rm
ea
se
co
m
po
ne
nt
s
P
ut
a
tiv
e
hi
gh
-a
ffi
ni
ty
C
o2
+
tra
n
sp
or
te
r;
he
av
y
m
et
al
s
ho
m
eo
st
a
si
s
L
eu
co
no
st
oc
ki
m
ch
ii
IM
S
N
U
1
11
54
,
L
ki
pL
4
72
6
92
-9
9%
pV
F
21
or
f5
D
G
Q
H
R
do
m
ai
n-
co
nt
ai
ni
n
g
hy
po
th
et
ic
al
pr
ot
ei
n
pu
ta
tiv
e
b
ac
te
rio
ph
a
ge
pr
ot
ei
n
B
a
ci
llu
s
ce
re
us
G
98
4
2
32
%
pV
F
22
or
f1
P
ri
m
os
om
a
lp
ro
te
in
N
'
D
N
A
re
pl
ic
at
io
n
fa
ct
o
r
L
eu
co
no
st
oc
m
es
en
te
ro
id
es
su
bs
p
.
m
es
en
te
ro
id
es
A
T
C
C
82
93
37
%
pV
F
50
ct
g1
.g
en
e5
T
ra
ns
po
sa
se
,I
S
11
0
fa
m
ily
D
N
A
in
te
gr
at
io
n/
re
co
m
bi
na
tio
n
S
tr
ep
to
co
cc
us
pn
e
um
on
ia
e
S
P1
9-
B
S
75
75
%
R
a
re
in
L.
la
ct
is
(s
in
gl
e
hi
t)
pV
F
18
or
f4
;
or
f2
3
G
C
N
5-
re
la
te
d
N
-a
ce
ty
ltr
an
sf
er
as
e
R
eg
ul
at
io
n
of
ce
ll
gr
o
w
th
an
d
de
ve
lo
pm
en
t
L
ac
to
co
cc
us
la
ct
is
M
G
13
63
;W
ei
ss
el
la
p
ar
am
es
en
te
ro
id
es
A
T
C
C
3
33
13
98
%
;
84
%
pV
F
18
or
f2
4
T
ra
ns
po
sa
se
,I
S
30
fa
m
ily
D
N
A
in
te
gr
at
io
n/
re
co
m
bi
na
tio
n
E
n
te
ro
co
cc
us
fa
ec
al
is
TU
S
oD
E
f1
1
10
0%
pV
F
21
gd
h
G
lu
ta
m
at
e
de
hy
dr
og
en
a
se
R
ev
er
si
bl
e
ox
id
a
tiv
e
de
a
m
in
at
io
n
of
g
lu
ta
m
at
e
L
ac
to
co
cc
us
la
ct
is
,p
G
dh
44
2
99
%
pV
F
21
or
f1
5
H
yp
ot
he
tic
al
p
ro
te
in
L
LK
F_
p
00
13
P
ut
a
tiv
e
ca
tio
n
ef
flu
x
sy
st
em
pr
ot
ei
n
L
ac
to
co
cc
us
la
ct
is
K
F1
47
,p
K
F
14
7A
99
%
pV
F
22
or
f9
H
yp
ot
he
tic
al
p
ro
te
in
P
ut
a
tiv
e
gl
yc
op
ep
tid
e
an
tib
io
tic
s
re
si
st
a
nc
e
pr
ot
ei
n
S
tr
ep
to
co
cc
us
th
e
rm
op
hi
lu
s
98
%
pV
F
22
or
f1
3
H
yp
ot
he
tic
al
p
ro
te
in
L
ac
to
co
cc
us
g
ar
vi
ea
e
,
pL
K
00
18
99
%
pV
F
50
co
n
tig
2
.g
en
e1
N
a+
/H
+
an
tip
o
rte
r
E
xc
ha
ng
e
of
so
di
um
/h
yd
ro
ge
n
io
ns
L
ac
to
co
cc
us
la
ct
is
,p
G
dh
44
2
10
0%
pV
F
50
co
n
tig
2
.g
en
e2
P
u
ta
tiv
e
K
+
tra
ns
po
rte
r
U
pt
ak
e
of
po
ta
ss
iu
m
L
ac
to
co
cc
us
la
ct
is
,p
G
dh
44
2
99
%
pV
F
50
co
n
tig
2
.g
en
e3
P
u
ta
tiv
e
K
+
tra
ns
po
rt
sy
st
em
T
rk
A
U
pt
ak
e
of
po
ta
ss
iu
m
L
ac
to
co
cc
us
la
ct
is
,p
G
dh
44
2
99
%
T
ab
le
4.
N
ov
el
ge
ne
sn
ot
fo
un
d
be
fo
re
in
L.
la
ct
is
an
d
ra
re
ge
ne
s
w
ith
ho
m
ol
og
ue
s
on
pl
an
t-
as
so
ci
at
ed
la
ct
oc
oc
ca
ls
tra
in
s
Chapter IV
189
FIGURES
cupin-like proteinli r t i
(N2 utilization)tili ti )
tnp
-IS
6770
or
f2
2
orf6
tnp1-IS1216
50
00
1000 0
15
00
0
orf15
or
f23
orf25
tn
p2
- I
S
1 2
1
6
orf4
or
f11
orf7
or f1
2
orf13
o
rf8
or
f2
1
re pB
o
rf
9
orf1 orf2
o rf5
o
r fX
h
s
d S
or
f1
8
18.977 kb.
or
f1
9 o
r f
20
pVF18
replication
region
GNAT
enzyme
pVF22
22,166 bps
GC% 35.1.
mobilization
region replicationli i
regioni
tetracyclinet t li
resistancei t
Mg2+ and Co2+
transporterst t
replicationli ti
regioni
cadmiumi
resistancei t
phage resistance
glutamatel t t
biosynthesis
pVF21
21,728 bps,
GC% 33.5
putative high-affinity
Co2+ transportert t
polysaccharide
deacetylase
(N( 2 utilization)tili ti )
GNAT
enzyme
18,977 bps,
GC% 33.9
r
Figure 1.
Chapter IV
190
Figure 1. Physical and genetic maps of plasmids pVF18, pVF21 and pVF22 of L.
lactis DPC3901. Position and orientation of genes is indicated by arrows. Inner
circles show the nucleotide numbering. An atomic force microscopy image of L.
lactis DPC3901 is shown within the black circle.
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Figure 2.
------------------------ AT-rich ---------------------------
repB_pVF22 TTTTGATTTTAAAT--------T-------------------------------------
repB_pVF21 TTTTTATTTTAAAACGAAAAATATAAGCTTTAGAGATATTTTAACCTTTGTTTCTTCAAA
repB_pVF18 CTTTGGTTTTAAAT--------T-------------------------------------
repA_pVF50 ATATGTCGTAAAAA--------T-------------------------------------
------------ AT-rich -----------> -- 22-bp DR -
repB_pVF22 -----------TTTGAAAAAA--ATAAAAAA-Aggcgaagcctat-attaatttatcata
repB_pVF21 ATATTTTTAATTTTAAAAAAA--ATAAAAA-AAggcgaagcctattatatatttatctta
repB_pVF18 -----------TTTGAAAAAA--ATAAAAAATAggcgaagcctattatatatttatctta
repA_pVF50 -----------TGCGTATTAGGGAGTAAAAAT-tgtgta-cctatgaCGTAAAAATGTTG
------->------ 22-bp DR ------>------ 22-bp DR ---->---22-bp
repB_pVF22 tata--tt-ttaatcttttattcttttgcgtcaaaaaaaagtg------agtgttttcaa
repB_pVF21 tata--tt-ttaatcttttattcttttgcgtcaaaaaaaagtt------agtatttttaa
repB_pVF18 tata--tt-ttaatcttttattcttttgcgtgggggaaaagtc------aatggtaacgc
repA_pVF50 TATATAATCGTAAAAAATGTTGCTT--GTGGCGTAAAAATGTTGCTGTAAATCG--TAAA
DR----> ------ 22-bp DR ------>----- 22-bp DR -----
repB_pVF22 ggggttaaaga---ataATAT-GTGGAGAAAAAACTGTTTATATATGGAGAAAAAACTGT
repB_pVF21 ggggttacagg---ATAATAT-AGCATAAAAAAACTGTGTATATAGCATAAAAAAACTGT
repB_pVF18 -catttatagaa--attaaAT-AGCCCAAAAAAACTATGTATATAGCCCAAAAAAACTAT
repA_pVF50 AATGTTGtattattactagacaagaataaaaaaatagtgtatatta---ataaaaacaaa
->------ 22-bp DR ----->-- 22-bp DR -->
repB_pVF22 TTATATATGGAGAAAAAACTGTTTATATAT-GGA-GAAtgtctactaccttctccatgta
repB_pVF21 GTATATAGCATAAAAAAACTGTGTATATAGCATAAAAAAgtc-atcagtttatg-ctata
repB_pVF18 GTATATAGCCCAAAAAAACTATGTATATAGCCCAAAAAAAac-atgaaattgtg-ttgtg
repA_pVF50 ggttatgacgtaaaaatgt--tgtattt--tata-taagtttttctatctttcttcTATA
_-10__------ IR ----><------------ IR -------------
repB_pVF22 ttgtggTATAATaaaaGCATGAAGAaa---cacttttcgtcgagagaaTCTTCATGCgta
repB_pVF21 ttatgaTATAATAAAAGTatgaagaa--caaACTTTTgaacgagaatttcttcatactta
repB_pVF18 ttgtgaTATAATaaaagcatAGAGAAA-tcgacggcaaaat--cagTTTCTCTatgctta
repA_pVF50 AAgtga---acgAAAAATa--cacaaTTTTTAcgattaaat--cagata--ttat-ttta
_RBS__ start codon
repB_pVF22 tctaaaaacactca-AAGGAGcgtatttctATG
repB_pVF21 cttatgaacacgca-GAGGAGcgtatctttATG
repB_pVF18 accaaaattactcatAAGGAGcaacttctcATG
repA_pVF50 tct--tgatactg--AAAGAGgg-gttaaaATG
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Figure 2. Multiple sequence alignment of the origin of replication (ori) region
upstream the replication initiator (rep) gene of L. lactis DPC3901 plasmids. The
putative AT-rich region, the 22-bp direct repeats (22-bp DR), the 6-9 bp inverted
repeats (IR), the promoter -10 signal (consensus sequence TATAAT) and ribosome
binding site (RBS) (consensus sequence AAGGAG), and the ATG start codon of the
rep gene are indicated in boldface and by dashed or solid arrows above the sequence.
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Figure 3.
1 21 41 61
MNSLISLEKVNYQIADQHIL HDVDWQIPAGAHITLTGPSG GGKSTLLRIIAAMISKTSGT LIFDGQPIESYDPIMYRRQV
Walker A
81 101 121 141
SYCFQQPTLFGETVADNLAF PYQIRKQVMDTKRVVTALNN VGLSERTLHQPIIE LSGGER QRVALIRNILFLPKVLLLDE
Walker C Walker B
161 181 201 216
VTAGLDENNKQIVHAWLRQL NEQDHVTTIMITHDATEIAA ADQLAKVVAGRLEVHA
(a)
(b)
(c)
1 21 41 61
Orf21 MNLAVNNTSLFLAAMLVLVA LGISLWQKLGLDRDIVIGVV RAVVQLFIVGYLLKYIFRVN NLWLTLAMIGFIIFNAAWNA
TOPCONS ooooMMMMMMMMMMMMMMMM MMMMMiiiiiiiiiiMMMMM MMMMMMMMMMMMMMMMoooM MMMMMMMMMMMMMMMMMMMM
81 101 121 141
Orf21 KKRGPGIDHALAISLLAIFV STGVTLGVLVLSGAIKFVPS QMIPISGMIASNSMVAIGLA YRSLNSQFHDQRQAVLERLA
TOPCONS iiiiiiiiiiMMMMMMMMMM MMMMMMMMMMMooooooooo MMMMMMMMMMMMMMMMMMMM Miiiiiiiiiiiiiiiiiii
161 181 201 221
Orf21 LGAGLLDASIAIVREAIRTG MSPTIDSAKTVGLVSLPGMM SGLIFAGVDPVRAIRYQIMV TFMLLSATSLGSIIACYLAY
TOPCONS iiiiiiiiiiiiiiiiiiii iiiiMMMMMMMMMMMMMMMM MMMMMoooooooooooooMM MMMMMMMMMMMMMMMMMMMi
241 251
Orf21 RNFYNEQKQL K
TOPCONS iiiiiiiiii i
aatatgagatctaaatgtttatattgggggtatggaaaat
orf18 orf19 orf20 orf21
-35 -10 RBS
ttg tccgaacagcgttcggattaattttaca
rho-independent terminator
tgatataatactccctagataggagaca
-10 RBS
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Figure 3. Sequence analysis of the putative polycistronic operon orfs18-21. (a)
Putative regulatory elements of the orfs18-21 operon. The ribosome binding site
(RBS), -10 and -35 promoter sequences and the rho-independent terminator signal are
shown in bold and underlined. (b) Location of the conserved domains typical of
ABC-transporter ATPases in Orf20: the Walker A (consensus GxxGxGKS/T, where
x is any residue) and Walker B (consensus hhhhDE, where h is a hydrophobic
residue) motifs involved in ATP binding, and the Walker C (consensus
LSGGQQ/R/KQR) motif involved in ATP hydrolysis are shown underlined. (c)
TOPCONS consensus prediction of membrane topology for Orf21 showing seven
trans-membrane motifs (i = inside ; M = trans-membrane; o = outside) typical of
ABC-transporter permeases.
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Figure 4. Growth curves of L. lactis DPC3901 (a), MG1363 (b), DPC3901-c1 (c)
and DPC3901-c2 (d) in media containing 0 (●), 1 (■), 2 (▲), 3 (◊), 4 (○), 5 (□) and 6 
mM (∆) cobalt chloride. The “minus“ or “plus” superscripts are indicative of absence
or presence, respectively, of the orfs18-21 and corA genotypes in each strain or
derivative.
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(a)
(b)
orfs18-21
corA
ldh
gdh
65 kb
51 kb
36 kb
16 kb
14 kb
12 kb
10 kb
8 kb
7 kb
6 kb
5 kb
4 kb
3 kb
2 kb
1 2 3 4 5
Figure 5. (a) Plasmid DNA profiles of L. lactis DPC3901 (lane 3) and its cured
derivatives DPC3901-c1 (pVF18-, lane 4) and DPC3901-c2 (pVF18- pVF22-, lane 5).
The plasmid profile of L. lactis DRC3 (lane 2) provides reference plasmids of large
sizes (36, 51 and 65 kb) as a complement to the 2 to 16 kb molecular size ladder (lane
1). (b) PCR-based detection of specific gene features in the plasmid complement of L.
lactis DPC3901, DPC3901-c1 and DPC3901-c2.
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Chapter V
The presence of pMRC01 promotes greater cell permeability and
autolysis in lactococcal starter cultures
International Journal Food Microbiology. (2009). 133:217–224.
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ABSTRACT
Conjugative transfer of plasmid-associated properties is routinely used to
generate food-grade derivatives of lactococcal starter strains with improved
technological traits. However, the introduction of one or more plasmids in a single
strain is likely to impose a burden on regular cell metabolism and may affect the
growth characteristics of the transconjugant culture. The aim of this study was to
evaluate the impact of the 60.2-kb plasmid pMRC01 (encoding for a bacteriophage
resistance system and production of the antimicrobial, lacticin 3147) on starter
performance. Five lactococcal strains (L. lactis HP, 255A, SK1, 712 and IL1403) and
their pMRC01-containing derivatives were compared in terms of technological
properties, including analysis of growth, acidification and autolysis rates. The
transconjugants exhibited lower specific growth rates and higher generation times
compared to the parental strains when grown at 30 C in glucose-M17, but the
presence of pMRC01 did not significantly affect the acidification capacity of strains
in 11% reconstituted skimmed milk and synthetic media. Levels of lactate
dehydrogenase were two-fold higher in supernatants of transconjugants than in those
of parental strains, after 24 and 72 h of growth at 30 C in glucose-M17, suggesting
that the presence of pMRC01 somehow accelerates and promotes cellular autolysis.
Analysis by flow cytometry following live/dead™ staining confirmed this result by
showing larger populations of injured and dead cells in pMRC01-carrying cultures
compared to the parental strains. The results of this study reveal that the plasmid
pMRC01 places a burden on lactococcal host metabolism, which is associated with an
increased cell permeability and autolysis, without significantly affecting the
acidification capacity of the starter. While the magnitude of these effects appear to be
strain dependent, production of the bacteriocin lacticin 3147 may not be involved.
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INTRODUCTION
Lactococcus lactis is a gram-positive homofermentative microorganism
exploited worldwide as one of the main components of starter cultures for the
manufacture of dairy and other fermented products. It has been estimated that over
109 litres of starter bacteria are annually used in food fermentation, resulting in cheese
production of 107 tons and human consumption close to 1018 lactococci: these figures
adequately depict the biotechnological and economical value of lactococcal strains
(Bolotin et al., 2001). Much of the genetic basis associated with the diversity and
technological superiority of commercial L. lactis starters is recognized to reside in
their plasmid complement. Plasmids are omnipresent among dairy L. lactis strains,
and most isolates contain multiple plasmids ranging in size from 2 to 80 kb. Modern
DNA sequencing technologies have decisively boosted the number of plasmid
sequences available, unravelling the diversity and contribution of these genetic
necessities to the performance of lactococcal starter. Many industrially important
traits, including lactose metabolism, proteinase production, citrate metabolism,
bacteriophage resistance, and bacteriocin and exopolysaccharide production are
generally plasmid-encoded. The self-transmissible nature of some plasmids has either
allowed the exploitation of these genotypes to improve the performance of industrial
starters or provided the genetic markers for the construction of food-grade vectors for
L. lactis (Lee and Moon, 2003, Mills et al., 2006).
A disadvantage associated with plasmid-mediated strategies for improvement of
starters is that the introduction of one or more plasmids in a single strain may impose
an additional burden to the regular cell metabolism. Plasmid genes compete with the
chromosomally-encoded genes for the limiting cellular resources available for DNA
replication and expression. Reallocation of energy and precursor metabolites into
plasmid replication and synthesis of plasmid proteins places a metabolic burden that
usually results in alteration of the growth kinetics of the transconjugant strain (Diaz
Ricci and Hernandez, 2000, Rozkov et al., 2004). Plasmid-host interaction has been
the focus of considerable research in recombinant microorganisms, most notably in
Escherichia coli. Diaz Ricci and Hernandez (2000), in reviewing these studies,
concluded that size, copy number, and gene expression are the plasmid properties
most likely to affect cell growth rate, and that the impact of gene over-expression is
significantly higher than that of size or copy number. The few studies that do exist in
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lactococci (el Alami et al., 1992, Kobayashi et al., 2002, Lee and Moon, 2003,
Pillidge et al., 2000) report of a negative impact of plasmid content on growth and
acidification rates of the lactococcal host cell, and tend to associate the metabolic
burden with the genetic information encoded on the plasmid (Kobayashi et al., 2002)
rather than with size or copy number (el Alami et al., 1992).
Nevertheless, the analysis, mobilization and exploitation of the genetic diversity
of plasmids naturally occurring in lactococci remains one of the most utilized and
promising tools for the food-grade improvement of industrial starters. Many plasmids
carrying industrially valuable traits have been recently described (Mills et al., 2006).
One of these is the 60.2-kb plasmid pMRC01 that was found in Lactococcus lactis
subsp. lactis DPC3147, a strain isolated from an Irish kefir grain (Ryan et al., 1996).
Useful characteristics of the plasmid include determinants encoding for conjugative
functions, bacteriophage resistance and lacticin 3147 production. Conjugal transfer of
this plasmid has been successfully performed in over 30 starter cultures giving rise to
strains with improved phage resistance and broad anti-microbial properties while
retaining sufficient acidification capacity (Coakley et al., 1997, Ryan et al., 1996).
Initial observations that pMRC01-bearing strains generally grow more slowly
and exhibit reduced rates of acid production compared to the parent strains prompted
a more detailed investigation of the metabolic load associated with the presence of
pMRC01 in lactococcal starters through a comparative analysis of growth,
acidification and viability rates of wild-type and pMRC01-transconjugant strains. The
results of this study reveal that the acquisition of pMRC01 places a metabolic burden
on lactococcal host that results in lower growth rate in synthetic media and greater
cell permeability and autolysis. Nevertheless, the plasmid does not significantly affect
the milk acidification times of the strains, thus allowing their use as starter cultures in
dairy industry. In this respect, it is arguable that the permeable physiological state of
plasmid-carrying strains may also be significant in terms of contribution to cheese
ripening and flavour.
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MATERIALS AND METHODS
Bacterial strains and media
The bacterial strains used in this study are listed in Table 1. Lactococcal strains
were routinely propagated at 30 C in M17 medium (Oxoid, Hampshire, England)
supplemented with 0.5% (wt/vol) glucose (GM17). 11% reconstituted skim milk
(RSM) was also used during the course of this study. Solid media contained 1.0%
(wt/vol) bacteriological agar (Oxoid, Hampshire, England). Where required, the
antibiotic rifampicin was added to agar at a concentration of 100 g/ml. Bacterial
strains were stocked in M17 containing 40% glycerol at -80 C. Working cultures
were stored at 4 C and transferred periodically. Selective plates containing lacticin
3147 and rifampicin were prepared as follows: an overnight culture of L. lactis
DPC3147 was centrifuged at 8,000 x g for 30 min and the resulting supernatant was
adjusted to pH 7.0 with concentrated NaOH, filter sterilized with Millipore
(Middlesex, England) HVLP filters (0.45 m pore size) and tempered to 45C. The
bacteriocin preparation was added to an equal volume of double-strength lactose
indicator agar (LIA) (McKay et al., 1972), containing rifampicin (100 g / ml) and
bromocresol purple (0.004%), to generate a final lacticin 3147 concentration of 400
arbitrary units / ml.
Detection of plasmid pMRC01 in lactococcal transconjugants
Plasmid DNA was extracted according to the method of (O'Sullivan and
Klaenhammer, 1993). Plasmid profiles were analyzed by electrophoresis on
horizontal 0.6% agarose gels (Sigma, St. Louis, USA) in TAE buffer (40 mM Tris–
HCl, 20 mM Acetic acid, 2 mM EDTA, pH 8.0) for 4 h at 80 V. Plasmid DNA
molecules were sized using HyperLadder I (0.2-10 kb) (Bioline, London, UK) and the
strain L. lactis subsp. lactis biovar. diacetylactis DRC3 as a source of high molecular
size markers (35, 51, 65 and 78 kb) (McKay and Baldwin, 1984). Where difficult to
visualize on plasmid profile, presence of pMRC01 in transconjugants was confirmed
by multiplex-PCR by using primers 5’-GGAGATGATTGACATGGA-3’ and 5’-
CTACTCTCTAACTCATCC-3’ designed to amplify a ca. 500-bp fragment spanning
both structural genes ltnA1 and ltnA2 (Dougherty et al., 1998), and primers 5’-
AGGTACGATCCCACTCACAGA-3’ and 5’-
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AATAGACTTTTTCAATCGCAACTC-3’ targeting a ca. 260-bp fragment in the
ORF61 of the replication region that is located just opposite the lacticin operon.
Lacticin 3147 production by transconjugants was estimated by an agar well diffusion
assay, using L. lactis subsp. cremoris HP as the indicator strain, and levels of
bacteriocin were calculated and expressed in arbitrary units (AU)/ml as previously
described (Ryan et al., 1996).
Measurement of bacterial growth rate
Standardization of culture inoculum prior to each of the analyses described
hereafter was considered crucial to establish a reliable correlation between the
presence of plasmid pMRC01 and any putative effect. Following overnight growth,
the bacterial density of each culture was thus measured by flow cytometry (FCM)
using the BD Cell Viability Kit and BD Liquid Counting Beads (BD Biosciences, San
Jose, USA) as described in the next subsection. Within each pair of wild-type and
pMRC01-carrying strains, inoculums were standardized to the culture with the lowest
count. The growth rate of L. lactis strains was measured in GM17 at 30 C. After
overnight propagation, the cultures were inoculated at 2% into GM17 and grown over
a 6-h incubation time. Samples were withdrawn at 1-h intervals to measure turbidity
with a UV-1700 spectrophotometer (Shimadzu, Kyoto, Japan) at 600 nm and to
determine growth rate parameters by plate counts. The max growth rate (max) of each
culture was calculated in the middle of the log phase according to the equation:
(log Nt - log Nt+1) / (0.301 xΔt)
where Nt and N t+1 are the number of cells (cfu/ml) respectively after t and t+1
time, 0.301 corresponds to log10 2, andΔt is the interval between times t+1 and t. The
generation time (G) was calculated using the equation: 1 / max.
Starter Activity Test
Acidification properties of wild-type and transconjugant strains were compared
by using the Heap-Lawrence starter culture activity test (Heap and Lawrence, 1981)
where strains are grown in RSM over a 5-h incubation time through a simulated
Cheddar cheese making temperature profile. Briefly, cultures were propagated over
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16 h at 22 °C in 11% RSM containing 1.9% (w/vol) -glycerophosphate and, where
required, 0.5% (wt/vol) glucose and 0.25% (wt/vol) yeast extract. For each pair of
wild-type and pMRC01-carrying strains, starter inoculums for the activity test were
standardized to the culture with the lowest turbidity at 410 nm by using the EDTA
turbidimetric method as modified by Heap and Lawrence (1981). Strains were then
inoculated into 11% RSM and incubated at 32 °C for 70 min. The temperature was
then increased to 40°C over 30 min, held for 160 min, and finally decreased to 32 °C
over 40 min. Starter activity was evaluated based on final pH. Acidification properties
of wild-type and transconjugant strains were also compared by measuring the final
pH after growth for 5 h in GM17 at 30 °C.
Viability of lactococcal strains
The degree of autolysis of Lactococcus strains was evaluated by monitoring the
levels of lactate dehydrogenase (LDH) released after 24 and 72 h of growth in GM17
at 30°C. LDH assay was performed according to a modified version of the method
outlined by (Wittenberger and Angelo, 1970), by measuring the decrease in
absorbance at 340 nm resulting from the pyruvate-dependent oxidation of NADH
(Sigma, St. Louis, USA) in the presence of fructose-1,6-diphosphate (Fluka, Buchs,
Germany). Activity is expressed as units per millilitre, where 1 U is the amount of
enzyme that catalyzes the oxidation of 1mol of NADH per min per ml.
Qualitative assessment of the autolytic phenotype of Lactococcus strains after 24
and 72 h of growth in GM17 at 30 °C was conducted by FCM. FCM analyses were
performed using a FACSCanto II flow cytometer (BD Biosciences, San Jose, USA)
equipped with two air-cooled lasers, a 20-mW solid state (emission, 488 nm) and a
17-mW HeNe (emission, 633 nm), and five sensors for the detection of forward
(FSC) and sideward (SSC) light scatter, green (FL1, 525 nm), yellow (FL2, 575 nm),
and far red (FL3, 695 nm) fluorescence. Cell viability was estimated by using the BD
Cell Viability Kit (BD Biosciences, San Jose, USA) as follows. Cultures were diluted
in 0.22 m-filtered 50 mM sodium phosphate buffer (pH 7), containing 0.01%
Tween-20 and 1 mM EDTA, to an approximate concentration of 106 cells per ml. 500
μl aliquots of each culture were incubated with 80 nM thiazole orange (TO) and 8M
propidium iodide (PI) for 5-10 min at room temperature. Whenever cell enumeration
Chapter V
211
was required, 10l of BD Liquid Counting Beads were added to each sample prior to
FCM analysis, and absolute counts were determined according to manufacturer’s
instructions (BD Biosciences, San Jose, USA). Validity of cell counts by FCM was
confirmed by running plate counting in parallel on some samples. Cell samples were
delivered at the low flow rate, corresponding to 300 to 500 cells per sec, until 10,000
cells were measured. Fluorescence signals were recorded by using the following
detector settings: FSC, 600; SSC, 400; FL1, 550; FL2, 500; and FL3, 700 with
logarithmic amplifications. A threshold was set at an SSC signal of 400 to reduce
background noise deriving from cellular debris. A total number of 10,000 events were
acquired by using FACSDiva software v.5.0.2 (BD Biosciences, San Jose, USA) and
analyzed using dot plots (i.e., bivariate displays in which each dot represents one
measured event) and population gates.
Statistical analysis
Analyses of growth, acidification and viability rates in L. lactis strains were
performed in triplicate, and the putative impact of the plasmid pMRC01 on these
cellular parameters was statistically evaluated by using unpaired Student’s t test at a
significance level of P < 0.05.
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RESULTS
Transconjugants harbouring pMRC01 generally exhibit lower growth rates than
parent strains
The physiological consequences of carrying the plasmid pMRC01 were
evaluated by using a panel of five well-known lactococcal starters (L. lactis HP,
255A, SK1, 712 and IL1403) that were compared to their pMRC01-bearing
transconjugants in terms of growth, acidification and viability rates. Preliminary tests
were performed in order to detect the presence of the plasmid pMRC01 in
transconjugants. All cultures were first tested for the lacticin 3147-producing
phenotype by agar well diffusion assay using L. lactis HP as the indicator strain
(Figure 1b). All transconjugants were found to produce lacticin 3147 at similar levels
(data not shown); in contrast, none of the parent strains produced the bacteriocin.
Agarose gel electrophoresis of plasmid profiles was performed to verify the
acquisition of the 60.2-kb pMRC01 by the transconjugants, using DPC3147 as
marker of pMRC01 position (Figure 1a). An additional 60-kb band, corresponding to
pMRC01, was evident in the profiles of most transconjugants. However, in some of
the transconjugants, the presence of pMRC01 was masked by similarly-sized resident
plasmids. In these cases, the presence of pMRC01 was confirmed by multiplex PCR
using two different sets of pMRC01-specific primers (Figure 1c).
It is known that the metabolic burden imposed by certain plasmids primarily
results in an alteration of the growth kinetics of the host cell (Kobayashi et al., 2002,
Lee and Moon, 2003, Pillidge et al., 2000). The growth characteristics of wild-type
and pMRC01-bearing L. lactis strains in GM17 at 30 °C were therefore analyzed and
the results are compared in Table 2. In general, the transconjugants exhibited lower
μmax and higher generation times compared to the parental strains, with differences
being significant (P < 0.05) in three (L. lactis 255A, SK1 and IL1403) of the five
strains tested. The extent of the impact of pMRC01 on the host growth rate in terms
of percentage difference between transconjugant and parent varied from 4 to 33%. L.
lactis 255A showed the largest percent reduction (33%) in growth rate, followed by
strains SK1 (14%) and IL1403 (11%), while differences for strains HP (8%) and 712
(4%) were statistically not significant (P > 0.05).
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Introduction of pMRC01 does not significantly affect acid production
Construction of improved derivatives of dairy starters through genetic
manipulation can pose the risk of negatively impacting on the strains’ technological
properties, e.g. by affecting the rate of acid production in milk. The acidification
capacities of the wild-type and pMRC01-bearing strains were first compared by using
the Heap-Lawrence starter activity test (Heap and Lawrence, 1981). Results of the
assay (Table 3) revealed that, in general, the transconjugants were slightly, but not
significantly (P > 0.05), less efficient acidifiers of milk compared to the parent
strains. Testing the acidification capacities of the strains in GM17 did result in similar
non-significant trends (Table 3).
Acquisition of pMRC01 is associated with greater cell permeability and autolysis
Bacterial cell viability is a very complex phenomenon, and cannot be merely
defined in terms of cells with an intact or a lysed membrane. A variety of
physiological states have been demonstrated to exist between live and dead, ranging
from dormant and injured cells (i.e. intact and metabolically active but noncultivable)
to dead cells with a permeabilized membrane (a stage preceding cell lysis) (Bunthof
and Abee, 2002, Bunthof et al., 1999, Bunthof et al., 2001, Niven and Mulholland,
1998). This is particularly the case after exposure to stress. The impact of carrying
pMRC01 on viability of the five lactococcal starters was evaluated in terms of cell
lysis as measured by released LDH and cell permeability as measured by the ability to
uptake PI.
In this respect, LDH is a key enzyme of the metabolism of most lactic acid
bacteria and given its cytoplasmic location, is commonly regarded as a good marker
of cell lysis (Bunthof et al., 2001, Wittenberger and Angelo, 1970). To examine the
impact of pMRC01 on cell integrity, LDH activities were measured in supernatants of
wild-type and pMRC01-bearing L. lactis strains during incubation at 30 °C in GM17
(Table 4). Following 24 h of growth, the mean levels of LDH were ca. two-fold
higher in supernatants of transconjugants than in those of parental strains, with
significant (P < 0.05) differences found in four (L. lactis 255A, 712, SK1 and
IL1403) out five strains. Cell autolysis increased with incubation time and, after 72 h
of growth, all the transconjugants tested exhibited significantly higher LDH activities.
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Qualitative discrimination between intact, injured/permeabilized, and dead
populations in wild-type and pMRC01-bearing strains of L. lactis was then
accomplished using the fluorescent nucleotide-binding dyes TO and PI. TO is
commonly used as a live stain, whereas PI is excluded by the intact cell membrane,
thus staining a cell only when the integrity of the membrane is compromised, i.e.
dead or injured. When used in combination, live cells are labelled green by TO while
injured or dead cells are labelled red by PI. Figure 2 shows the biplots of green (FL1)
and red (FL3) fluorescence of L. lactis strains at different stages of growth in GM17
at 30 °C after live/dead staining with TO and PI dyes. Total cell populations were
gated on dot plots of SSC vs. FL2, while TO- and PI-labelled cells were identified
and gated on dot plots of SSC vs. FL1 and SSC vs. FL3, respectively. Differentially-
labelled cells were best discriminated on dot plots of FL1 vs. FL3. FCM biplots of
cultures during log phase appeared to consist of a major group of cells that were alive
and replicating, and by a small subpopulation of cells whose membranes were
damaged or injured, as indicated by an increased permeability to PI; levels of these
injured cells were found to be significantly higher in four out of five transconjugants
compared to wild-type strains (Table 5). Within this population, cells with higher TO
fluorescence intensities were still sufficiently intact to retain their macromolecular
contents and they were thus metabolically active, while cells with lower TO
fluorescence intensities were most likely non-viable. Cell autolysis increased notably
with incubation time in both wild-type and transconjugant strains. After 24 h of
growth, cell injury was still significantly higher in four out of five strains carrying
pMRC01, with the transconjugant of L. lactis SK1 showing the highest percent of
permeabilization (24.9% of the total population), followed by transconjugants of
strains 255A (7.3%), IL1403 and 712 (3%). At this stage, cell lysis did not show any
particular trend being larger in two transconjugants (255A and IL1403) as well as in
two wild-type (SK1 and HP) strains. The increase in cell lysis, after 72 h of growth,
was generally associated with the corresponding reduction in injured and live cells.
Nevertheless, large groups of injured cells were still present in transconjugants of
strains 712 and SK1, respectively accounting for 14.6% and 12.2% of the total
population. As a general trend, transconjugants exhibited larger cell permeabilization
(SK1, 712 and IL1403) and lysis (SK1, 255A and IL1403) than wild-type strains even
after 72 h of growth.
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Lacticin 3147 production is not responsible for the observed plasmid-associated
metabolic burden
The introduction of pMRC01 seems to place a metabolic load on the lactococcal
starters tested by affecting growth rate in synthetic media and the strains ability to
lyse over time. Therefore, we investigated the role of lacticin 3147 gene expression as
potential factor for the observed effect by using a strain derivative (DPC5559) of the
Cheddar cheese starter DPC4268 that carries the cointegrate plasmid pMRC02
(Trotter et al., 2004). This construct originated from the spontaneous integration of a
17-kb region from pMRC01, encompassing the lacticin 3147 operon, into pMT60, a
plasmid resident in DPC4268. The DPC5559 strain containing the cointegrate
displayed bacteriocin production and immunity in addition to the native phenotypes
of pMT60 as exhibited in DPC4268 (Trotter et al., 2004).
The DPC5559 strain was first tested for the level of lacticin 3147 production that
was found to be similar to those of the other transconjugants used in this study (data
not shown). Growth, acidification and viability rates of DPC4268 (ltn-) and DPC5559
(ltn+) strains were then compared and the results are reported in Table 6. Although the
lacticin 3147-producing strain exhibited slightly lower rates of growth and
acidification, and higher levels of LDH activity compared with the wild-type, these
differences were found to be not significant (P > 0.05). FCM analysis (Figure 3)
confirmed these results by showing not significantly different (P > 0.05) populations
of injured and dead cells in the fluorescence dot plots of DPC4268 and DPC5559
strains over a 72-h incubation time.
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DISCUSSION
The plasmid pMRC01 has proved to be an extremely versatile food-grade tool
for the genetic improvement of dairy starters, as it provides cultures with significant
phage resistance and also broad anti-microbial properties without significantly
affecting their technological characteristics (Coakley et al., 1997, Ryan et al., 1996).
However, observations that pMRC01-containing strains grow more slowly and
exhibit reduced rates of acid production compared to the parent strains prompted a
more detailed investigation of the metabolic burden of the presence of pMRC01 in
lactococcal starters.
Comparative analyses of growth, acidification and viability rates in wild-type
and pMRC01-containing strains clearly revealed a plasmid impact on cell
metabolism. The first and most visible effect of the plasmid load was an alteration of
the growth kinetics of the host cell. All the transconjugants exhibited lower growth
rates and higher generation times compared to the parental strains, with the extent of
pMRC01 impact being strain dependent and fluctuating between 4 and 33%. Similar
results have already been reported in lactococci. Pillidge and coworkers (2000) noted
a decrease in the growth rate of four commercial L. lactis subsp. cremoris starter
strains after conjugal transfer of phage resistance plasmids. In another study,
Kobayashi and coworkers (2002) found that a small cryptic plasmid was able to
significantly affect the growth rate of L. lactis subsp. lactis biovar. diacetylactis
DRC1. Considerable research has been performed on the plasmid-host interaction in
other microorganisms, mostly in Escherichia coli (Diaz Ricci and Hernandez, 2000,
Rozkov et al., 2004). From these studies, it is well recognized that the presence of
certain plasmids places a metabolic burden on the biochemical capacities of the host
cell. The accepted explanation for this phenomenon is that plasmid DNA replication
and expression rely on the same cellular pool of metabolic components generally
exploited only by chromosomal genes. As soon as the extra demand of energy and
metabolites exhausts the limiting cellular reserves, the cell enters a phase of
metabolic starvation that in turn reduces the growth rate of the culture (Diaz Ricci and
Hernandez, 2000). Therefore, it is not surprising to find that plasmid-free cells grow
more quickly than plasmid-bearing cells.
The observation that the introduction of pMRC01 did not significantly affect the
technological properties of the lactococcal starters tested was unexpected: the
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transconjugants retained milk acidification capacities similar to those of the parent
strains and sufficient for commercial cheese manufacture. This significant finding is
of major importance as it means that pMRC01-mediated improvement of strains does
not preclude their use as starter cultures for dairy industry. However, this finding was
in apparent contradiction to the aforementioned decrease in growth rate of the
pMRC01-bearing strains and also to the results of other studies reporting a plasmid-
mediated impact on both growth and acidification rates of the host cell (Lee and
Moon, 2003, Pillidge et al., 2000). FCM analysis of cell viability in log phase offered
a plausible explanation for this result. Fluorescence dot plots of pMRC01-carrying
transconjugants differed from those of wild-type strains by the presence of a larger
percent of injured and permeabilized cells in the transconjugant population. The FCM
results suggested that these cells were not lysed but that their membrane integrity was
compromised. It is well known that after exposure to various forms of sub-lethal
stress, cultures may contain injured bacteria that fail to grow on common growth
media but nevertheless are still metabolically active, as demonstrated by the
observation that they may recover their ability to grow when given a suitable
environment (Bunthof and Abee, 2002). These uncultivable but metabolically-active
cells would not be detected by viable plate counting techniques used for growth rate
calculation, but they may well contribute to fermentation processes. Hypothetically,
with their metabolic routes still functioning, injured cells are likely to contribute to
the acidification process. Similar contribution might derive from the cells exhibiting
low TO and high PI fluorescence. These cells are dead as they are intensely stained
by PI, but the fact that they are also capable of taking up the TO stain suggests the
presence of an essentially intact but permeabilized membrane. This permeabilized
state has been demonstrated to represent an intermediate stage following cell death
and preceding cell lysis (Niven and Mulholland, 1998). Permeable cells have
previously been detected by FCM analysis in L. lactis cultures (Niven and
Mulholland, 1998) and in dairy starters and probiotic products (Bunthof and Abee,
2002). Again, such cells would not contribute to the growth kinetics of the cultures
but might participate in the fermentation process. Membrane permeabilization may in
fact lead to a higher acid production rate by facilitating the access of the substrates to
intracellular enzymes. It is thus plausible that the higher population of injured and
permeabilized cells present in pMRC01-bearing strains might account for the
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different growth rates and the similar acidification capacity found between
transconjugants and wild-type starters.
Overall, LDH and FCM assays showed that the presence of pMRC01 somehow
promotes cell permeabilization and accelerates autolysis in lactococcal strains. It is
reasonable to speculate that these physiological states of pMRC01-carrying strains
may be relevant in terms of contribution to cheese ripening and flavour development,
when used as cheese starters. Finally, we note that strains belonging to the lactis
subspecies (L. lactis SK1, IL1403 and 712) were found to be the most permeabilized
and, overall, the most affected by the presence of pMRC01 compared to members of
the cremoris subspecies. This finding is in agreement with the general view that
cremoris strains are more robust and suitable as starters for cheese manufacture than
strains belonging to the lactis subspecies (Feirtag and McKay, 1987, Pillidge et al.,
2000).
The finding that the presence of pMRC01 places a metabolic burden on the
lactococcal host prompted us to investigate the putative mechanism behind this
phenomenon. Many of the L. lactis starters used in this study contain numerous
endogenous plasmids of various sizes that bear genes involved in important
technological properties (lactose metabolism, proteolysis, bacteriocin production,
phage resistance). These plasmids often have similar theta replicons with tight copy
number control and it is likely that the introduction of pMRC01 in these strains could
affect stability and copy number of the resident plasmids; incompatibility between
pMRC01 and the endogenous plasmids might be one of the reasons for the modified
properties of transconjugants. However, we noted that L. lactis IL1403, a plasmid-
free strain, was among the transconjugants to be most affected by acquisition of
pMRC01; in this case, it is clear that the metabolic load may not be explained with
any compatibility issues and must be associated with some intrinsic characteristics of
pMRC01. Size, copy number, and gene expression are plasmid characteristics
commonly acknowledged to impact on cellular growth rate, with the impact of gene
over-expression being strikingly higher than the effect of size or copy number (Diaz
Ricci and Hernandez, 2000). Similarly, the few studies carried out on this topic in
lactococci point to the genetic information encoded on the plasmid as the main cause
of the decline of the growth rate in the host cell (Kobayashi et al., 2002). The most
significant genetic determinants located on the plasmid pMRC01 are those encoding
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for an abortive infection phage resistance mechanism, and those responsible for the
production of and immunity to lacticin 3147 (Coakley et al., 1997). Considering that
the expression of lacticin 3147 structural proteins has been shown to be constitutive
(McAuliffe et al., 2001), we targeted the lacticin 3147 genetic information as a
potential factor in the observed pMRC01-asscociated metabolic burden. However, no
significant differences were found in terms of growth, acidification and viability rates
between DPC4268 and its derivative carrying the 17-kb lacticin gene cluster.
Considering that all transconjugants were also found to produce lacticin 3147 at
similar levels, these results overall suggest that the expression of lacticin 3147 genes
might not be responsible for the metabolic load of lactococcal starters reported in this
study.
Speculation that the phage resistance mechanism encoded by pMRC01 might
play a role in determining the plasmid burden is an alternative idea supported by
some reports. Kobayashi and coworkers (2002) demonstrated that, out of seven
resident plasmids, only a small cryptic plasmid significantly reduced the growth rate
of L. lactis subsp. lactis biovar. diacetylactis DRC1. The 7.4-kb plasmid contained
just six open reading frames and encoded only for a relevant hsdS subunit of a type I
restriction-modification system. Additionally, the four lactococcal plasmids, reported
by Pillidge and coworkers (2000) to exert a negative impact on growth and
acidification rates of four cheese starters, were all encoding a phage resistance
mechanism, and particularly an Abi system in the case of pNP40 and pMU1311. The
Abi mechanism of pMRC01 has been shown to target the phage-lytic cycle at a point
after phage DNA replication (Coakley et al., 1997). However, although the complete
sequence of pMRC01 has been elucidated, the identification of the Abi system has
proven difficult due to low levels of sequence homology between known Abi genes
(Dougherty et al., 1998). This renders difficult the creation of an accurate knock-out
of the phage resistance mechanism in order to investigate its contribution to the
plasmid-mediated effect.
To conclude, strains carrying pMRC01 have thus been shown to be sufficiently
good acid producers, phage-resistant, and with the ability to produce bacteriocin to
control spoilage and non-starter microorganisms (Coakley et al., 1997, Ryan et al.,
1996); this study). After considering all these characteristics and the disadvantages
reported for other plasmid- or nisin-mediated strategies (Lee and Moon, 2003,
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Lipinska, 1973, Pillidge et al., 2000), the plasmid pMRC01 may be fairly regarded as
one of the most efficient and versatile tools for the improvement of cheese starter
cultures available to date.
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TABLES
Table 1. Bacterial strains and plasmids used in this study
Description Sourcea or reference
SK1 Cheese starter TFRC culture collection
712 Cheese starter; contains plasmids of 2.7; 3.8; 7.9; 13.7 and
50.2 kb
TFRC culture collection
IL1403 Plasmid-free derivative of IL594 Chopin et al. (1984)
DPC3147 Lacticin 3147 producer Ryan et al. (1996)
DRC3 DNA size marker; contains plasmid of 2; 3.4; 4.8; 5.2; 35.8;
51; 65 and 78 kb
McKay and Baldwin (1984)
HP Cheese starter TFRC culture collection
255A Cheese starter TFRC culture collection
DPC4268 Cheese starter; contains plasmids of 40; 44; 55 and 60 kb TFRC culture collection
DPC5559 DPC4268 transconjugant containing pMRC02; contains
plasmids of 40; 44; 55 and 80 kb
Coakley et al. (1997)
pMRC01 Conjugative 60-kb plasmid from L. lactis DPC3147; encodes
abortive infection mechanism and lacticin 3147 production
and immunity
Ryan et al. (1996); Coakley
et al. (1997)
pMRC02 Cointegrate non-conjugative 80-kb plasmid from L. lactis
DPC5559; encodes proteinase activity and lacticin 3147
production and immunity
Trotter et al. (2004)
Strain or plasmid
Plasmids
L. lactis subsp. cremoris
L. lactis subsp. lactis
Strains
L. lactis subsp. lactis biovar. diacetylactis
aTFRC, Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland
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Table 2. Comparison of maximum growth rate (max) and generation time in wild-
type (Wt) and pMRC01-containing transconjugant (Tc) strains of L. lactis grown at
30C in GM17
L. lactis
strain
HP 0.86 (± 0.12) 0.79 ± (0.06) 1.18 (± 0.17) 1.27 (± 0.10)
SK1 1.18 (± 0.01) a 1.01 (± 0.03) b 0.85 (± 0.01) b 0.99 (± 0.03) a
712 0.74 (± 0.07) 0.71 (± 0.05) 1.36 (± 0.14) 1.41 (± 0.10)
255A 1.42 (± 0.02) a 0.96 (± 0.07) b 0.70 (± 0.01) b 1.04 (± 0.07) a
IL1403 1.05 (± 0.06) a 0.94 (± 0.03) b 0.96 (± 0.05) b 1.07 (± 0.03) a
m max (h-1) Generation time (h-1)
Wt pMRC01-Tc Wt pMRC01-Tc
a,bMeans with different superscripts were significantly different (P < 0.05); Values are
means of three replicates (± SD).
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Table 3. Acidification capacity of wild-type (Wt) and pMRC01-containing
transconjugant (Tc) strains of L. lactis grown in different media and conditions
L. lactis
strain Wt pMRC01-Tc Wt pMRC01-Tc
HP 5.37 (± 0.18) 5.68 (± 0.35) 6.06 (± 0.04) 6.08 (± 0.04)
SK1 4.91 (± 0.24) 4.94 (± 0.21) 5.67 (± 0.03) 5.70 (± 0.02)
712 5.15 (± 0.01) 5.19 (± 0.03) 5.75 (± 0.05) 5.77 (± 0.03)
255A 4.83 (± 0.17) 4.95 (± 0.13) 5.51 (± 0.02) 5.55 (± 0.02)
IL1403 6.34 (± 0.05) 6.36 (± 0.05) 6.31 (± 0.03) 6.34 (± 0.02)
11% RSM GM17
Values are means of three replicates (± SD).
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Table 4. Levels of lactate dehydrogenase (LDH) in supernatants of wild-type (Wt)
and pMRC01-containing transconjugant (Tc) strains of L. lactis grown at 30 C in
GM17
L. lactis
strain Wt pMRC01-Tc Wt pMRC01-Tc
HP 0.76 (± 0.30) 1.90 (± 1.12) 9.19 (± 1.52) b 23.40 (± 5.10) a
SK1 3.44 (± 1.17) b 6.46 (± 0.87) a 13.49 (± 1.25) b 19.57 (± 2.17) a
712 2.97 (± 0.33) b 6.27 (± 0.58) a 15.82 (± 0.65) b 47.33 (± 1.87) a
255A 27.20 (± 1.94) b 46.37 (± 0.40) a 67.97 (± 0.51) b 81.53 (± 3.30) a
IL1403 29.47 (± 1.91) b 56.32 (± 3.29) a 41.39 (± 3.03) b 62.34 (± 4.89) a
LDH (24 h) LDH (72 h)
a,bMeans with different superscripts were significantly different (P < 0.05); Values are
means of three replicates (± SD).
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Table 6. Comparative analysis of maximum growth rate (max), generation time,
acidification capacity and levels of released lactate dehydrogenase (LDH) of lacticin
3147-negative DPC4268 and lacticin 3147-positive DPC5559 strains of L. lactis
grown at 30C in GM17
DPC4268 DPC5559
m max (hr-1) 1.10 (± 0.13) 0.98 (± 0.22)
Generation time (hr-1) 0.92 (± 0.11) 1.06 (± 0.27)
pH (in 11% RSM) 4.78 (± 0.13) 4.88 (± 0.11)
pH (in GM17) 5.41 (± 0.01) 5.45 (± 0.02)
LDH (24 h) 13.21 (± 1.08) 14.21 (± 1.80)
LDH (72 h) 21.58 (± 3.03) 27.27 (± 3.31)
L. lactis
Parameters
Values are means of three replicates (± SD).
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FIGURES
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Figure 1. (a) Plasmid DNA profiles of lactococcal starters and their pMRC01
derivatives: lane 4, SK1; 5, SK1.pMRC01; 6, 255A; 7, 255A.pMRC01; 8, 712; 9,
712.pMRC01; 10, IL1403; 11, IL1403.pMRC01; 12, HP; 13, HP.pMRC01; 14,
DPC4268; 15, DPC5559. Lane 1 contains a 0.2-10 kb molecular weight marker, and
lane 2 the strain L. lactis DRC3 as a source of high molecular size markers (35, 51,
65 and 78 kb). The plasmid profile of DPC3147 (lane 3) was used as reference for
pMRC01 position (indicated by the asterisk). (b) Agar well diffusion assay using L.
lactis HP as indicator strain to test lacticin 3147 production in pMRC01 derivatives of
lactococcal starters. Samples and lanes are as indicated in panel a. (c) Multiplex-PCR
by using primers targeting the replication region (~ 260 bp) and lacticin operon (~
500 bp) of pMRC01 in order to confirm the acquisition of the entire plasmid in
transconjugants.
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Figure 3. FCM analysis of cell viability after TO and PI labelling in lacticin 3147-
negative DPC4268 (a) and lacticin 3147-positive DPC5559 (a’) during growth at 30
C in GM17.
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Chapter VI
Microarray-based targeting of the abortive infection mechanism of
pMRC01 during bacteriophage infection of the lactococcal host
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ABSTRACT
The lactococcal plasmid pMRC01 harbours a potent abortive infection (Abi)
mechanism whose genetic determinant(s) are yet to be identified. Changes in
pMRC01 gene expression at an early (15 min) and late (30 min) stage of infection
with the lytic phage c2 were analyzed using pMRC01-based microarrays in order to
detect the putative activation of the Abi system, or elements of the system. Three
genes (orf51, orf58 and orf62) were differentially regulated at both time-points,
whereas six additional genes (orf5, orf9, orf18, orf45, orf46 and orf56) were
differentially expressed only after 30 min. Of the genes differentially regulated at
both time points, orf58 and orf62 were negatively regulated throughout phage
infection, whereas a switch from repression to activation was observed for orf51.
Orf62 encodes an initiator of plasmid replication whose down-regulation could be
associated to the phase where the phage switches host metabolism off to use the cell
replication machinery for its own replication. Orf51 and orf58 both encode
transcriptional regulators and their differential regulation throughout phage infection
implies that the functioning of the Abi system is most likely subject to complex
regulatory control. The Rgg-like protein ORF51 is a bifunctional regulator similar to
many phage repressors. The initial down-regulation of orf51 might serve to activate
the Abi system of pMRC01 by removing the ORF51-mediated transcriptional
inhibition, whereas the successive gene up-regulation would restore a negative
control to avoid accumulation of the Abi effector/s above concentrations that are toxic
for the cell. ORF58 is a CopG-like regulator, whose homologues are also known to
affect phage development. ORF58 might interact with ORF51 to create a complex
regulatory system modulating the activity of the putative Abi effectors, which we
suggest to be orf50 and orf49. These constitutively expressed genes encode proteins
exhibiting topology and functional similarities to the two-component Rex system that
aborts lytic growth in phage λby causing membrane depolarization. Similarly to
RexA, the membrane-anchored ORF50 might use its protein kinase-like activity to
cause a conformational change in the putative channel protein RexB-like ORF49,
thereby triggering channel opening and consequent membrane depolarization. The
ORF58 regulator might be involved, directly or in network with ORF51, in
controlling ORF50 activity.
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INTRODUCTION
Lactococcus lactis strains are extensively used by the dairy industry for their
fermentation abilities, but they are susceptible to the action of virulent
bacteriophages, which are ubiquitous and frequently outnumber these bacteria in the
dairy environment. Lactococcal strains have thus developed several molecular
mechanisms to defend themselves against invading phages. These anti-phage systems
can affect viral multiplication by preventing phage adsorption to the cell, blocking
DNA injection, cutting the foreign DNA that has entered the cell or halting phage
development at any stage between DNA injection and cell lysis. This latter
mechanism, denoted as abortive infection (Abi), is characterised by a premature death
of the infected cell and release of few or no progeny particles. As a consequence,
further propagation of phage is prevented and the bacterial population survives.
Whether cell death results from the irreversible damage caused by phage infection or
from the Abi mechanism itself is still unclear but may vary given the diversity of Abi
systems identified to date (Chopin et al., 2005, Emond and Moineau, 2007, Forde and
Fitzgerald, 1999).
The majority of these mechanisms are located on plasmids, except for the
chromosomally-encoded AbiH and AbiN. Another common feature of Abi genes is a
surprisingly low GC content (24-29%) when compared to that of the lactococcal host
(35.4%). Additionally, protein homology is rarely observed between lactococcal
Abis: AbiC and AbiP are only 22% identical, AbiA and AbiK share 23% homology,
whereas AbiD, AbiD1 and AbiF identities range from 28 to 46% (Chopin et al.,
2005). Very little is still known about the mode of action of most Abi systems, but
those characterized have revealed ability to interfere with various stages of the phage
lytic cycle. AbiA (Dinsmore and Klaenhammer, 1994), AbiF (Garvey et al., 1995),
AbiK (Boucher et al., 2000), and AbiR (Twomey et al., 2000) rapidly halt phage
DNA replication by an unknown mechanism. AbiD1 blocks phage DNA replication
and packaging through a decrease of a RuvC-like endonucleolytic activity, which
generally facilitates the removal of branched DNA structures (Bidnenko et al., 1995).
AbiP prevents both phage DNA replication and temporal transcription switch
(Domingues et al., 2004). AbiG inhibits mRNA synthesis (O'Connor et al., 1999),
whereas AbiB triggers the breakdown of phage transcripts through the induction of an
RNase 10 to 15 min after infection (Parreira et al., 1996). AbiT has been suggested to
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be activated by one of the late viral mRNAs or proteins and to rapidly cause
premature cell death (Bouchard et al., 2002).
An Abi mechanism has been previously associated with the fully sequenced 60-
kb lactococcal plasmid pMRC01, which also includes the genetic determinants for
production of and immunity to the bacteriocin lacticin 3147 and for conjugative
transfer of the plasmid (Coakley et al., 1997, Dougherty et al., 1998, Ryan et al.,
1996). Using bacteriocin immunity as a selectable marker, pMRC01 has been
successfully transferred to a variety of lactococcal starters, resulting in the generation
of strains with improved phage resistance. For example, the presence of pMRC01 in
L. lactis MG1363 was shown to reduce by 6-fold the size of plaques formed by the
prolate-headed phage c2 compared to those produced in the plasmid-free host. The
anti-phage system was assessed to be of the Abi type and to target the phage-lytic
cycle at a point after phage DNA replication (Coakley et al., 1997). Despite many
efforts, the exact location of this Abi mechanism still remains unknown.
Induction of Abi mechanisms following phage infection is known to occur both
in E. coli and in L. lactis systems (Bidnenko et al., 2002, Molineux, 1991). In this
study, we have used oligonucleotide microarrays to investigate changes in expression
levels of pMRC01 genes during an early and late stage of infection with the lytic
phage c2 in an attempt to identify the Abi components. Our transcriptional analyses
showed two transcriptional regulators (ORF51 and ORF58) to be differentially
regulated throughout phage infection. This finding could imply that both proteins
interact to create a complex regulatory system modulating the activity of the
pMRC01 Abi effectors, which we suggest may be represented by ORF50 and ORF49.
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MATERIALS AND METHODS
Bacterial strains
A pMRC01-containing derivative of L. lactis subsp. lactis IL1403 was used to
investigate the genes responsible for the Abi phenotype of pMRC01 during phage
attack. L. lactis subsp. cremoris MG1363 served as the sensitive host for propagation
of the lytic phage c2 at high titers. Lactococcal strains were routinely propagated at
30 C in M17 medium (Oxoid, Hampshire, England) supplemented with 0.5%
(wt/vol) glucose (GM17). Solid media contained 1.0% (wt/vol) bacteriological agar
(Oxoid, Hampshire, England). Bacterial strains were stocked in M17 containing 40%
glycerol at -80 C. Working cultures were stored at 4C and transferred periodically.
Propagation of phage c2 to high titres, 1013 plaque forming unit (pfu)/ml, was
obtained by polyethylene glycol precipitation followed by caesium chloride gradient
centrifugation as previously described (Chapter I, this thesis).
Microarray design
The whole genome sequences of L. lactis IL1403 (2,310 genes), pMRC01 (64
genes) and phage c2 (39 genes) were used to design 50-mer oligonucleotide probes
for each gene which were subsequently spotted onto glass slides in duplicate. Control
elements on each array included negative-control probes from unrelated Arabidopsis
thaliana genes. Oligonucleotide probe design and microarray production were carried
out by Ocimum Biosolutions Ltd. (Hyderabad, India).
Transcriptional analyses of the global gene response of pMRC01 during phage
infection
An overnight culture of L. lactis IL1403.pMRC01 was used to prepare a fresh
0.5% inoculum in 40 ml of GM17 broth, which was propagated at 30 °C to mid-log
phase (OD600 = 0.4). The culture was split in two 20-ml aliquots (experimental and
reference), to which were added phage c2 (MOI = 800) (experimental) or TMN
buffer (reference), and 10 mM CaCl2. Experimental and reference cultures were
further incubated at 30 °C to allow phage infection. Samples were withdrawn after 15
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and 30 min of phage infection and immersed in a -80 °C ethanol bath for 5 min to
prevent any changes in gene expression profiles.
Total RNA extraction, mRNA enrichment, cDNA preparation and labelling,
microarray hybridization, scanning, and data analysis were performed as previously
described (Chapter I, this thesis). Validation of microarray data was obtained by
quantitative Real-Time PCR (qRT-PCR) analysis as previously described (Chapter I,
this thesis).
Computational prediction of subcellular localization and function of pMRC01
proteins.
A number of computational tools were used to predict sub-cellular localization
and function of pMRC01 proteins. Prediction of protein function was attempted by
using the PFAM database (Finn et al., 2010), the Conserved Domain Database (CDD)
(Marchler-Bauer et al., 2009), and the InterProScan service
(www.ebi.ac.uk/Tools/InterProScan). This latter tool predicts the occurrence of
functional domains and motifs/signatures in a protein by combining 12 different
databases and their relative protein signature recognition methods (Zdobnov and
Apweiler, 2001). Prediction of topology in putative alpha-helical membrane proteins,
including a specification of the membrane spanning segments and their in/out
orientation relative to the membrane, was obtained by using the TOPCONS server
(http://topcons.cbr.su.se/index.php). This server uses the prediction from five
different topology prediction algorithms (SCAMPI-seq, single sequence mode;
SCAMPI-msa, multiple sequence mode; PRODIV-TMHMM; PRO-TMHMM; and
OCTOPUS) as input to the TOPCONS hidden Markov model (HMM), which gives a
consensus prediction for the protein, together with a reliability score based on the
agreement of the included methods across the sequence (Bernsel et al., 2009).
Finally, presence of a putative signal peptide sequence was predicted with the SignalP
3.0 Server (www.cbs.dtu.dk/services/SignalP) by using neural networks (NN) and
hidden Markov models (HMM) trained on Gram-positive bacteria (Emanuelsson et
al., 2007).
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RESULTS
Global transcriptional analysis of pMRC01 response during phage infection.
Activation of Abi mechanisms in response to phage infection is a well
documented phenomenon, which has been demonstrated in all Escherichia coli
systems that have been studied in detail (Molineux, 1991). In lactococci, most abi
genes appear to be expressed in a constitutive manner, often at low levels, and are not
subjected to increased expression following phage infection (Chopin et al., 2005).
However, an exception to this is represented by AbiD1, where the expression of an
early-acting phage gene has been shown to stimulate the translation and drastically
increase the efficiency of the Abi system (Bidnenko et al., 2002). In an attempt to
identify the genes responsible for the Abi phenotype of pMRC01, whole-genome
DNA microarrays were used to analyse changes in plasmid gene expression occurring
during host infection with the lytic phage c2. According to Garvey et al. (1995), Abi
systems may be segregated depending on whether they act prior to or at the level of
DNA replication (early) or after replication has occurred (late). The Abi system of
pMRC01 has been shown to delay phage DNA replication by 5 min, which is
suggestive of an early-acting mechanism (Coakley et al., 1997). However, the exact
step of the infective process being critically affected by this Abi system, the
components involved, and its mode of action still remain unsolved. Therefore, global
expression of pMRC01 genes was analysed after 15 and 30 min of phage infection in
order to identify the genetic components responding to phage challenge.
Analysis of the DNA microarray data revealed that the presence of phage c2
within the host triggered the differential expression of 3 and 9 genes in pMRC01 after
15 and 30 min, respectively (Figure 1). All genes (orf51, orf58 and orf62) repressed
after 15 min of phage infection were also found to be differentially regulated after 30
min. Orf58 and orf62 were negatively regulated throughout the infection process,
whereas an interesting switch from repression to activation was noted for orf51.
Computational analysis of amino acid (aa) sequence revealed that the products of
orf51, orf58 and orf62 are likely to be involved in DNA replication or control of the
replication/transcription processes. The gene product of orf51 is a 282 aa-long protein
containing a conserved N-terminal helix-turn-helix (HTH) DNA-binding domain
(PFAM01381), typically found in bacterial plasmid copy control proteins, bacterial
methylases, and various bacteriophage transcription control proteins (Wintjens and
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Rooman, 1996). Additionally, its C-terminal domain (TIGR01716) exhibits
homology to the Rgg/GadR/MutR family of transcriptional regulators, which are
involved in modulating a variety of physiological processes (Dmitriev et al., 2006,
Redon et al., 2005, Skaugen et al., 2002). The small product (88 aa) of orf58 contains
an N-terminal Ribbon-helix-helix (RHH) domain (IPR002145) similar to that found
in transcriptional repressors of the CopG family (PF01402), which are involved in the
control of copy number in rolling circle-replicating plasmids. Interestingly, despite
the structural resemblance of the RHH domain to the HTH region of DNA-binding
proteins, this bi-helical region in CopG proteins has been shown to play a role not in
DNA recognition but in oligomerization and maintenance of the functional structure
(Gomis-Ruth et al., 1998). Orf62 encodes a protein of 384 aa containing domains
typical of RepB proteins (PFAM06430; PFAM01051), which are widespread in theta-
replicating lactococcal plasmids (Seegers et al., 1994) and use their nicking/closing
topoisomerase I-like activity to initiate plasmid replication.
Following 30 min of infection, six additional genes (orf5, orf9, orf18, orf45,
orf46, and orf56) were differentially regulated in pMRC01. Orf5 and orf9 belong to
the large conjugal region of pMRC01 that has been shown to promote efficient
transfer of the plasmid to a variety of lactococcal strains, including derivatives of
commercial starters (Coakley et al., 1997, Dougherty et al., 1998, Ryan et al., 1996).
This region is composed of 16 genes organized in an operon-like structure, many of
which encode proteins believed to be involved in conjugation but whose functions are
mostly unclear (Dougherty et al., 1998, Grohmann et al., 2003). The gene product of
orf5 (TraA) is a well conserved protein with relaxase (TIGR02768) and nickase
(PFAM03389) activity, which is known to introduce a nick at the origin of transfer
oriT to initiate single-stranded plasmid DNA transmission from the donor to a
recipient cell (Grohmann et al., 2003). Orf9 encodes a 115-aa long protein (TraC)
whose N-terminal region shows weak homology to a family of conserved but
functionally uncharacterised proteins (DUF3487). Additionally, the C-terminus of
TraC shows a low similarity match to proteins of unknown function that are predicted
to be integral membrane proteins (PF01988). This was confirmed by protein topology
analysis, which predicted TraC as being anchored to the membrane by both terminal
segments, with the remainder of the protein projecting towards the cytoplasm to form
two trans-membrane helices with an in/out (positions 27-47) and out/in (positions 52-
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72) orientation relative to the membrane (Figure 2). Similarly, orf18 was found to
encode a protein (131 aa) exhibiting weak similarities to proteins of unknown
function (PF10883) and with predicted localization on the cytoplasmic membrane
(PF03748). The topology model predicted an N-terminal trans-membrane helix in
ORF18, but this was later found to be a signal peptide by the SignalP algorithms,
which also allocated the most likely cleavage site between positions 21 and 22 (VG-
FK) or 28 and 29 (KS-TQ) (Figure 3). Thus, ORF18 is likely to be a secreted protein.
The genes orf45 and orf46 are located on the complementary strand of pMRC01
and overlap by 8 bp, which is indicative of translational coupling. Although, a
putative ribosome binding site (RBS) AAGGAG was identified upstream of orf46,
strongly resembling the Shine-Dalgarno (SD) sequence pattern (TAAGGAGG)
(Shine and Dalgarno, 1974), no terminator sequence was found downstream of orf45.
The 91-aa long protein encoded by orf46 contains the DUF2089 domain (PF09862),
which is found in various hypothetical prokaryotic proteins of unknown function.
ORF46 is likely to be a cytosolic protein as no trans-membrane segments were
detected by topology analysis. The protein encoded by orf45 is 100 aa long and
shows weak similarity to the DUF3139 family (PF11337) of proteins with unknown
function. The topology model predicts ORF45 as being a membrane protein
containing three trans-membrane helices alternating out/in (positions 4-24, 53-73)
and in/out (positions 27-47) orientation relative to the membrane (Figure 4). Finally,
the gene product (94 aa) of orf56 is likely to be involved in site-specific DNA
recombination as it exhibits a typical N-terminal resolvase (PF00239) domain,
containing the active site and the dimerization interface, and a C-terminal HTH
domain (PF02796) involved in DNA-binding.
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DISCUSSION
The conjugative 60-kb lactococcal plasmid pMRC01 has been shown to confer
phage resistance through an Abi system conferring complete resistance to the small
isometric-headed phage 712 and resulting in a 6-fold reduction of plaques size
produced by the prolate-headed phage c2. The phage resistance mechanism seems to
target the phage-lytic cycle at a point after phage DNA replication (Coakley et al.,
1997). Induction of Abi mechanisms following phage infection is known to occur
both in E. coli and in L. lactis systems (Bidnenko et al., 2002, Molineux, 1991). The
probability that phage infection may also trigger the activation of the Abi system of
pMRC01 was therefore investigated by using DNA microarrays and following
changes in plasmid gene expression occurring at an early (15 min) and late (30 min)
stage of the viral infection. A total of 9 genes were found to be differentially
regulated in pMRC01, with only three of them (orf51, orf58, and orf62) being
regulated at both time-points. Repression of 7 (orf5, orf18, orf45, orf46, orf56, orf58
and orf62) out of 9 genes after 30 min of infection might be related to the initiation of
the process leading to cell death. Most of the regulated genes encode hypothetical
proteins whose functions have been presumptively deduced by using algorithms
predicting structural topology and presence of conserved domains.
Orf51, orf58, and orf62 were the only genes regulated after 15 min of phage
infection and at both time points. Analyses of conserved domains suggest that their
gene products are likely to play a role in DNA replication or control of the
replication/transcription processes. ORF62 acts as initiator protein of plasmid
replication and the expression of its cognate gene is obviously down-regulated during
phases of the infection where the phage is switching host metabolism off to use the
cell machinery for its own replication. More interesting is the putative function of the
proteins encoded by orf51 and orf58. The protein encoded by orf51 exhibits two
different conserved domains that are both indicative of a regulatory activity for this
protein. ORF51 possesses an N-terminal HTH DNA-binding domain found in many
phage and bacterial regulators, including the repressor cI of the coliphage 434
(Wintjens and Rooman, 1996). This regulator protein has been shown to function
both as transcription activator and repressor, thereby regulating the transcription at
two adjacent, but divergent, promoters in order to develop or maintain the lysogenic
state over the lytic one (Xu and Koudelka, 2001). Additionally, the C-terminal
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domain of ORF51 exhibits homology to the conserved family of Rgg-like regulators
that are widely distributed in low-GC Gram-positive bacteria, including both
pathogenic and commensal species (Dmitriev et al., 2006). Members of the Rgg
family are involved in modulating a variety of physiological processes. Rgg of
Streptococcus gordonii is an activator of the expression of the glucosyltransferase G
gene involved in extracellular glucan formation (Sulavik and Clewell, 1996). In S.
mutans, the Rgg-like protein MutR induces the transcription of the mutAMTFEG
operon, which encodes the synthesis of the lantibiotic mutacin (Qi et al., 1999),
whereas in Lactobacillus sakei, the plasmid-encoded LasX protein regulates the
synthesis of and immunity to the lantibiotic lactocin S (Rawlinson et al., 2002,
Skaugen et al., 2002). In L. lactis, the Rgg-like regulator GadR activates transcription
of the gadBC operon, which is associated with glutamate-dependent acid tolerance
(Redon et al., 2005). Some Rgg-like regulators, such as LasX, have been shown to
possess a bivalent regulatory capacity enabling them to act both as an activator and a
repressor (Rawlinson et al., 2002). A temporally controlled expression program
seems to regulate the transcription of orf51 in pMRC01 during phage infection, with
the gene being down-regulated (-2.16) after 15 min and then up-regulated (+1.22)
after 30 min. This might correlate with the host growth phase, as already observed for
other Rgg members. In the pathogen S. pyogenes, RopB regulates the transcription of
the gene encoding for a secreted cysteine protease, the expression of which involves
control of transcription in response to the growth phase. Interestingly, the
transcription of the ropB gene itself was also found to be subjected to growth phase
control (Neely et al., 2003). Alternatively, down-regulation of orf51 after 15 min of
phage infection may suggest repression of a regulatory capacity in order to activate
the Abi system of pMRC01, whereas its later up-regulation may imply restoration of
the negative control over the same.
This putative association of a regulatory protein with the Abi gene/s of pMRC01
would resemble the structure and functioning of some known Abi systems. In L.
lactis, the anti-phage efficiencies of AbiU and AbiK have been shown to be under
control of the putative repressor genes abiU2 and orf4, respectively (Dai et al., 2001,
Fortier et al., 2005). In both cases, the repressor binds to the abi gene promoter, thus
resulting in decreased expression of the Abi protein and a weaker phage resistance
phenotype. A similar regulation scheme affects the polycistronic operon pifCAB
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aborting T7 infection in E. coli, where PifC negatively controls the expression of the
Abi protein PifA (Miller and Malamy, 1983). Interestingly, inactivation of the abiK
repressor orf4 has been shown to result in a stronger phage resistance phenotype, but
not in increased amount of AbiK. This protein is present in the cell before infection
and its expression is not affected by phage infection, a finding which was correlated
with the efficacy of AbiK depending on the intracellular concentration of the protein
(Fortier et al., 2005). Over-expression of many Abi proteins has been shown to be
lethal for the host, both in L. lactis and E. coli, which is probably the reason for the
constitutive transcription of almost all abi genes (except abiD1) known to date
(Chopin et al., 2005). Based on these findings, it may be hypothesized that the initial
down-regulation of orf51 serves to activate the Abi system of pMRC01 by removing
the transcriptional inhibition, whereas the successive up-regulation may restore a
negative control to avoid accumulation of the Abi protein above concentrations that
are toxic for the cell.
Assuming that orf51 is involved in regulating the Abi phenotype of pMRC01,
the gene(s) responsible for the antiphage mechanism itself may be located close to
orf51. Analysis of the nucleotide region surrounding orf51 on pMRC01 reveals the
presence of four genes (orf52-51-50-49) transcribed in the same direction. They
appear to be organized in a putative polycistronic operon, as it is possible to identify
sequences resembling an RBS and a -10 promoter signal upstream of orf52 and a rho-
independent terminator downstream of orf49 (Figure 5). The product of orf52 (296
aa) is likely to be a transcription regulator as it contains an N-terminal HTH DNA
binding domain (PF00165) and a C-terminal effector binding domain involved in
protein dimerization (PF06445), which are typical of the AraC/XylS family of
bacterial transcription activators (Gallegos et al., 1993). Interestingly, the location of
these domains within ORF52 appears to be inverted compared to what is generally
observed in AraC/XylS regulators. Orf50 possesses a much lower GC content
(25.8%) than the average in pMRC01, which is a typical characteristic of abi genes
(Chopin et al., 2005), and encodes a protein (605 aa) containining a conserved protein
kinase catalytic domain (PF00069), with predicted active sites in residues 300 and
318. Protein kinases use their phosphorylation activity to generate a conformational
change of the target protein, thereby affecting protein functionality. This allows them
to play a role in a multitude of cellular processes, including division, proliferation,
Chapter VI
245
apoptosis, and differentiation (Hanks and Quinn, 1991). The C-terminus of ORF50
shares weak homology to a domain found in Lanthionine synthetase C-like proteins
(PF05147), a family of highly divergent proteins thought to be lantibiotic modifying
enzymes and that includes the nisin biosynthesis protein NisC from L. lactis
(Lubelski et al., 2008). The C-terminus of ORF50 is also predicted to contain a trans-
membrane region (residues 543-563), whereas the remainder of the protein is located
on the cytosolic side (Figure 6). ORF49 (407 aa) is likely to belong to the Major
Facilitator Superfamily (MFS) of transporters (PF07690), which are single-
polypeptide secondary carriers capable only of transporting small solutes in response
to chemiosmotic ion gradients (Pao et al., 1998). Topology analysis confirmed this by
predicting ORF49 as an integral membrane protein with 12 trans-membrane domains
spanning the entire length of the protein (Figure 7). Orf50 and orf49 genes overlap by
4 bp, which is indicative of transcriptional coupling (Figure 5). Their localization
immediately downstream of the regulator gene orf51 suggests that both genes may be
under the direct control of orf51, as generally observed for Rgg regulated genes (Qi et
al., 1999, Rawlinson et al., 2002, Skaugen et al., 2002, Sulavik and Clewell, 1996).
The organization and functionality of the polycistronic operon orf52-49
strikingly resembles that of the phage-encoded Rex system of phage λ(Parma et al.,
1992, Shinedling et al., 1987). In this case, phage lytic growth is aborted by a two-
component system encoded by rexA and rexB genes, which are under the control of
the upstream cI repressor gene. Shortly after λphages infect a sensitive host, these
three genes are transcribed as a polycistronic RNA from the promoter for repressor
establishment. Abortion of lytic growth in phage λ is characterized by termination of
macromolecular synthesis, loss of active transport, hydrolysis of ATP, and cell death
due to depolarization of the cytoplasmic membrane. RexB is an inner membrane
protein with four trans-membrane domains forming an ion channel, which is
predicted to remain in the closed conformation in absence of RexA. In response to a
signal generated by lytic growth, two or more RexA molecules bind to RexB causing
opening of the channel and depolarization of the membrane (Parma et al., 1992).
RexA is thought to reside in the membrane but little is known about its mode of
action (Shinedling et al., 1987). Structural and functional similarities suggest that
ORF49 and ORF50 may be the pMRC01 counterparts of Rex proteins of phage λ. 
Twelve membrane-spanning domains and sequence similarity to MFS transporters
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strongly suggest that ORF49 may play a RexB-like role as channel protein, whereas,
similarly to RexA, ORF50 is membrane-anchored and may use its protein kinase-like
phosphorylation activity to cause a conformational change in ORF49, thereby
triggering channel opening and consequent membrane depolarization. Finally, the
bifunctional regulator ORF51 might control the amount of ORF49 and ORF50 in the
cell, in a similar fashion to the cI repressor-mediated regulation of the RexA/RexB
(Parma et al., 1992). In a previous study (Mills, 2005), the role exerted by each gene
of the orf52-49 operon in the Abi mechanism of pMRC01 was evaluated by using a
sequential gene knockout approach to inactivate individual genes. Disruption of any
of these genes led to an increase in plaque size from pinpoint (in the presence of
pMRC01) to plaques of 1 to 2 mm, which is indicative of an involvement of the
operon in the Abi phenotype as also suggested by our transcriptional and
computational analyses. All these observations concur to support a role for orf50 and
orf49 in the Abi system of pMRC01. Both genes were not differentially regulated
during phage infection, which would imply that ORF50 and ORF49 are expressed in
a constitutive manner. This is consistent with the constitutive levels observed for
most lactococcal Abi proteins, even during phage infection, a finding that has been
associated with a putative toxicity of the Abi proteins for the cell (Chopin et al.,
2005). However, differential expression of the ORF51 regulator throughout phage
infection would be expected to be accompanied by regulation of the downstream
genes orf50 and orf49, which are putatively under its control. This apparent
contradiction finds its support in the mechanism of action of AbiK. Although the anti-
phage efficiency of AbiK is regulated by ORF4, inactivation of this repressor
surprisingly results in a stronger phage resistance phenotype but not in increased
amount of AbiK (Fortier et al., 2005). Additionally, in E. coli strains lysogenic for λ,
it has been demonstrated that the rex genes are sufficient to control the growth of
phage T4 mutants and that the cI repressor is not required. This might suggest a
partial independence of the expression of Rex-like genes orf50 and orf49 from the
repressor orf51, which is supported by the finding of putative RBS and -10 promoter
signals upstream of orf50 (Figure 5).
The involvement of membrane proteins has been established for some Abi
systems in lactococci. Two putative integral membrane-spanning helices have been
identified near the N-terminal end of AbiC (Durmaz et al., 1992). The AbiP protein
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was shown to possess a topology strictly resembling that of ORF50, with an N-
terminal membrane-spanning domain and a nucleic acid binding domain freely
accessible in the cytoplasm. AbiP halts phage DNA replication 10 min after infection,
which is consistent with the mechanism observed in pMRC01, and inhibits the
switch-off of phage early transcripts normally observed 15 min after infection. AbiP
effect on phage development has been suggested to depend on the nucleic acid
binding activity displayed by the membrane-bound protein (Domingues et al., 2008),
which is consistent with the notion that replication of viral DNA occurs at the inner
membrane at the site of injection (Edgar et al., 2008). In pMRC01, it is tempting to
speculate that the phosphorylation activity of ORF50 might also be involved in
altering the functionality of one or more host enzymes important for phage DNA
replication.
Another differentially regulated gene was orf58 , whose putative protein product
exhibits homology to the Cop family of transcriptional repressors controlling plasmid
replication. Structure and mode of action of these repressors have been studied in the
family prototype CopG, which is a small protein (45 aa) encoded by the promiscuous
streptococcal plasmid pMV158. CopG controls plasmid replication by regulating the
expression of the initiator repB gene, which is co-transcribed with gene copG from
the single promoter Pcr. Upon binding to the Pcr promoter, CopG represses the
synthesis of the bicistronic cop-rep mRNA and thus regulates both the expression of
its own gene and that of the initiator repB gene (del Solar et al., 2002).
Transcriptional repression by CopG may be achieved by hindering RNA polymerase
binding to the Pcr promoter or, alternatively, by displacing RNA polymerase once the
enzyme has formed a stable complex with Pcr (Hernandez-Arriaga et al., 2009). In
pMRC01, a stretch of 2.5 kb of sequence, containing three genes encoding
hypothetical proteins, separate orf58 from the repB gene (orf62). Despite domain
homology to CopG-like proteins, it seems therefore unlikely that ORF58 controls
plasmid replication in pMRC01. Alternatively, a putative role for ORF58 in
interacting with the incoming phage may be suggested by the function of another
protein with similar structural topology to CopG. Within the RHH class of DNA-
binding proteins, CopG is the smallest protein and represents the minimal DNA-
binding structure as it contains no more than the RHH motif. As a member of this
class, which exhibits cooperativity based on protein–protein interactions, CopG
Chapter VI
248
generates two protein dimers upon binding to the target DNA (Gomis-Ruth et al.,
1998). Interestingly, structural studies found the CopG dimer to be almost identical to
that of the Mnt repressor of the Arc superfamily from Salmonella typhimurium phage
P22, although this latter protein is slightly bigger (53 aa) and contains an additional
N-terminal region which also interacts with the target DNA (del Solar et al., 2002,
Raumann et al., 1994). The Mnt repressor has been shown to be required for super-
infection exclusion and maintenance of lysogeny in phage P22 (Gough, 1968), in
addition to regulating the temperature-dependent induction of the prophage (Gough,
1970). During lysogeny or early lytic growth, the Mnt repressor maintains or induces
the lysogenic state by preventing the expression of the ant gene, whose product is an
anti-repressor that has the capacity to inactivate a second repressor (c2) involved in
maintenance of lysogeny (Susskind and Botstein, 1978). In phage P22 channelled
towards lysogeny, levels of c2 repressor are thus high and DNA synthesis shows to be
delayed to a greater extent than protein synthesis (Steinberg and Gough, 1975).
Similarly to Mnt, ORF58 might play a role in aborting the phage lytic cycle in
pMRC01-containing hosts by interacting with a second regulatory protein (ORF51)
or possibly with one of the putative Abi effectors (ORF50 and ORF49). Interestingly,
the most potent and selective inhibitor of the cGMP-dependent protein kinase,
namely DT-2, was found to use its bi-dentate structure to bind the catalytic domains
of a dimeric PKG (Pinkse et al., 2009). ORF58 possesses an RHH domain that has
been shown to play a role in oligomerization of CopG-like regulators, which in turn is
crucial to the protein functionality (Gomis-Ruth et al., 1998). It is therefore plausible
to speculate that dimers of ORF58 might interact with the protein kinase domain of
ORF50, thereby blocking the phosphorylation activity of this latter protein and
ultimately resulting in a negative regulatory control over the Abi system of pMRC01
in absence of phage. Thus, during phage infection, repression of orf58 would remove
the inhibition over ORF50 activity and lead to expression of the Abi phenotype.
Orf58 also exhibits a GC content of 26.2%, which is definitively lower than pMRC01
average (30.1%). This finding further supports a role for orf58 in the Abi phenotype
of pMRC01, as it is well known that Abi genes are characterized by a lower GC
content compared to that of the DNA element containing them (Chopin et al., 2005).
While results of our transcriptional analyses do not allow the clear identification
of candidate genes for the Abi phenotype of pMRC01, they do provide some
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evidence to support a proposed mode of action of this anti-phage mechanism. Two
transcriptional regulators (ORF51 and ORF58) are shown to be differentially
regulated throughout phage infection, a finding which may imply that the functioning
of the Abi system relies on complex interactions among different regulators. One of
these regulators is an Rgg-like protein (ORF51) that, according to ours and previous
results (Mills, 2005), might be involved in the Abi phenotype together with other
genes of the orf52-49 operon. Some Rgg-like proteins, such as RopB of S. pyogenes,
have been found to interact with additional regulators in order to alter gene
expression (Loughman and Caparon, 2007). In pMRC01, the additional regulator
might be represented by the CopG-like ORF58 protein, whose homologues are also
known to affect phage development. Both proteins might interact to create a complex
regulatory system modulating the activity of the Abi effector/s, which we suggest
may be represented by ORF50 and ORF49. These proteins are constitutively
expressed and share structural and functional similarities with the Rex two-
component system of phage λ(Parma et al., 1992, Shinedling et al., 1987). Some
structural characteristics of ORF58 also suggest that this regulator might be directly
involved in controlling the switching of the Abi system. A potential cross-talk
between the ORF51 and ORF58 regulators or a separate regulatory activity of ORF58
itself might also explain the failure of the individual gene inactivation approach in
restoring full phage sensitivity in the host as observed in absence of pMRC01 (Mills,
2005). Further studies are needed to verify our hypotheses and to definitively identify
the genetic determinants governing the Abi system of pMRC01.
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FIGURES
(a)
15 min 30 min 15 min 30 min
pMRC01 orf 5 Nicking enzyme (traA) 680 30.24 -1.16
orf 9 TrsC protein (traC) 115 26.14 1.25
orf 18 Hypothetical protein 131 27.27 -1.22
orf 45 Hypothetical protein 100 28.38 -2.01
orf 46 Hypothetical protein 91 29.71 -1.64
orf 51 Putative rgg protein 282 30.27 -2.16 1.22 -4.58 3.63
orf 56 Conserved hypothetical protein 94 29.12 -1.28
orf 58 Hypothetical protein 88 26.21 -2.34 -1.01 -3.96 -2.64
orf 62 RepB protein 384 33.59 -1.76 -1.67 -2.23 -1.61
L. lactis IL1403 Down-regulated genes 123 160
Up-regulated genes 84 106
Microarrays qRT-PCROrganism /
plasmid
Gene Predicted function
Length
(aa)
GC (%)
(b)
Figure 1. (a) Transcriptional response of pMRC01 genes after 15 and 30 min of
phage infection. The numbers of up- and down-regulated genes of the host strain L.
lactis IL1403 is also shown (b) Location of regulated genes on pMRC01 physical
map. Genes that are either negatively or positively regulated at both time-points are
shown in red or in green, respectively. Genes showing different regulation between
time-points are shown in azure.
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(a)
(b)
Figure 2. Topology prediction in ORF9 (TraC) according to the algorithms
SCAMPI-seq, SCAMPI-msa, PRODIV, PRO, and OCTOPUS (a), and determination
of the consensus prediction for ORF9 by the TOPCONS hidden Markov model (b).
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(a)
(b)
(c)
Figure 3. Topology prediction in ORF18 according to the algorithms SCAMPI-seq,
SCAMPI-msa, PRODIV, PRO, and OCTOPUS (a), and determination of the
consensus prediction for the protein by the TOPCONS hidden Markov model (b).
Prediction of signal peptide sequence in ORF18 by using the SignalP-NN algorithm,
with the most likely cleavage sites enclosed within red squares (c).
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(b)
Figure 4. Topology prediction in ORF45 according to the algorithms SCAMPI-seq,
SCAMPI-msa, PRODIV, PRO, and OCTOPUS (a), and determination of the
consensus prediction for the protein by the TOPCONS hidden Markov model (b).
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543 563
(a)
(b)
Figure 6. Topology prediction in ORF50 according to the algorithms SCAMPI-seq,
SCAMPI-msa, PRODIV, PRO, and OCTOPUS (a), and determination of the
consensus prediction for the protein by the TOPCONS hidden Markov model (b).
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13-33 76-96 145-165 228-248 292-312 356-376
(a)
(b)
43-63 98-118 170-190 265-285 314-334 381-401
Figure 7. Topology prediction in ORF49 according to the algorithms SCAMPI-seq,
SCAMPI-msa, PRODIV, PRO, and OCTOPUS (a), and determination of the
consensus prediction for the protein by the TOPCONS hidden Markov model (b).
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Lactococcus lactis strains are essential components of modern industrial starters
and as such their sensitivity to infection by virulent homologous phages calls for the
adoption of adequate measures to protect these cultures and their technological
efficiencies. The combination of Good Manufacturing Practices and rotation of
cultures carrying multiple natural anti-phage defence mechanisms has greatly
improved the reliability and lifespan of industrial lactococcal starters, but the phage
capacity to evolve and circumvent the resistance mechanisms requires the continuous
devise of alternative solutions to counter the phage threat. In recent years, the
sequencing of many phage genomes has provided a better understanding of phage-
host interactions in Lactococcus by revealing insights into the life cycles and adaptive
mechanisms of these viruses, and allowing in some cases the identification and
structural elucidation of the phage components required for specific adsorption to and
penetration of the host cell membrane (Emond and Moineau, 2007, Spinelli et al.,
2006, Tremblay et al., 2006). Much less attention has been reserved for the analysis
of the molecular response of the host to these early steps of phage infection, which
might allow the identification of potential gene targets for the rational design of novel
and sophisticated phage resistance and control strategies.
Chapter II of this thesis attempts to bridge this knowledge gap by providing for
the first time in L. lactis a holistic view of the host genetic reprogramming at the
onset of a lytic phage challenge. It shows that the cell senses the phage presence as a
cell envelope stress and responds in a targeted manner by activating stress membrane
signalling and regulatory elements, collectively redefined as the CesSR stimulon, that
are also stimulated by other membrane stressors (i.e. lysozyme and antimicrobial
peptides) in L. lactis (Martinez et al., 2007, Veiga et al., 2007). Interestingly, a
further link between phage invasion, membrane stress and host response is provided
by a recent study in E. coli showing that clustered, regularly interspaced short
palindromic repeats (CRISPRs)-mediated immunity to foreign invading DNA
requires the presence of the BaeSR two-component system involved in envelope
stress response (Perez-Rodriguez et al., 2011). These findings suggest that the
bacterial systems responsive to cell envelope stress are not merely involved in
maintaining membrane integrity but ultimately committed to the wider role of
preserving cell viability. The transcriptional data of Chapter II also contribute to
describing the putative molecular mechanisms adopted by the cell to restore the PMF
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physiological value, which is usually disrupted following phage infection in both
gram-positive and gram-negative bacteria (Labedan and Letellier, 1981). Finally, this
study creates the premise for the design of novel anti-phage approaches by identifying
the cell-wall TAs modifying dlt operon as a target of further investigations regarding
its putative role in phage resistance. It is certainly open to different interpretations
whether the results of Chapter II are indicative of host intelligence or simply a
metabolic response to the phage threat. In the opinion of the author of this thesis, the
articulation of such a complex strategy, which putatively aims at evading phage
invasion, optimizing energy resources and recovering full fitness, is strongly
indicative of a planned, optimal selection and use of the genetic assets by the host. It
suggests a degree of host intelligence till now undiscovered in the simplest of living
organisms and that could correspond to the same one triggering bacterial evolution
where the strategy that succeeds in providing a competitive advantage becomes a
learnt behaviour.
In order to widen the repertoire of solutions available to combat the phage threat,
researchers have recently searched for novel L. lactis strains or genetic traits from
natural ecological niches and good quality artisanal products. These natural strains are
expected to possess a larger, and mostly plasmid-encoded, genomic diversity
compared to industrial strains and therefore can be exploited to replace, complement
or genetically improve the starter cultures currently used in dairy industry (Cogan et
al., 1997, Delgado and Mayo, 2004, Salama et al., 1995). Chapter III confirms the
value of the approach targeting natural isolates as it shows an intriguing abundance
and diversity of plasmids in a collection of raw milk cheese isolates, as well as a
wealth of genetic traits in the 8-plasmid complement of L. lactis subsp. cremoris
DPC3758 with the potential to improve the technological properties of dairy starters.
By carrying multiple anti-phage systems, food-grade selectable markers and
functional conjugative/mobilization regions, these natural plasmids are a tremendous
addition to the range of genetic tools available to researchers to obtain novel starter
formulations with enhanced robustness and long-term efficiency (Coffey and Ross,
2002, Mills et al., 2006). Chapter III provides the gene knowledge base for their
rational exploitation, and it also reaffirms the major role played by plasmids in
contributing to host fitness and preservation within its ecological niche.
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The plasmid complement is probably the major reservoir of genotypes
specifically linking a strain to a particular niche, and can therefore be used as a sort of
bar-coding system containing traceability markers of the organisms’ origin. Examples
of such plasmid gene markers are those promoting efficient utilization of milk
substrates and a competitive advantage in dairy strains, or those contributing to the
growth on plant cell walls substrates and to a greater tolerance of the numerous
environmental stresses in natural isolates (Mills et al., 2006, Rodionov et al., 2006,
Siezen et al., 2005, Siezen et al., 2008, Teuber et al., 1999). Based on these
considerations, it was very intriguing to find a sort of dairy-natural hybrid plasmid
complement in the raw milk cheese isolate L. lactis subsp. lactis biovar. diacetylactis
DPC3901 (Chapter IV), which includes not only a milk-specialized plasmid, but also
plasmids carrying numerous genotypes novel to Lactococcus and typical of bacteria
associated with the plant ecosystem, as well as rare genes previously exclusive to
plant-derived lactococcal plasmids (Tanous et al., 2007, Tanous et al., 2002). The
presence of these traits in a dairy strain can be reasonably inferred as genetic traces of
a previous plant niche inhabited by the organism where they served a real
colonization advantage. This hypothesis is highly feasible as plant-associated strains
are considered the original source of dairy strains (Salama et al., 1995, Siezen et al.,
2008) and can be theoretically retrieved from raw milk cheeses where the absence of
pasteurization preserves the natural milk microflora. No clear evidence of such an
origin has ever been documented in Lactococcus but the numerous plant gene
markers found in L. lactis DPC3901 plasmids almost certainly suggest a plant origin
for the raw milk cheese isolate and provide for the first time the genetic basis to
support the concept of the plant-milk transition for Lactococcus strains. The
interesting findings of Chapter IV deserve further investigations, such as the
sequencing of the entire genome of L. lactis DPC3901, which might provide the
definitive genetic basis to further support or confute the plant-origin hypothesis.
Following the isolation of novel plasmids carrying traits of technological interest,
improved derivatives of lactococcal starters can be generated by using a food-grade
delivery approach (Coffey and Ross, 2002). However, this process is likely to impose
a burden on regular cell metabolism and may affect the growth characteristics of the
derivative strain (Kobayashi et al., 2002, Lee and Moon, 2003). Chapter V reveals
that the acquisition of pMRC01, a large 60-kb plasmid carrying anti-phage system
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and bacteriocin production genotypes, does not significantly affect the acidification
capacities of lactococcal starters. This finding is very important as implies that
plasmid-improved derivatives of starter cultures can be efficiently used in dairy
industry. The metabolic burden placed by pMRC01 on the host results in lower
growth rate and increased cell permeability and autolysis, which, again, does not
preclude its industrial application. Indeed, strains prone to lysis are particularly
sought and utilized as components of dairy starters due to the early release of
intracellular enzymes that contributes to accelerate cheese ripening and flavour
development (Beresford and Williams, 2004).
Plasmid pMRC01 has been extensively exploited to enhance the phage resistance
of lactococcal strains as it harbours conjugative functions and a potent Abi
mechanism. Despite the plasmid’s complete sequence has been recently obtained, the
Abi genetic determinant(s) are yet to be identified (Coakley et al., 1997, Dougherty et
al., 1998, Mills et al., 2006). In Chapter VI, pMRC01-based microarrays were used to
detect the putative activation of the Abi system, or elements of the system, during the
early and/or late stage of a lytic infection. Results suggest that the functioning of the
Abi system could be subjected to a complex regulatory control by the bivalent Rgg-
like ORF51 and CopG-like ORF58 proteins. These regulators are likely to modulate
the activity of the putative Abi effectors, which might be the constitutive proteins
ORF50 and ORF49 exhibiting topology and functional similarities to the two-
component Rex system that aborts phage λ lytic growth via membrane depolarization
(Parma et al., 1992). Chapter VI does not provide a definitive identification of
pMRC01 Abi system but identifies potential regulators of its activity, which might be
targeted by using a gene knock-out approach in order to finally elucidate the elements
and mechanisms conferring the Abi phenotype to pMRC01-carrying cells.
In addition to phage protection, pMRC01 also confers the host with the ability to
produce a ribosomally-synthesized peptide or bacteriocin named lacticin 3147. This
broad spectrum antimicrobial has proved to be very effective in increasing the safety
of fermented dairy foods (McAuliffe et al., 1999, O'Sullivan et al., 2006, Scannell et
al., 2000b) as well as in contributing to enhance cheese quality and aroma (Fenelon et
al., 1999, Martinez-Cuesta et al., 2006, Ryan et al., 2001). Similarly to lacticin 3147,
many other bacteriocins (i.e. enterocin AS-48, lacticin 481, variacin, and sakacin P)
produced by different LAB hold great potential for bio-preservation and shelf-life
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extension of food products. These antimicrobials have been successfully used for the
selective inhibition of certain food pathogens, without affecting the natural beneficial
microflora, or for wider preservative function (Galvez et al., 2008), and are therefore
the primary candidates for future commercial exploitation in food preservation.
However, the outcomes of most recent research have shown that the effectiveness of
bacteriocins can decrease in response to a number of physicochemical and
microbiological factors related to the particular food matrix (Schillinger et al., 1996),
whereas the combination of bacteriocins with selected hurdles often results in a more
effective form of preservation (Galvez et al., 2008). It is likely therefore that one of
the major directions of future research on food protection will be the exploitation of
bacteriocinogenic cultures or their pure bacteriocins within a hurdle technology
program. In particular, the combination of bacteriocin-activated packaging films and
traditional hurdles holds promise for the extension of shelf-life and improvement of
microbiological safety of food products.
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